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Abstract 
Large-scale insect cell culture utilizing the baculovirus expression vector system (BEVS) 
can be used to produce biopharmaceuticals such as vaccines and therapeutic proteins. 
Biopharmaceutical production processes are generally complex and sensitive to many process 
parameters and changes, but on-line monitoring in this area is relatively limited and the 
fundamental understanding of the intricate relationships between significant process parameters 
and the process outcome, especially on the multi-liter or multi-m
3
 scale, is rarely conclusive. 
Dielectric spectroscopy (DS), which is based on the frequency dependent measurement of the 
passive dielectric properties of materials, was applied to large-scale insect cell cultures infected 
with a baculovirus under low multiplicity of infection conditions to produce a recombinant 
protein of the virus-like particle class. DS not only allowed the qualitative monitoring of the 
infection and recombinant protein production process within the culture in real-time but also the 
detection of important culture events, e.g. the peak in baculovirus production/concentration. 
Additionally, DS seemed to be able to serve as a predictive tool for the overall recombinant 
protein yield early in the process. Partial Least Square models were successfully developed 
allowing monitoring of the cultures progress in terms of cell density, size, and even nutrient 
concentration replacing the need for discrete sampling and therefore reducing contamination 
risks. In summary, DS has been demonstrated to have the potential to increase bioprocess 
understanding and the repeatability of recombinant protein production in the BEVS but 
ultimately also to satisfy the increased requirements for process monitoring as delineated 
recently in the Process Analytical Technology initiative by the Food and Drug Administration. 
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Chapter 1 - Introduction 
1.1 Research Motivation 
The baculovirus expression vector system (BEVS) is widely used for the production of 
recombinant proteins ranging from antibodies over enzymes to virus like particles (VLP)
1
. VLP 
can be used as active agents in vaccines since they are generally immunostimulating but non-
pathogenic in the target host. Biopharmaceutical production processes are generally complex and 
sensitive to many process parameters and changes. On-line monitoring in this area is relatively 
limited and the fundamental understanding of the intricate relationships between significant 
process parameters and the process outcome especially on the multi-liter or multi-m
3
 is rarely 
conclusive. In 2004, the Food and Drug Administration (FDA) introduced the Process Analytical 
Technology (PAT) initiative to tackle this problem
2
. Described as a tool for designing, analyzing, 
and controlling processes through timely measurements of critical parameters to ensure the final 
product quality, it introduced more stringent requirements for bioprocess monitoring and control. 
 
Dielectric spectroscopy (DS), which is based on the frequency dependent measurement of 
the passive dielectric properties of materials, has been suggested as a technique supporting the 
PAT goals
3, 4
. Initial application of DS in bioprocessing was mainly in the brewing industry but 
the technique is emerging as a useful tool in biopharmaceutical research and production for both, 
adherent and suspended cells
5-11
. DS is usually used to monitor the viable cell density on-line but 
could potentially also provide more insight into more intricate properties like the physiological 
state of the cells
5
. The possible use of DS as an on-line tool to gain insight into intricate 
processes of a cell culture infected by a virus and producing a recombinant protein are subject of 
the work presented here. 
 
For the specific case of application of DS in insect cell cultures and the BEVS only a few 
reports can be found in the literature
11-15
. Because of instrument limitations, frequency scanning 
was not applied until recently and only limited use of the obtained spectra was prevalent. Maybe 
most importantly reports of monitoring of infected insect cells generally focused on synchronous 
infections at a high virus to cell ratio (multiplicity of infection, MOI). This is usually not 
preferred in the large scale BEVS processes due to the large amount of costly virus seed 
2 
 
required. The focus on high MOI potentially leads to deviations between laboratory work and 
industrial processes due to the significant impact of small changes in parameters like cell to virus 
ratio or the time of infection
1
. There is also only limited data available that links the obtained DS 
data to the cell’s physiological state, the infection progress, and parameters like the medium 
nutrient limitations. The work presented here attempts to advance the DS technique towards 
monitoring of large-scale cell culture of insect cells under low MOI conditions exploring not 
only the current state of the culture but attempting to predict the success of product formation 
already at an early stage. 
1.2 Research Objective and Hypothesis 
This PhD research project focused on the application of DS in an industrial bioprocess at 
the multi-liter bioreactor scale utilizing the BEVS to produce a recombinant protein of the VLP 
class that serves as the immunostimulating agent in a vaccine. Monitoring the process with the 
DS and connecting the DS data with information gathered by off-line analyses will advance the 
understanding of the processes itself and its potential deviations in the low MOI range. This will 
be accomplished by utilizing a newly developed DS instrument specialized for the use in the 
biopharmaceutical field together with a range of analyses performed off-line to quantify key 
bioprocess parameters. It is anticipated that this will allow the application of DS on-line on a 
routine basis in industrial scale bioprocesses based on the BEVS to not only follow the process 
and detect important events but also identify deviations from the normal and their causes and 
even to supply predictive capability for the success or failure of a given batch cell culture. 
Eventually DS along with the information derived in this work will contribute to satisfy the 
increased requirements for on-line process monitoring as delineated in the PAT initiative by the 
FDA. 
1.2.1 Hypothesis 
The data from dielectric spectroscopy applied on-line to large scale insect cell cultures 
infected with a baculovirus to produce recombinant protein can give real time information on the 
physiological state of the culture, and ultimately can be used to predict future success or failure 
of the intricate culture/infection/protein expression process at low initial multiplicities of 
infection. 
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1.3 Dissertation Outline 
A roadmap to the work presented here and the relation to the hypothesis is given in 
Figure 1.1. The need for a reproducible cell culture system that can then be interrogated via DS 
requires a significant ramp-up. This is reflected in a substantial amount of work that was done 
prior to applying DS to cell cultures to support the hypothesis (above). 
 
 
Figure 1.1. Overall thesis structure and relationship to hypothesis. 
 
Chapter 2 describes the use of the baculovirus expression vector system for the 
production of recombinant proteins and highlights properties, advantages, and challenges. In 
addition it introduces the reader to the concept of virus like particles as an immunostimulating 
agent in vaccines. A short summary of the properties of the porcine circovirus type 2 and its 
associated diseases and impact in the swine producing industry is given. The chapter also 
explains the need for process monitoring and control in biopharmaceutical processes and the new 
emerging concept of process analytical technology as introduced by the Food and Drug 
Administration. Dielectric Spectroscopy is presented as a tool with capabilities supporting the 
PAT initiative and the basic theory of DS is described. Additionally the current applications in 
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the cell culture technology in both research and industry is summarized for both, mammalian and 
insect cell cultures. 
Chapter 3 presents the materials and methods. Methods range from insect cell culture 
initiation and scale up to several off-line analyses performed for bioreactor samples. The 
different types of studies performed at the multi-liter bioreactor scale are also presented 
including preparation and post process decontamination and cleaning. The use and configuration 
of the dielectric spectroscopy instrument and probes is presented. 
 
Chapter 4 shows results obtained from the different dielectric spectroscopy studies 
performed at the multi-liter bioreactor scale. The DS data is related to the off-line methods. 
Based on these results different potential applications of the dielectric spectroscopy in the 
industrial scale routine production of recombinant proteins utilizing the baculovirus expression 
vector system are presented. 
 
Chapter 5 summarizes the major findings and gives an outlook on potential research in 
this field to foster deeper understanding of the dielectric spectroscopy in the BEVS and its 
promising applications in the industry. 
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Chapter 2 - Background 
The large-scale production of biologically potent materials such as vaccines is perhaps 
one of the most challenging frontiers for biochemical engineering. The requirements for 
consistency and purity of the product that is to be injected directly into the tissue or bloodstream 
of a human or animal are exceptional due to the potentially catastrophic outcome should the 
material be of unreliable potency, or should it contain undesirable components. The basic 
concept of a cell culture based vaccine production system that relies on a virus to import the 
genetic information for production of a target particle (recombinant protein in this work) into the 
living insect cell is shown in Figure 2.1. The specific system used in this work will be described 
in detail below. 
 
 
Figure 2.1. Basic concept of recombinant protein production with the BEVS. The genetic 
code for a specific target protein, here PCV2 ORF2, is introduced into the genetic code of a 
recombinant baculovirus. This recombinant baculovirus is then used to infect insect cell 
cultures. Infected insect cells will produce both, new recombinant baculovirus and the 
desired target protein. Following the cell culture process itself are downstream processing 
and eventually formulation to make up e.g. a vaccine. The box confines the cell culture 
based production process itself and is in the focus of this work. 
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This work establishes dielectric spectroscopy (DS) as a powerful tool to monitor a system 
as shown in Figure 2.1 above throughout the process of producing a target protein. This extends 
even to prediction of the final process success at an early stage in the culture. This may have a 
significant impact on process economics since a given culture can be terminated early on without 
expending more resources. The fundamentals of DS are described in detail below. The principle 
of DS is to take advantage of the response of living cells to a rapidly alternating electrical field. 
Both concentration and electrical potentials are maintained by the organism's metabolism across 
the membrane of a living cell. The storage and release of electrical energy depending on the 
frequency of an externally applied field is used in DS to derive information on the system where 
the system can range from suspension of unicellular organisms to an entire human. 
 
2.1 The Baculovirus Expression Vector System for Recombinant Protein 
Production 
The baculovirus expression vector system is nowadays generally considered to be one of 
the most common and widely used systems for the production of recombinant proteins
1, 16, 17
. 
First established in the 1980s
18
 it utilizes a host insect cell line such as Spodoptera frugiperda 
(Sf-9 or Sf-21) or Trichchoplusia ni (BTI-Tn-5B1-4) derived cell lines into which the genetic 
code for the desired recombinant protein is transduced by infection with a recombinant 
baculovirus. Most commonly used baculovirus vectors are based on the Autographa californica 
multiple nucleopolyhedrovirus (AcMNPV), a lytic DNA virus with a double stranded circular 
genome condensed within a rod-shaped nucleocapsid
19
. Foreign genes are usually introduced 
into non-essential baculovirus genes encoding for occlusion body proteins, which are under the 
control of the strong polyhedrin and p10 promoters. This allows a recombinant protein 
expression at levels up to 50 % of the total host cellular protein
1, 16, 20
. 
 
Insect cell cultures are usually grown at 27 to 28 °C at which cells double approximately 
every 24 hours. The optimum pH is reported to be in the range of 6.2 to 6.9 and maintained by a 
phosphate buffer system. The pH is often left uncontrolled in insect cell cultures due to the high 
buffer capacity of the cells
1, 21
. Insect cell culture medium usually contains relatively high levels 
of carbohydrates and free amino acids because of a high tolerance of the cells before switching to 
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a wasteful overflow metabolism and is similar in cost to medium used in mammalian cell culture 
processes. Insect cells seem to be more shear sensitive than mammalian cells and therefore shear 
force protecting agents like Pluronic F68 are often added to the medium
1
. One of the main 
advantages in addition to the potential high target protein yield of insect cell culture based 
bioprocesses is that the innately adherent cell lines could be adapted to suspension culture which 
allows a simplified recombinant protein production at a large scale. Other advantages of insect 
cells include improved posttranslational modifications over bacteria and yeast, a broad range of 
recombinant target proteins to be produced, safety and the relatively ease of handling. Insect 
cells are generally capable of posttranslational modifications like glycosylation, fatty acid 
acetylation, phosphorylation and disulfide bond formation but patterns are not necessarily 
equivalent to those of mammalian cell lines
1, 17, 22
. Thousands of different proteins have been 
expressed with the baculovirus expression vector system ranging from antibodies over enzymes 
to virus like particles that serve as vaccines, and even multi-protein complexes
1
. Overall the 
baculovirus expression vector system is often seen as a good compromise between the fast and 
relatively inexpensive bacterial expression systems which often do not provide acceptable 
protein folding and posttranslational modifications, and mammalian cell culture based processes 
which produce correctly folded and modified proteins but have  relatively low yields and high 
costs
23
. 
 
Main parameters to be considered in the BEVS for large-scale production of recombinant 
proteins are the cell and virus concentration and the physical status of the cell at the time of 
infection. Due to the lytic nature of the baculovirus there is a limited time and number of protein 
molecules each cell can produce before lysis and it is important to optimize infection kinetics to 
ensure sufficient nutrient supply and maximize the yield. The time of infection in a culture is 
therefore a very important parameter to consider
1, 24
. Two different strategies are generally 
applied in the BEVS to produce recombinant proteins. The first is the infection of the culture 
with an amount of virus particles which is enough to infect all cells immediately (synchronous 
infection). While this promotes reproducibility, it requires substantial amounts of virus seed 
stocks because a multiplicity of infection (MOI, the ratio of virus particles to cells) of 5 or higher 
is required to achieve this. A second strategy utilizes an infection at a very low MOI (often 
below 1) and therefore is dependent on subsequent production of new virus particles to 
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completely infect the culture and induce recombinant protein expression in the cells. This 
approach is generally preferred in large-scale industrial processes since it requires significantly 
lower amounts of virus seed. On the other hand, small deviations in characteristics like cell 
density or time of infection may be amplified in such a process causing variability in the process 
outcome. Therefore a good understanding of the process kinetics is desirable to develop efficient 
and robust large-scale production processes
1
. 
 
In this work, the baculovirus expression vector system was used to produce a virus like 
particle resembling the main viral capsid protein of the type 2 porcine circovirus. The porcine 
circovirus is a very small non-enveloped DNA virus with a single stranded circular genome of 
1.7 kb
25, 26
 and belongs to the genus Circovirus in the family Circoviridae
27, 28
. It was first 
observed 1974 as contaminant in a continuous porcine kidney cell line (PK-15) but isolates did 
not affect the health of challenged pigs
26, 29, 30
. In the 1990s a new infectious disease initially 
called postweaning multisystemic wasting syndrome (PMWS) to describe the clinical symptoms 
found in herds was reported in Canada but subsequently detected around the world
25, 31, 32
. The 
disease can be characterized by wasting, paleness of the skin, enlargement of the lymph nodes, 
respiratory distress, occasional diarrhea and icterus
25, 26
 and commonly affects piglets four to 
twelve weeks old. Symptoms usually develop in an affected herd over a period of time
33
 and 
even though PMWS is a low morbidity disease with only 5 to 30 % of the animals in a herd 
showing clinical signs at the same time
34, 35
, it has a high case mortality. In acute outbreaks the 
overall mortality in a herd can be 10 % or higher
36
. Due to this, economical losses are high and 
have a significant impact on pig producers worldwide. Common and essential infectious agent 
identified was the porcine circovirus but analyses revealed significant genetic differences 
between the strain found in herds showing postweaning multisystemic wasting syndrome and the 
strain derived earlier from PK-15 cell cultures. To distinguish between the two the non-
pathogenic is usually referred to as porcine circovirus type 1 (PCV1) while the one associated 
with postweaning multisystemic wasting syndrome is called porcine circovirus type 2 (PCV2)
26, 
29, 37
. Retrospective analyses of samples detected porcine circovirus type 2 as early as 1969
29
 but 
the exact role of the virus in postweaning multisystemic wasting syndrome remains unclear. 
Infection with the virus does not always produce the disease suggesting that other host-
dependent factors or co-infections with other pathogens might be of importance. In addition 
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PCV2 has been linked with a variety of other diseases including porcine dermatitis and 
nephropathy syndrome, porcine respiratory disease complex and others
26, 27
. Because of the 
abundance of symptoms and diseases related to porcine circovirus type 2 and with PMWS only 
representing a fraction of those the term porcine circovirus associated disease (PCVAD) was 
introduced in 2006 to describe any PCV2-associated disease
29
. 
 
The genome of PCV2 contains three major open reading frames (ORFs) which encode 
for different virus proteins. While ORF1 and ORF3 encode for replication-associated and 
apoptotic proteins, respectively, the major viral capsid protein with a size of approximately 
30 kDa is encoded by ORF2 which is the main immunostimulating agent in infected animals
25, 27, 
38, 39
. 
 
This fact was utilized in the development of a BEVS based process for the cell culture 
based production of the ORF2 protein as the immunostimulating antigen in a vaccine against 
PCV2 in swine. The genetic code contained in ORF2 was introduced into an AcMNPV and 
allows expression of the PCV2 ORF2 protein under the strong polyhedrin promoter. Once 
expressed in the cell the ORF2 seems to self-assemble and form virus like particles
38
. In this 
specific case, a specialized suspension insect cell line derived from Sf-9 cells (from now on 
referred to as Sf-9 clone) is used as the biological host to express the protein. 
 
2.2 Process Monitoring and Control 
Monitoring and characterization of bioprocesses is very important and essential in 
developing an understanding of the relationships between process parameters and the process 
outcomes such as a specific product. This is generally required by regulatory agencies for 
validation and documentation
40
.Main parameters monitored in a bioprocess include cell density, 
culture medium conditions (temperature, pH, pO2 or D.O., pCO2.) as well as medium metabolite 
concentrations (carbohydrates, amino acids, waste byproducts) and product concentration and 
quality. But while many processes ideally require a timely and accurate measurement of these 
parameters for the control of e.g. feeding or perfusion rates to accomplish maximum 
productivity
5
, both, the availability of real-time monitoring techniques as well as the fundamental 
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understanding of the relationships between process parameters and process outcome, are limited. 
Small changes in a seemingly innocuous process parameter can have a significant impact on the 
process and even growth rates can often not be predicted from the available knowledge of the 
organism or controlled easily
41
. Improved process monitoring could accelerate process 
development as well as help achieve the efficient and consistent production of high quality 
product
42
. 
2.2.1 Methods of Monitoring 
Currently, key parameters routinely monitored in bioprocess are the temperature, pH, 
dissolved gas (O2 and CO2), cell and virus concentration as well as concentrations of culture 
medium metabolites. Other parameters are concentration of electrolyte and trace minerals, 
conductivity, and viscosity. It is expected that more parameters will emerge in the future as the 
availability of monitoring techniques and process understanding expands
43
. Four different 
categories of bioprocess monitoring are recognized: in-line, on-line, at-line and off-line. For 
both, in-line and on-line, the analysis is performed directly interfaced to the process or within a 
recirculation loop of liquid from the process, respectively, without the need of discrete sampling. 
At-line and off-line both describe an analysis performed on a sample taken from the process. In 
the case of at-line the analysis is performed in close physical proximity to the process itself while 
off-line describes an analysis in a separated location
44
. 
 
The following chapters describe common available methods for cell and biomass 
concentration determination as well as quantification of metabolite and product concentrations. 
 
2.2.1.1 Cell and Biomass Concentration 
The cell or biomass concentration (both viable and non-viable) is generally considered as 
one of, if not the most important parameter in bioprocesses and therefore accurate and real-time 
measurements are highly desired
45
. 
 
Different in-line and on-line methods are currently available to measure cell density and 
cell size distribution in real-time. Most of them are based on optical methods and image analysis 
and can provide additional information about cell morphology but they generally require a well-
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mixed and representative cell suspension for reasonably accurate estimations of the state of a cell 
culture. Examples include different types of in-situ microscopy, focused beam reflectance and 
particle vision measurement
5, 44
. Other examples for optical methods are optical density 
measurements, acoustics, laser light-, Raman-, and fluorescence spectroscopy
44
. Infrared and 
laser turbidity have also been applied for this purpose
5
. A common disadvantage of optical 
sensors is their vulnerability to fouling and changes in culture medium turbidity, light dispersion, 
cell debris or other interferences
5, 44
. The options for the in-line monitoring of immobilized cell 
cultures on micro-carriers or in a fixed bed have been very limited. Today several optical 
methods (light absorbance and/or scattering, real-time imaging) as well as the measurement of 
the culture medium density enable estimates of the cell or biomass concentration under those 
conditions
46
. 
 
A range of commercial analyzers is available for the direct determination of the cell or 
biomass concentration at-line and off-line, e.g. Cedex (Roche Applied Science) or Vi-Cell XR 
(Beckman Coulter) which are based on an automated trypan blue staining and image analysis
47
. 
Disadvantages of at-line or off-line methods are the risk of contamination due to the sampling 
and the delay until availability of the result
44
. Methods including the quantification of DNA
48-50
 
or the use of available data of the dissolved oxygen, glucose or lactate concentration in the 
culture medium have been used to calculate the cell or biomass concentration indirectly
44
. 
 
Another very important parameter related to the cell or biomass concentration is the 
viability as it additionally represents the state of the culture. Estimation of this parameter is 
usually performed utilizing one of the available permeability, functional, reproductive or 
morphological assays
51
. 
 
2.2.1.2 Substrate and Metabolite Concentration 
Concentrations of substrates and metabolites (glucose, glutamine, lactate, glutamate, 
oxygen, carbon dioxide) can be measured using probes, enzymatic kits (photometric) and 
bioanalyzers (electrochemical) or chromatographic methods (HPLC, Ion chromatography). 
Examples for the measurement of glucose concentrations off-line and on-line include 
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potentiometric
52
, flow injection analysis
53, 54
 and fluorescence
55
 based sensors but challenges 
regarding stability, calibration and validation remain
56
. Near and mid infra-red have been used to 
measure glucose, glutamine, glutamate, proline, lactic acid, ammonia, and dissolved carbon 
dioxide in-line of bioprocesses but background interferences complicate analysis
44, 57, 58
. Another 
example is the use of Raman spectroscopy
59
. 
 
Measurements of substrate or metabolite concentrations can be used for an indirect 
estimation of the cell and biomass concentration, e.g. by concluding from the cells oxygen 
uptake rate in perfusion cultures to the viable biomass present
60
. 
 
2.2.1.3 Product Concentration 
A specific protein (as in the work presented here) or molecule may be the desired product 
of a bioprocess. Quantifications are commonly performed off-line by HPLC or ELISA, but in-
line sensors, e.g. based on Raman spectroscopy, also have also been applied, depending on the 
type of the product
59, 61-64
. 
2.3 Process Analytical Technology 
The Process Analytical Technology (PAT) initiative was introduced by the FDA within 
the ―GMP-Initiative for the 21st Century‖ in 2004 and has been supported by authorities around 
the world since then
2, 64
. PAT is usually described as a tool for designing, analyzing, and 
controlling pharmaceutical manufacturing through timely measurements of critical quality and 
performance parameters with the goal of ensuring final product quality. The FDA states that 
―quality cannot be tested into products, it should be built-on or should be by design‖ and 
categorizes the tools to be applied within the PAT framework as 1. multivariate tools for design, 
data acquisition, and analysis, 2. process analyzers, 3. process control tools, 4. continuous 
improvement, and knowledge management tools
2, 65, 66
. Combining these tools is hoped to result 
in a better process understanding and consistent and improved yields, but also minimization of 
waste, prevention of rejects and reprocessing, and overall cost reduction and product real -time 
releases
2
. 
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Bioprocesses are notoriously sensitive to even small changes in sometimes seemingly 
innocuous process parameters because these can lead to significant variations in growth or 
productivity due to sometimes unknown processes or dependencies. Current real-time in-line or 
on-line monitoring is often limited to temperature, pH, and dissolved oxygen with limited ability 
to detect or control those small changes in a culture especially at large scale (multi-liter to multi-
m
3
). With the PAT initiative increased requirements for bioprocess monitoring were 
implemented to improve the understanding and eventually control of bioprocesses
3
. 
 
Several key technologies were suggested by the FDA to support the PAT initiative 
including near infra-red spectroscopy, UV-VIS, NMR, MS, HPLC, fluorescence measurements, 
and imaging technology
2, 57, 64, 66, 67
. In addition to these, DS is considered to be a promising tool 
and has been the focus of recent work
3, 4
. The work presented here extends the use of DS to 
process monitoring and predictive capabilities for virus infected insect cell cultures under low 
MOI conditions. 
 
2.4 Dielectric Spectroscopy as a Tool for Process Analytical Technology 
Bioprocesses are used for the production of specific products ranging from a molecule to 
whole organisms. DS is considered to be a promising tool for the real-time in-line and on-line 
monitoring of such processes. It allows non-invasive and non-destructive continuous monitoring 
of suspension as well as adherent cell cultures
5
. Breweries have been using DS to monitor yeast 
concentration and budding
68, 69
 but the technique has now evolved into applications in the cell 
culture technology. Examples include the application in bacterial, yeast, mammalian, and insect 
cell cultures
5-11
. 
 
While application of DS as a timely and accurate method to determine cell and biomass 
concentration in-line and on-line of bioprocesses within the framework of PAT has already been 
discussed in the literature
5, 45, 57
 it also has potential to allow more detailed insight into the cells 
physiological state. The extension of DS to monitor the progress of a cell culture after infection 
with a virus and perhaps even predictive capabilities towards the target product is the hypothesis 
that is pursued in the work presented here. 
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2.4.1 Basic Theory of Dielectric Spectroscopy 
DS is based on the measurement of the passive dielectric properties of a material or 
system. An alternating electrical field of potentially varying frequency is applied to the material 
placed in between or around two electrodes and the electrical response measured. Materials 
ranging from cement paste over yeast suspensions in breweries and now cell cultures have been 
investigated utilizing DS. The technique is well established to interrogate interfacial 
electrochemical phenomena in corrosion
70
. Even selected tissues or the entire human body can be 
subjected to DS to derive information on body composition etc.
71
. 
 
2.4.1.1 Physical Principle and Applications 
In cell culture technology and bioprocesses the materials investigated by DS are usually 
suspensions or adherent cells in the cell culture medium. The medium is an electrically 
conductive solution or suspension containing low molecular solutes (salts, nutrients), cell debris, 
and virus particles as in the work presented here. Depending on the frequency of the alternating 
electrical field applied, biological material exhibits specific responses in terms of energy storage 
(capacitance) or dissipation (conductance) and the lag in those responses in time (relative to the 
applied signal) can be detected. A simple mechanical analog is a spring which stores energy 
(extension) and releases this energy (contraction) without lag. However, if a dashpot is added, 
say, in parallel to the spring, or in some other configuration, the response to an applied becomes 
much more complex, depending on the dashpot’s properties and the configuration. Responses of 
cell suspensions to DS are usually only constant in a specific frequency range and tend to 
decrease or increase in a series of characteristic steps, called dispersions, for capacitance and 
conductance, respectively, with increasing frequency. Figure 2.2 shows the four observed 
dispersions observed for cell suspensions or biological tissues in regard to the capacitance 
(permittivity). 
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Figure 2.2. Observed dispersions in the permittivity(capacitance) for biological materials 
such as cell suspensions or tissues over a range of frequencies. Different dispersions are 
ascribed to specific phenomena. α: tangential flow of ions across the cell surface, ß: charge 
build-up at the cell membrane, δ: rotation of macromolecular side-chains and bound 
water, γ: dipolar rotation of small molecules. From: 72. 
 
The dispersions are caused by the subsequent loss of specific polarization processes when 
the frequency increases. The α-dispersion is ascribed to tangential flow of ions across the cell 
surface, the ß- dispersion to charge build-up at the cell membranes, the δ-dispersion to the 
rotation of macromolecular side-chains and bound water and the γ-dispersion to the dipolar 
rotation of small molecules like water
72
. 
 
The dielectric properties of cells in suspension are rather complex because they consist of 
layers of materials with significantly different properties
72
. Depending on the cell type, surface 
structures like pili or glycoproteins are present and an electrical double layer is formed between 
the negatively charged cell surface and the surrounding aqueous culture medium that contains 
highly mobile anions and cations from salts etc. The latter is regarded as highly conductive 
mainly due to salts. If a cell wall is present, it adds another layer of complicated porous 
structures with large amounts of polysaccharides integrated which change their properties 
depending on the ion concentration in the surrounding medium. The cells cytoplasm surrounding 
membrane is usually a thin lipid bilayer and has channel-, receptor-, and pump proteins 
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integrated for ion exchange and other functions. In addition, cells maintain an electrical 
membrane potential. Because transport of ions is highly regulated, the cell membrane is usually 
assumed to be essentially non-conductive. The cytoplasm on the other hand is generally regarded 
as highly conductive because it contains various amounts of salts, proteins, nucleic acids and 
other small molecules. In addition, intracellular membranous structures are often present
72
. 
Figure 2.3 shows this schematically. 
 
Changes in the physiological state of a cell will often be reflected in changes of the 
parameters discussed above in some way and therefore also in dielectric properties of cells. DS 
allows determining specific values representing the physiological state, e.g. the membrane 
capacitance Cm, the membrane conductance Gm or the intracellular conductivity ζi. Those values 
are dependent on the folding and permeability of the membrane, and the mobility of the ions 
within the cell’s cytoplasm73-75. 
 
 
Figure 2.3. Schematic representation of a cell suspension in a DS field. The highly 
conductive cytoplasm is surrounded by an essentially non-conductive membrane. The cell 
culture medium surrounding the cell is aqueous and conductive. 
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DS in cell cultures and bioprocesses with the goal of estimating cell or biomass 
concentrations is usually performed in the ß-dispersion range of 0.1 – 10 MHz and is therefore 
causing the build-up of charge differences across the cells essentially non-conducting lipid-based 
cell membrane, and polarization
76
. Suspended cells are basically acting as capacitors within the 
conductive culture medium
9
. Figure 2.4 shows the generally observed decrease in measured 
capacitance with increasing frequency known as ß-dispersion. At low frequencies the 
polarization process is slow and results in a high measured capacitance. With increasing 
frequency the polarization and measured capacitance decreases because less and less ions are 
able to migrate to the cell membrane to build up charge and eventually only the medium 
background capacitance is measured. The shape of the ß-dispersion is dependent on the cell type 
and shape which can be characterized by three characteristic parameters dielectric increment Δε, 
characteristic frequency fc and Cole-Cole α and can be described by the Cole-Cole equation (see 
Equation 1)
77-79. ε∞ describes the background (medium) permittivity measured on the high 
frequency plateau. 
 
Figure 2.4. Schematic drawing of the ß-dispersion observed for biological materials. The 
ß-dispersion can be described with the characteristic parameters dielectric increment Δε, 
characteristic frequency fc, and the Cole-Cole α. From: 12. 
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Equation 1 
 
According to theory, those values are dependent on specific parameters of the cell 
suspension even when the physiological state does not change. The dielectric increment Δε is 
dependent on the volume of the cells and increases with an increasing fraction of cells in a 
suspension. The characteristic frequency fc, defined as the frequency at 50 % of the permittivity 
difference between the low and high frequency plateau, decreases with an increasing cell size 
because of the change in time it takes to polarize the cells. The Cole-Cole α is thought to increase 
with the width of the cell size distribution
77, 78, 80
. These relationships are shown in Figure 2.5 
and Figure 2.6. 
 
 
Figure 2.5. Capacitance ΔC, characteristic frequency fc, and medium background 
capacitance C∞. From: 77. 
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Figure 2.6. Change of the characteristic frequency fc with cell size. From: 5. 
 
It is important to note that the measured capacitance of viable cells with an intact 
membrane in suspension is very high compared to non-viable cells with either a leaky or even 
broken membrane. Cell debris, gas bubbles and other media components essentially do also not 
contribute directly to the DS measurement or can be compensated for by subtracting out the 
background capacitance at the high frequency plateau
6, 7, 46
. This means that it is theoretically 
also possible to use DS for the measurement of cells growing adherently, e.g. on micro-carriers
81
. 
Usually lower capacitance and shifted fc signals are observed for adherent cells compared to 
those in suspension
82, 83
. 
 
2.4.1.2 Mathematical Description 
The treatment of the rather complex biological cell as a simple conductive spherical core 
with a thin shell of a low conductivity membrane lead to the development of several relatively 
simple so called shell models describing the dielectric properties successfully within the radio 
frequency range
72
. Models for single
84
 and multiple
85
 shells as well as ellipsoidal shapes were 
developed
86
. 
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DS as it is applied in cell culture and bioprocesses is based on the measurement of the 
frequency dependent capacitance C in F and conductance G in S of the cell system at hand, 
usually in the frequency range of 0.1 -10 MHz where the ß-dispersion phenomenon can be 
observed. Both macroscopic variables depend on the system measured but also perhaps on the 
probe geometry and interactions at the probe interface with the surrounding medium. Often C 
and G are converted into their probe independent parameters permittivity ε in F m-1 and 
conductivity ζ in S m-1 by using 
 
      Equation 2 
 
      Equation 3 
 
where k in m
-1
 is the electrode constant
72
. Based on the single shell model for 
representation of a cell Schwan found that the dielectric increment Δε or the change therein was 
correlated by  
 
   
        
 
 
Equation 4 
where r is the cell radius in m, P the volume fraction of the cells in the suspension 
measured (dimensionless) and Cm the specific membrane capacitance in F m
-287
. Here P is given 
by 
 
  
 
 
        
Equation 5 
 
where N is the cell density in cells m
-3
 and a spherical cell shape is assumed. This 
predicts a linear correlation of Δε increasing with the volume fraction P and the cell density N. 
This has been widely confirmed and examples are given exemplary in Figure 2.7. 
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Figure 2.7. Linear correlation of Δε with cell density for different types of cells. Here the 
relative permittivity is used. From: 72. 
 
Additionally it was found, that the characteristic frequency fc can be described with  
 
   
 
          
 
  
 
 
    
 
 
Equation 6 
 
where ζi and ζe are the intracellular and medium conductivity in S m
-1
, respectively
87
. 
The medium conductivity can be obtained from the actually measured suspension conductivity 
by using the Bruggeman equation
88
 
 
   
  
        
 Equation 7 
 
The relationships above depend not only on the cell number (concentration/density) or 
size, but also on more intricate parameters like the specific membrane capacitance Cm or the 
intracellular conductivity ζi. These are indicators for the physiological state of a cell. It is 
therefore clear, that DS might be used to theoretically investigate some aspects of the 
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physiological state of a cell but often complex mathematical correlations to compensate for 
extraneous influences on the parameters based on information obtained by off-line sample 
analysis for reference is required akin to a calibration for the cell suspension of interest
9, 12, 46, 77, 
79
. 
 
2.4.2 Applications 
While the focus of this work is the application of DS in industrial bioprocesses and the 
use as a tool for PAT, it should be mentioned, that this technique has been widely applied for 
research on cells outside of the biopharmaceutical production area itself. DS helped to detect the 
existence of the cellular membrane early in the 20
th
 century
89
 but has also been used to describe 
differentiation processes of mesenchymal stem cells
90
 or to assess cell adhesion and 
morphological changes of several other cell lines
82, 91-96
. Cell death due to apoptosis, necrosis or 
induced by cytotoxic agents has also been monitored with DS
97-100
 as well as the inhibitory effect 
of a protein kinase on 3T3 fibroblast cells
101
. Another example is the monitoring of tissue growth 
within a micro-porous polymer scaffold
102
 but detecting and monitoring of infection processes in 
mammalian cells has also been reported
103
. DS has also been proposed for the detection of living 
organisms in extreme organisms such as Martian soil
104
. 
 
The literature gives several examples of the application of DS in biopharmaceutical 
production processes. The focus is generally on the monitoring of cell or biomass concentration, 
and cell death caused by physical or chemical stresses or virus infection but other areas of 
interest may include changes in cell size and morphology or cell metabolism. The 
immobilization process of adherently growing cells is of interest and can be followed with DS. 
Limitations generally occur in cases where the measurement has to be performed within 
specialized geometries such as hollow fiber modules
105
. Examples for both, mammalian and 
insect cell cultures, are presented. 
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2.4.2.1 Mammalian Cell Culture 
Several different mammalian cell lines have been monitored with DS. Many of the 
publications focus on CHO cells in various types of reactors and process modes for both, 
suspension and adherent cells. DS was successful in determining viable cell densities for two 
different suspension cell lines as well as in detecting depletion of specific nutrients, e.g. 
glutamine, in the culture medium of batch and fed-batch processes
106
. In the same work the 
characteristic frequency fc could be correlated to the oxygen uptake rate and so to metabolic 
activity. Later research confirmed the influence of the nutrient concentrations on the intracellular 
conductivity of the cells
73
. Models derived from the capacitance spectra (linear, Cole-Cole, PLS) 
were able to predict cell related parameters like cell density, volume, mean size and oxygen 
uptake rate in batch, fed-batch and perfusion cultures. It was noticed that correlations weakened 
when cells entered the stationary and death phase of their growth cycle, presumably due to 
changes in the physiological state and thereby the dielectric properties of the cells
77, 88
. It was 
possible to correlate the capacitance to the size, their membrane area, and changes in the 
physiological state represented by nucleotide triphosphates or protein content and the glutamine 
consumption rate in a hybridoma suspension cell culture. In addition, the immobilization 
progress for adherent cells could also be followed by monitoring changes in the capacitance. 
Capacitance values for adherent cells were generally much lower than for cells in suspension due 
to a lower specific membrane capacitance Cm
9
. Another example are adherently growing Vero 
cells producing rabies virus
107
. Batch and perfusion cultures exhibited the predicted linear 
relationship between viable cell density during the growth and virus production phase. 
Additionally cell lysis and changes in the specific membrane capacitance Cm and the intracellular 
conductivity ζi could be followed through changes in the characteristic frequency fc. 
 
As stated above, the dielectric properties of cells often change during the stationary and 
death phase. It is often assumed that the cell’s membrane loses its integrity or changes its 
permeability during these phases which decreases the capacitance (or permittivity) signals 
measured. Generally, the capacitance measured overall decreases during cell death due to cell 
lysis but it is unclear how different types of cell death such as apoptosis, or traumatic cell death, 
impact the dielectric properties specifically. In addition to the actual cell death, other events like 
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osmotic or shear stress, virus infection or intercalation of solvents into the membrane could be 
monitored applying DS
74
. 
 
2.4.2.2 Dielectric Spectroscopy of Insect Cell Culture and Relationship to the Work 
Performed Here 
The baculovirus expression vector system is one of the most common and widely used 
systems for the production of recombinant proteins
1, 16, 17
. Nevertheless, research on the 
application of DS in insect cell cultures is relatively scarce. 
 
In 1999 capacitance measurements of both, uninfected and baculovirus infected insect 
cells, here Spodoptera frugiperda Sf-9, was apparently reported for the first time
11
. Experiments 
were performed in a 3.5 L (total volume) bioreactor and it was found that measurements 
correlated well with the viable biovolume of uninfected cells and after synchronous infection 
(MOI 10). Cell size changes accounted for most of the increase seen in the permittivity post 
infection. Temporary cell size leveling approximately 18 – 24 hours post infection could also be 
detected with the measurements as well as the onset of cell lysis. The highest product 
concentration (ß-galactosidase) corresponded to an accelerated decrease in permittivity late in 
the death phase. 
 
The same research group extended their research on DS in insect cell cultures by 
monitoring high cell density fed-batch cultures up to 5.2 x 10
7
 cells ml
-1
 for uninfected and 
1.7 x 10
7
 cells ml
-1
 for infected cultures
13
. The focus of this research was the evaluation of 
different feeding strategies to enhance cell growth and productivity and the usefulness of DS 
under those conditions was confirmed. In addition, the CO2 evolution rate as one physiological 
parameter during growth and infection was correlated to DS measurements of Sf-9 and High-5 
cells
15
. The peak in CO2 evolution coincided with a plateau in the DS signal and the release of 
virus particles into the medium. The peak was delayed approximately 40 h for low MOI infection 
of 0.001 compared to infection at an MOI of 10. It was suggested, that DS could be used as a 
tool to detect the time of harvest. 
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The work cited above performed DS measurements only at one fixed frequency. More 
sophisticated DS at multiple frequencies has been reported more recently. One study compared 
the frequency-dependent permittivity signal to different off-line biovolume measurements for Sf-
9 cells infected at a MOI of 10 in a 1.2 L bioreactor culture
12
. It was found that correlations for 
biovolume measurements obtained by Vi-CELL XR and CASY 1 correlated well throughout the 
whole infected culture (MOI 10). In addition, changes in the characteristic frequency fc could be 
explained with a concurrently changing cell diameter, but it was proposed that cell membrane 
properties also had an influence on this parameter. A second study applied DS in a large scale 
(40 L) production process for recombinant adeno-associated vectors (rAAV) and three different 
baculoviruses (total MOI 3)
14
. It was possible to optimize the process by determination of the 
optimum time of harvest in real-time by detecting a specific second maximum in the permittivity 
signal at the time of the maximum product yield. 
 
Summarized, literature reporting the application of DS in insect cell cultures and the 
BEVS is very limited with only five publications available. Synchronous infections at a high 
MOI were the main focus of the early research in 1999 and 2000 with only one publication 
reporting the application of DS using a low MOI (MOI 0.001). Generally, important parameters 
such as time of infection and cell density at infection changed significantly from experiment to 
experiment. Variations in these parameters can have a significant effect on the BEVS process 
and it was therefore difficult to compare the results presented in a ―normalized‖ way. 
Additionally, due to instrument limitations, measurements were generally only performed at a 
single fixed frequency and information gathered was therefore limited. More recent research 
performed in 2007 applied DS measurements at multiple frequencies, the so-called frequency 
scanning, but again focused on high MOI infections. Obtained DS spectra were used for a 
qualitative assessment of the process progress, but no attempt was made to use the data for 
modeling or even yield prediction. Except in one report, all experiments were performed at a 
relatively small scale (working volumes of less than 3.5 L). 
 
The work presented here attempts to advance the DS technique towards monitoring of 
large-scale cell culture of insect cells and the BEVS under low MOI conditions exploring not 
only the current state of the culture but attempting to predict the success of product formation 
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already at an early stage. A standardized approach in terms of cell state, age, and density at the 
time of infection was taken to reduce the number of unidentified factors potentially affecting the 
process. A range of off-line analyses was performed to relate the DS data with culture progress 
and state. The high number of experiments performed additionally allowed an evaluation of the 
robustness of DS and the instrument used in this work, something of high importance for the 
potential application in industrial-scale routine production. 
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Chapter 3 - Materials and Methods 
3.1 Materials 
3.1.1 Cell lines and Recombinant Baculovirus 
Suspension Spodoptera frugiperda (Sf-9 clone) insect cells were used as the biological 
host for the recombinant protein production with the BEVS in this work. A recombinant 
baculovirus carrying the gene for the PCV2 ORF2 target protein was used to infect the cells and 
trigger recombinant protein production. Adherent Spodoptera frugiperda Sf-9 insect cells were 
used in the end-point dilution assay for the quantification of recombinant baculovirus in culture 
samples. Both cell lines and the recombinant baculovirus were kindly provided by Boehringer 
Ingelheim Vetmedica, St. Joseph, MO. 
 
3.1.2 Culture Medium, Antibiotics and Supplements 
Sf-9 clone spinner flask cultures for cell scale-up as well as bioreactor cultures were 
cultivated in EX-CELL 420 (serum-free, with L-glutamine, SAFC Biosciences, Lenexa, KS). A 
sterile 200 mM L-glutamine solution (in saline, suitable for cell culture, SAFC Biosciences, 
Lenexa, KS) was used in the supplementation experiments. Dimethyl sulfoxide (sterile-filtered, 
biotechnology performance certified, Sigma-Aldrich, St. Louis, MO) was used as additional 
cryo-protectant in the preparation of the working cell bank. Sf-9 cultures were also maintained in 
EX-CELL 420 medium but supplemented with 5 vol-% of fetal bovine serum (Sigma-Aldrich, 
St. Louis, MO) and gentamicin sulfate as antibiotic (sterile-filtered, endotoxin- and hybridoma-
tested, Sigma-Aldrich, St. Louis, MO). 
 
3.1.3 Bioreactor and Associated Instrumentation 
Experiments in this work were carried out in two BioClave 20 L stirred tank reactors 
(Applikon Biotechnology, Foster City, CA). Each bioreactor was equipped with two upwards 
directed pitched-blade impellers (3 blades, 45°). A set of ADI 1030 BioController and ADI 1035 
BioConsole was used to control temperature, agitation, and dissolved oxygen while pH was 
monitored but not controlled. Dissolved oxygen was measured using polarographic OxyProbe 
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sensors (Broadley James, Irvine, CA) and pH was measured with a FermProbe gel electrode 
(Broadley James, Irvine, CA). Dissolved oxygen was controlled by aeration of the culture with 
air or oxygen using an L-shaped sparger located under the lower impeller. Dielectric 
spectroscopy was performed in-line of the bioreactors with the iBiomass 465 instrument 
(FOGALE nanotech, Nimes, France). 
 
3.1.4 Chemicals, Reagents and Antibodies 
Several chemicals were used in the preparation of ELISA buffers. They included sodium 
carbonate (Na2CO3, ACS grade), sodium bicarbonate (NaHCO3, ACS grade), dibasic sodium 
phosphate (Na2HPO4, ultrapure) (all Sigma-Aldrich, St. Louis, MO), sodium chloride (NaCl, 
ACS grade), monobasic potassium phosphate (KH2HPO4, ACS grade), and potassium chloride 
(KCl, UPS grade) (all J.T. Baker, Phillipsburg, NJ). Tween 20 (cell culture tested, Sigma-
Aldrich, St. Louis, MO), 10 N hydrochloric acid (NF grade) and non-fat dry milk (Best Choice, 
Kansas City, KS) were also used for this purpose. Deionized water was used to make up these 
buffers (Boehringer Ingelheim Vetmedica, St. Joseph, MO). A TMB microwell peroxidase 
substrate system (KPL, Gaithersburg, MD) and normal rabbit serum (Jackson ImmunoResearch, 
West Grove, PA) were additional reagents used in this assay. Methanol (biotech grade, 99.93 %) 
and acetone (histological grade, ≥ 99.5 %) were used as a fixative in the end-point dilution assay 
for recombinant baculovirus quantification. Sigmacote (silicone solution in heptane) was used to 
siliconize spinner flasks to reduce cell attachment (all Sigma-Aldrich, St. Louis, MO). Phosphate 
buffered saline (powder, pH 7.4, biotechnology performance certified, Sigma-Aldrich, St. Louis, 
MO or liquid, pH 7.4, Invitrogen, Carlsbad, CA) and bovine serum albumin (≥ 98%, lyophilized 
powder, Sigma-Aldrich, St. Louis, MO) were additionally used in this work for various purposes. 
 
Several different antibodies were used in this work. A single anti-baculovirus envelope 
gp64 protein phycoerythrin-labeled antibody (eBioscience, San Diego, CA) was used in the 
quantification of the fraction of infected cells. An anti-baculovirus envelope gp64 protein 
antibody (eBioscience, San Diego, CA) together with a fluorescein-labeled goat anti-mouse IgG 
(H+L) antibody (KPL, Gaithersburg, MD) was used in the end-point dilution assay for 
recombinant baculovirus quantification. Three different antibodies were used in the ELISA assay 
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for the quantification of recombinant PCV2 ORF2 protein. Here a swine anti-PCV2 ORF2 
polyclonal antibody was used as a capture antibody while a monoclonal antibody against 
PCV2 ORF2 served as a detection antibody (both provided by Boehringer Ingelheim Vetmedica, 
St. Joseph, MO). A goat anti-mouse IgG (H+L) antibody conjugated with horseradish peroxidase 
(Jackson ImmunoResearch, West Grove, PA) was also used. 
 
3.2 Creation of Sf-9 Clone Cell Working Cell Bank 
Bioprocesses for the production of recombinant proteins are generally dependent on 
biological factors, e.g. the quality of the cells used, but it is often difficult to obtain a good 
measure of what this so-called quality really is and by what it is affected. Often cell productivity 
changes over the lifetime and passaging of a culture and therefore their use is generally limited 
within a specific passage range in the industrial biopharmaceutical production, e.g. 20 to 50 post 
initiation of a new working stock culture the master cell bank. To minimize the effects of 
variations in the biological system used in this work, it was decided to prepare a new Sf-9 clone 
cell working cell bank and to initiate and scale-up a new culture for each bioreactor-scale 
experiment. This prevents significant deviations in the passage number of cells used for the 
bioreactor experiments and ensures a consistent biological system as good as possible. 
 
For this, a total of approximately 5 L of Spodoptera frugiperda Sf-9 clone cell culture 
(passage 31) was dispensed into multiple sterile 250 ml centrifuge beakers and centrifuged at 
200 g and 4 °C for 5 minutes Avanti J-25I, Beckman Instruments, Palo Alto, CA). The 
supernatant was discarded and approximately 5 ml of cold EX-CELL 420 medium was added to 
each beaker. The cells in each beaker were resuspended and collected in a sterile Erlenmeyer 
flask. Cold EX-CELL 420 medium and dimethyl sulfoxide (final concentration approximately 
9 vol-%) were added to dilute the cells further and as a cryo-protectant, respectively. The cell 
suspension was then dispensed into pre-chilled (4 °C) 2 ml vials at a fill volume of 1.5 ml. 
Subsequently the vials with the cell suspension were gradually cooled down by holding them at -
20 °C and -70 °C for approximately 3 and 39 hours, respectively, before placing them into long 
term storage tanks under liquid nitrogen. The final viable cell density was determined to be 
4.56 x 10
7
 cells ml
-1
. 
30 
 
3.3 Sf-9 Clone Cell Initiation and Scale-Up 
For each Sf-9 clone cell initiation two vials of the Sf-9 clone cell working cell bank were 
retrieved from the liquid nitrogen storage tank and thawed at room temperature. Once the content 
of the vials was thawed it was mixed by pipetting up and down once and then added to a 250 ml 
spinner flask with approximately 75 ml of pre-warmed (27 °C) EX-CELL 420 medium and 
incubated in a walk-in incubator on a stirrer plate (passage 32). Incubation conditions for this 
initial and all subsequent Sf-9 clone cell spinner flask cultures during scale-up were 27 ± 2°C 
and 100 RPM (P2005, Bellco Biotechnology, Vineland, NJ) with all caps loosened to allow gas 
exchange. After four days of initial incubation, the cell culture was sampled and a cell count 
performed. Based on the results of the cell count the cell culture was then adjusted to a working 
volume of approximately 150 ml at a viable cell density of approximately 1.00 x 10
6
 cells ml
-1
 
by, if required, removal of old cell suspension and addition of fresh pre-warmed (27 °C) 
EX-CELL 420 medium. This and every subsequent culture during scale-up was then incubated 
for three days (passage 33) before the sampling and passaging procedure was repeated. Scale-up 
was done through subsequent passaging into a 1000 ml spinner flask at a target working volume 
of 350 ml (passage 34), a 3000 ml low-profile spinner flask at a target working volume of 
1000 ml (passage 35), and eventually three 3000 ml low-profile spinner flasks at a target 
working volume of 1000 ml (passage 36). Target planting viable cell density in each case was 
1.00 x 10
6
 cells ml
-1
. The last three spinner flasks cultures were incubated for another three days 
before usually used for bioreactor-scale experiments. In rare occasions the cultures had to be 
passaged one more time (passage 37), before they were used due to unforeseen delays but it was 
assumed that this did not affect the bioreactor-scale experiment significantly. Figure 3.1 
schematically shows the cell initiation and scale-up process. Spinner flasks used were siliconized 
after each third use to reduce cell attachment to the glass walls. 
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Figure 3.1. Schematic of Sf-9 clone cell initiation and scale-up. Cells were passaged every 
three days (with the exception of the initial 75 ml culture which was passaged after four 
days). Two of the last three 1000 ml cultures were then used for planting of 7.5 L working 
volume bioreactor precultures. 
 
3.4 Bioreactor Experiments 
All experiments performed in this work were conducted in bioreactors to ensure a 
consistent, monitored and, most importantly, controlled environment for the cell cultures 
ensuring, e.g. a sufficient oxygen supply. Two autoclavable BioClave 20 L stainless steel 
bioreactors (15 L working volume, see Figure 3.2) were used in this work. The vessels were 
monitored and controlled by a set of Applikon ADI 1030 BioController and ADI 1035 
BioConsole, respectively. The bioreactors dimensions and their configuration are shown in Table 
3.1. 
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Figure 3.2. Applikon BioClave 20 L bioreactors with ADI 1030 BioController and 
ADI 1035 BioConsole. The red circle indicates location of the DS pre-amplifier and probe. 
 
Table 3.1. Bioreactor dimensions and controller set-points. 
 Applikon BioClave20 
Type Stirred tank reactor 
Total Volume in L 20 
Working Volume in L 15 
Overall Height H in mm 715 
Internal Diameter D in mm 210 
H/D Total Volume 3 
H/D Working Volume 2.1 
Impeller Type Pitched-blade, 3 x 45°, upward 
Number of Impellers 2 
Impeller Diameter d in mm 100 
D/d 2.1 
  
Temperature in °C 27 ± 2 °C 
Agitation in RPM 100 
Dissolved Oxygen in % 40 
pH Monitored 
Sparger type L-sparger below lowest impeller 
Aeration in SLPM 0.1 Air + 1.0 O2 
Aeration in vvm 0.07 
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Details on each study and experiment are given below. Because all experiments were 
conducted at a working volume of approximately 15 L and therefore required a relatively large 
amount of Sf-9 clone cells, an additional cell expansion step had to be included after cell scale up 
in spinner flasks. This was accomplished by allowing another cell growth step directly in the 
20 L bioreactors at a working volume of approximately 7.5 L. When the required cell density 
was reached this so called preculture was then simply back diluted with fresh medium to meet 
the 15 L working volume scale for any subsequent experiment. The additional cell growth in the 
controlled environment of the bioreactor also served as an additional quality control phase for the 
uninfected cells. 
 
3.4.1 Bioreactor Preparation 
Before each bioreactor experiment, the pH-, dissolved oxygen-, and dielectric 
spectroscopy probes were visually inspected for any damage and replaced if necessary. 
Additionally the electrolyte for the dissolved oxygen probe was replaced and the probe polarized 
for at least 6 hours before calibration was performed. Probe calibrations or functionality checks 
were performed with pH buffer 4.01 and 7.00 (Thermo Fisher Scientific, Beverly, MA) and pure 
nitrogen and air, respectively. The dielectric spectroscopy pre-amplifier and probe was checked 
with the iBiomass simulator and internal procedures by the software. Once checks and 
calibrations had been performed satisfactorily, the three probes were installed into the vessel. 
Every addition port of the vessel was equipped with an appropriate quick-connect and 0.2 µm 
filter. The quick-connects themselves were wrapped in blue autoclave paper and aluminum foil. 
The vessel’s vent ports were also quipped with 0.2 µm filters. The sampling line was equipped 
with a Luer-lock connector and bagged in an autoclave bag. For sterilization, approximately 
75 ml of deionized water was added to the 20 L bioreactor to support steam production inside the 
vessel during autoclaving. The bioreactor was then autoclaved at 122.5 °C for 30 minutes, 
usually the day before starting the scheduled experiment (91422 ARB2, Getinge, Rochester, 
NY). Once the autoclave cycle was completed, the vessel was removed from the autoclave and 
allowed to cool down to approximately room temperature before reconnecting the probes to the 
controller and iBiomass pre-amplifier and instrument, respectively. Approximately 6.5 L of 
EX-CELL 420 was then added aseptically to the vessel and the vessel temperature and agitation 
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controls set to their respective set points (see Table 3.1) and allowed to stabilize over-night. 
Additionally air sparging was set to a low level and started to allow oxygen saturation for 
subsequent D.O. probe calibration the next day. Specific procedures undertaken for the dielectric 
spectroscopy probes are described below in Chapter 3.5. 
 
3.4.2 Precultures for Cell Expansion 
The main purpose of the precultures was further cell expansion after the spinner flask 
scale for support of the experiments performed at 15 L working volume. Several off-line 
analyses were performed to evaluate and quantify the Sf-9 clone cell growth process and its 
metabolic behavior under the given conditions. Dielectric spectroscopy was utilized to monitor 
the growth process in-line and in real-time and to establish correlations with the viable 
biovolume and cell density taking into account process and probe variations. Combining both 
eventually allowed a deeper insight into the physiological state of the cells. 
 
Once bioreactor preparation as described above was completed, a medium sample was 
taken from the bioreactor for pH offset and the medium dissolved oxygen concentration control 
was started. The preculture was planted at a cell target concentration of 0.50 x 10
6
 
viable cells ml
-1
 (at the final working volume of 7.5 L) with Sf-9 clone cells from a scale up 
spinner flask culture. The working volume of the culture was adjusted to approximately 7.5 L by 
addition of EX-CELL 420 medium immediately post planting. The cells were then grown for 
approximately two days until the culture achieved a viable cell density of approximately 
2.00 x 10
6
 viable cells ml
-1
. Samples for off-line analyses were taken from the bioreactor 
approximately every 24 hours starting immediately post planting. 
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A total of 13 precultures were grown in order to support subsequent experiments at the 
15 L working volume scale. At the end of each preculture specific characteristic parameters were 
calculated to obtain a measurement of the quality of these cells, including the specific growth 
rate µ in h
-1
, the cell doubling time tD in h and metabolite utilization rates qi in mmol cell
-1
 s
-1
. 
Equation 8 to Equation 10 show how these parameters were obtained. 
 
  
         
     
 
Equation 8 
 
   
   
 
 
Equation 9 
 
   
 
 
     
         
 
 Equation 10 
 
with viable cell density X in cells ml
-1
, process time t in h, and nutrient/metabolite 
concentration c in mmol L
-1
. 
 
3.4.3 Infection at Low MOI 
The Infection at Low MOI study focused on investigating the differences between and 
deviations within the recombinant PCV2 ORF2 protein production process in the range of 
MOI 0.01 to 1.00 and was performed in the 20 L bioreactor at a working volume of 
approximately 15 L. Industrial scale bioprocesses based on the BEVS system usually are 
operated in this range of MOI to reduce the amount of costly virus seed required. On the 
downside, small MOI and/or variations in viable cell density are easily amplified in such 
situations, potentially leading to undesirable process variations
1
. For this study three replicates at 
each MOI were performed with all other parameters (bioreactor and biological) kept constant to 
assure comparable results. Sf-9 clone cells grown in the precultures described above in 
Chapter 3.4.2 were utilized in these experiments. Experiment order was randomized to reduce 
potential bias of undetected factors affecting the experiments. One additional culture with no 
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addition of virus seed was performed to serve as an uninfected control. Table 3.2 gives an 
overview of the experiments performed in this study. 
 
Table 3.2. Overview of performed low MOI experiments and utilized precultures. 
Preculture # Used for Low MOI Experiment # 
1 MOI 0.10 #1 
2 MOI 0.01 #1 
3 MOI 1.00 #1 
4 MOI 0.10 #2 
5 MOI 1.00 #2 
6 MOI 0.01 #2 
8 MOI 0.01 #3 
9 MOI 0.10 #3 
10 MOI 1.00 #3 
11 Uninfected Control 
 
Once the preculture had grown to a viable cell density of approximately 2.00 x 10
6
 viable 
cells ml
-1
 EX-CELL 420 medium was added to back-dilute the culture to a target viable cell 
density of 1.00 x 10
6
 viable cells ml
-1
 at a target working volume of approximately 15 L. 
Medium addition was done in steps to avoid lowering the culture temperature below 25 °C. For 
infection of the culture the recombinant PCV2 ORF2 baculovirus seed was removed from the -
70 °C storage, thawed in a water bath at 27 °C (Precision, Winchester, VA) and added to the 
culture together with approximately 150 ml of pre-warmed EX-CELL 420 medium. The seed 
volume required for infection at the specific target multiplicity of infection was calculated 
accordingly to the procedures in our lab using Equation 11. Predetermined seed titer was 
8.1 ± 0.5 log10 TCID50 ml
-1
. TCID50 stands for 50 % Tissue Culture Infective Dose and 
describes the concentration of virus particles that infects 50 % of the inoculated cultures. It is 
known to the author that this underestimates the ―real MOI‖ slightly compared to a MOI 
calculation based on plaque forming units (pfu). Nevertheless, with the pre-established error of 
the TCID50-based virus quantification method of ± 0.5 log10 TCID50 ml
-1
 the difference is not 
significant. Where applicable this is indicated. 
 
                       
                      
          
 
Equation 11 
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Samples for off-line analyses were taken from the bioreactor approximately every 
24 hours starting immediately post infection until the harvest criterion (cell viability ≤ 10 %) was 
achieved, usually after approximately 168 to 216 hours post infection (day 7 to 9 post infection), 
depending on the multiplicity of infection. Bioreactor decontamination and cleaning was then 
performed as described below in Chapter 3.4.5. 
3.4.4 Medium Supplementation for Uninfected Sf-9 Clone Cell Growth 
During the bioreactor cultures performed in the low MOI study described above it was 
observed, that one of the main metabolites, namely L-glutamine, was rapidly depleted in the 
culture medium in both, uninfected an infected cultures. Since the depletion happenend relatively 
early in the cultures, usually after 48 to 72 hours, this could have had a significant negative 
impact on the respective cultures in terms of cell growth or recombinant PCV2 ORF2 
baculovirus and protein production. Spent medium analysis of samples from additional unrelated 
experiments confirmed this observation and provided even more insight into possible metabolite 
limitations (data not shown). Interestingly, DS signals also exhibited specific behaviors around 
the time of L-glutamine depletion in the culture medium as described below in Chapter 4.2. 
Based on these observations an additional set of medium supplementation experiments for 
uninfected Sf-9 clone cells were designed to address and investigate this issue. 
 
This study consisting of a total of two bioreactor experiments was performed in the 20 L 
bioreactors at a working volume of approximately 15 L. Sf-9 clone cells grown in the precultures 
described above in Chapter 3.4.2 were utilized in these experiments. Once the preculture had 
grown to a viable cell density of approximately 2.00 x 10
6
 viable cells ml
-1
 EX-CELL 420 
medium was added to back-dilute the culture to a target viable cell density of 
1.00 x 10
6
 viable cells ml
-1
 at a target working volume of approximately 15 L. Medium addition 
was done in steps to avoid dropping the culture temperature below 25 °C.  
 
One of the two performed cultures was a replicate of the uninfected control culture from 
the low MOI study described in Chapter 3.4.3, while the second culture was fed multiple times 
with a 200 mM L-glutamine solution during the experiment in order to prevent depletion. This 
culture was supplemented every time the L-glutamine concentration in the media had dropped 
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below approximately 2.0 mmol L
-1
 and L-glutamine levels were brought back up to 
approximately 6.0 mmol L
-1
. It was taken care not to exceed this level to avoid any other 
potential side effects on the cells metabolism. Samples for off-line analyses were taken from the 
cultures at an increased frequency (approximately every 8 h) starting from approximately 24 h 
into the process to obtain more information about changes in the culture during the observed 
L-glutamine depletion. Both cultures were contaminated late in the process during the stationary 
phase of the growth cycle and were therefore terminated. Because insect cells are usually 
passaged or infected during the exponential phase of the growth cycle, this did not compromise 
the usefulness of the obtained data and information. Bioreactor decontamination and cleaning 
was then performed as described below in Chapter 3.4.5. 
 
3.4.5 Bioreactor Decontamination and Cleaning 
Once the respective bioreactor experiment had been finished, the cell culture broth was 
harvested into a sterile carboy and decontaminated using a sodium hypochlorite solution. For 
bioreactor decontamination, approximately 5 L of deionized water were then added to the 20 L 
bioreactor and the vessel autoclaved as described earlier. Following cool down to approximately 
room temperature, the vessel was drained and all filters removed from any tubing and addition 
ports. Subsequent cleaning in place (CIP) was performed by refilling the vessel with 
approximately 19 L of deionized water with 0.5 % of a potassium hydroxide based cleaning in 
place solution. The vessel was heated up to 50 °C and held at this temperature for a minimum of 
3 hours. The vessel was then allowed to cool-down to room temperature, usually over-night, 
drained and rinsed three times with deionized water to remove any chemical residuals. All 
probes were then removed and stored according to the instructions. 
 
3.5 Dielectric Spectroscopy 
Dielectric spectroscopy was performed with the iBiomass 465 instrument (FOGALE 
nanotech, Nimes, France). Measurements were made directly in-line of the bioreactors with 
sterilizable probes connected to a pre-amplifier and eventually one of four channels of the 
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instrument. These probes have two pairs of electrodes at their tip. Figure 3.3 shows the pre-
amplifier and probe as well as the electrode configuration at the probe’s tip. 
 
 
Figure 3.3. FOGALE nanotech iBiomass 465 pre-amplifier and probes. The two electrode 
pairs for applying the alternating electrical field and measuring resulting response are 
shown. Modified from: 108. 
 
One electrode pair was used to apply an alternating electrical field to the culture medium 
surrounding the probe’s tip while the second pair was used to measure the response. The 
instrument principally functions as a capacitance and conductance meter by utilizing a bridge 
circuit with a variable reference capacitor and resistor. These measurements were performed at a 
total of 17 frequencies evenly distributed over a log-scale between 300 to 10000 kHz, the so-
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called frequency scan. In addition to the raw capacitance measurements at these frequencies, 
further proprietary processing and modeling within the instrument’s software also provided the 
user with the three characteristic ß-dispersion parameters dielectric increment Δε, characteristic 
frequency fc and Cole-Cole α. The so-called Biomass signal based on the dual-frequency method 
and the low-frequency conductivity of the culture were provided also. The Biomass signal is 
often used for viable biovolume estimation because due to the nature of its measurement it is 
believed to be independent, or at least less influenced, by changes in viable cell radius. In other 
words, whereas Δε would exhibit significant differences in two measurements of the same 
volume fraction of viable cells P with two different cell sizes r, the Biomass signal would give 
the same absolute value. This behavior is presented schematically in Figure 3.4. Both, the 
dielectric increment Δε as well as the Biomass signal were given by the instrument as 
permittivities rather than capacitances. 
 
 
Figure 3.4. Effect of cell size on ß-dispersion at constant viable biovolume. Measurement in 
the fc region (Biomass signal, FOGALE frequencies) ensures cell-size independent 
estimations of the viable biovolume. From: 108. 
 
Measurements with the instrument could be performed in up to four channels 
simultaneously. Before installation of the dielectric spectroscopy probes into the bioreactor and 
use during an experiment the performance of the pre-amplifier and the probe itself was verified 
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with the simulator tip and internal procedures. The simulator tip basically simulates a sensor 
measurement and the instrument verifies the functionality based on the obtained measurements. 
Once vessel sterilization, cool-down and initial medium addition was accomplished, two manual 
cleaning cycles were applied to the probe. The cleaning consists of applying proprietary 
predefined voltages to the probe. After medium temperature and signal stabilization the Biomass 
signal and frequency scan measurements were zeroed to adjust for the medium background. Data 
recording was started immediately before planting of the cultures into the bioreactors and set to 
an acquisition time of 30 minutes. For the dual-frequency Biomass measurement the ―Animal 
Cell Culture‖ mode (1000 kHz measurement frequency, 10000 kHz background frequency, 
signal integration ―high‖ (5 minutes)) was chosen to ensure a measurement at a frequency 
slightly higher than the fc observed for the cells in preliminary experiments to obtain a signal 
independent of the cell radius. At the time of harvest the recording was stopped and the data 
retrieved from the instruments storage for subsequent analysis. Once decontamination and 
cleaning of the vessel had been performed as described earlier in 3.4.5 the dielectric 
spectroscopy probes were stored dry capped in the provided holder. 
3.6 Quantification of Medium Nutrient and Metabolite Concentrations 
The YSI 2700 Select Biochemistry Analyzer (YSI, Yellow Springs, Ohio) was utilized to 
quantify culture medium concentrations of four major insect cell culture metabolites, namely 
D-glucose, L-glutamine, L-lactate and L-glutamate. The sensor principle is based upon 
membrane-immobilized oxidase enzymes coupled with an electrochemical probe and is shown in 
Figure 3.5. 
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Figure 3.5. Sensor principle of the YSI 2700 Select Biochemistry Analyzer. The substrate 
(or analyte) diffuses through the first polycarbonate membrane and is oxidized by an 
immobilized oxidase. The produced H2O2 diffuses through a cellulose acetate membrane 
and is oxidized at the platinum anode of the sensor. The resulting electron flow is linearly 
proportional to the analyte concentration. From: 109. 
The probe’s face is covered with a three-layer membrane containing the immobilized 
oxidase and is exposed to the buffer-filled sample chamber
109
. Each analyte requires a specific 
oxidase enzyme and so membrane. Once the sample is injected into the sample chamber the 
analyte diffuses through the first polycarbonate membrane and is rapidly oxidized according to 
the reactions shown below. As a result, H2O2 is produced. 
 
            
               
                                      
Equation 12 
 
            
               
                          
Equation 13 
 
              
                 
                                        
Equation 14 
 
To determine the amount of L-glutamine in a sample, two enzymes are co-immobilized in 
one membrane. 
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Equation 15 
  
              
                 
                                        
Equation 16 
 
The produced H2O2 subsequently diffuses through a cellulose acetate membrane and is 
oxidized at the platinum anode of the probe. The cellulose acetate membrane serves as a barrier 
for other chemical compounds with a molecular weight above approximately 200 g mol
-1
 
potentially interfering with the oxidation and contributing to the sensor current. This reaction 
produces an electron flow, which is linearly proportional to the steady state H2O2 concentration, 
and thus the analyte concentration in the sample, in absence of mass transfer limitations. 
 
    
              
                      
  Equation 17 
 
Analytes were quantified in pairs in two dual-channel instruments equipped for either 
D-glucose and L-lactate or L-glutamine and L-glutamate analysis. This allowed the simultaneous 
measurement of the latter two in cell culture samples containing both analytes by subtraction of 
the quantified ―free L-glutamate‖ from the ―total L-glutamate‖ detected on the L-glutamine 
channel (see reactions above). 
 
                                                   Equation 18 
 
The instrument performance was verified before each analysis with provided standards of 
known analyte concentration. In case performance was outside of established ranges the 
membrane on the affected channel was replaced. The analysis with the YSI 2700 Select 
Biochemistry Analyzer has an accuracy of ± 5 % of the measured concentration
109
. 
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3.7 Quantification of Viable Cell Density, Cell Viability and Mean Cell 
Diameter 
The Vi-CELL XR analyzer (Beckman Coulter, Brea, CA) was utilized to determine total 
and viable cell density, cell viability and mean total and viable cell diameter of a Sf-9 clone cell 
culture sample. This instrument performs an automated analysis based on the trypan blue dye 
exclusion method and utilizes video imaging of a flow through cell. Trypan blue is usually 
incapable of entering a viable cell through the cell membrane because of its high molecular 
weight (961 g mol
-1) and negative charge and viable cells therefore appear ―unstained‖ on the 
flow through cell images. Cells with a damaged membrane however will take up the dye and 
therefore appear ―stained‖. However, it should be noted that the trypan blue exclusion method 
tends to overestimate cell viability
110, 110
. Differences of 20 to 30 % cell viability compared to 
other methods have been reported
111, 112
. For analysis with the Vi-CELL XR analyzer 
approximately 1 ml of well-mixed cell culture sample was dispensed into a sample cup, the 
sample information entered into the software and the analysis started. The instrument 
automatically mixed the sample with the trypan blue dye and analyzed 50 images taken of the 
flow through cell in order to obtain the parameters mentioned above. Two different instrument 
settings, called ―cell type‖, were used for analysis. Cell culture samples with cell viabilities 
above approximately 50 % were analyzed with the standard Sf-9 clone setting. Because these 
settings did not yield reliable results for samples with cell viabilities below approximately 50 % 
and a lot of cell debris, a second ―Sf-9 clone low viability‖ setting was used in these cases. But 
while this setting allowed a better estimation of cell density and viability, as determined by 
visual inspection of the obtained flow cell images, mean total and viable cell diameters were 
usually estimated significantly higher than before. The analysis with the Vi-CELL XR 
instrument has an accuracy of ± 10 % of the measured cell density Table 3.3 gives an overview 
of the used analyzer settings. 
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Table 3.3 Vi-CELL XR “cell type” settings used in this work. “Sf-9 clone” settings were 
used for uninfected cells and until day 5 post infection. Afterwards “Sf-9 clone low 
viability” was used. 
 
 
3.8 Quantification of Fraction of Infected Cells by Flow Cytometry 
To follow the infection process in the cultures post infection a flow cytometric technique 
was utilized in this work. A monoclonal antibody against the baculovirus envelope protein gp64 
labeled with the fluorochrome phycoerythrin (excitation 488 nm, emission 575 nm) allowed the 
direct identification of infected cells within a sample using an EPICS XL flow cytometer 
(Beckman Coulter, Miami, FL). The gp64 protein is essential for virus infectivity and spread in a 
culture and is expressed on the surface of infected insect cells as early as 6 h post infection
113-115
. 
 
Daily routine decontamination and cleaning procedures of the Beckman Coulter 
EPICS XL flow cytometer were performed before and after each set of samples. Twice filtered 
(0.2 µm) 3 % sodium hypochlorite solution was run (300 s) once through the instrument 
followed by three times twice filtered (0.2µm) deionized water. When a large number of events 
(> 50) was detected during any of the runs, this procedure was repeated. Additionally vacuum 
line maintenance was performed at the end of each analysis with twice filtered (0.2µm) 
deionized water. The performance of the instrument was verified daily by using Flow Check 
fluorospheres after the initial decontamination and cleaning procedure. 5000 events were 
collected and acceptance limits were > 90 % of events in the forward and side scatter box, 
> 99 % of events in each channel gate and a coefficient of variance < 2 % in each channel. 
Sf-9 clone Sf-9 clone low viability
Minimum cell diameter 8 µm 5 µm
Maximum cell diameter 30 µm 40 µm
Minimum circularity 0.3 0.3
Dilution factor 1 1
Cell brightness 70 % 80 %
Cell sharpness 150 150
Viable cell spot brightness 40 % 70 %
Viable cell spot area 30 % 20 %
Decluster degree High Low
Aspirate cycles 1 1
Trypan blue mixing cycles 2 2
Cell type setting
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For sample preparation, the culture volume equivalent to a total number of 1.00 x 10
6
 
viable cells was dispensed into each of two centrifuge tubes and centrifuged at 500 g and 4 °C 
for 5 minutes (Labnet Z 382K, Hermle, Wehingen, Germany). Subsequently, the supernatant was 
discarded. The sample was washed twice by resuspension of the pellet in 500 µl of cold (4 °C) 
phosphate buffered saline (pH 7.4) with 0.2 % of bovine serum albumin (to reduce unspecific 
binding) followed by centrifugation as described above. One of the samples was then 
resuspended in 100 µl of a labeled anti-baculovirus envelope gp64 protein solution. Monoclonal 
antibody (0.125 µg per sample) was used as recommended by the manufacturer and confirmed 
by titration experiments
116
. The remaining sample was resuspended in 100 µl of cold (4 °C) 
phosphate buffered saline (pH 7.4) with 0.2 % of bovine serum albumin to serve as a negative 
control. The samples were then incubated in the dark at 4 °C for 30 minutes. Following the 
incubation the samples were centrifuged as described above and the supernatant discarded. The 
samples were then washed twice in PBS as described above and subsequently resuspended in 
1 ml of cold (4 °C) phosphate buffered saline (pH 7.4) with 0.2 % of bovine serum albumin for 
analysis on Channel 2 (575 nm) of the EPICS XL flow cytometer. The FL2 fluorescence of the 
negative control sample was used as a cut-off with events having a higher fluorescence being 
defined as phycoerythrin-stained and therefore baculovirus infected. Events (30000) were 
collected for each sample and results were reported as percentage below and above the set cut-
off (software EXPO 32 ADC, Applied Cytometry Systems, Sheffield, UK). Only viable cells as 
determined by forward and side scatter discrimination were considered because dead cells tend 
to bind antibodies unspecifically
117
. Table 3.4 shows important instrument settings for this 
analysis. These settings allowed inclusion of the whole cell population post infection despite 
significant differences in cell size and granularity. 
 
Table 3.4. EPICS-XL settings for the fluorescence channels used in this work. 
Channel Volts Gain 
FS 20 1.00 
SS 625 2.00 
FL2 (PE) 567 1.00 
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3.9 Quantification of Recombinant PCV2 ORF2 Baculovirus by Titration 
An antibody-based end-point dilution assay was used to quantify the recombinant PCV2 
ORF2 baculovirus concentration in bioreactor experiment samples. Stock cultures of adherent 
Sf-9 cells were routinely passaged in tissue culture flasks to provide the cells needed for the 
actual titrations performed in 96-well plates. Both procedures are described below. Per scheduled 
assay day, 22 samples plus 2 accompanying reference samples were analyzed. 
 
Sf-9 Cell Stock Cultures 
Tissue culture flasks with a viable Spodoptera frugiperda Sf-9 cell sheet of seven days of 
age were selected and examined visually under the microscope (CK2, Olympus, Melville, NY) 
for cell confluence and adherence. If determined to be acceptable, the old growth media was 
discarded and the cells dislodged by aspirating and dispensing approximately 10 ml of 
EX-CELL 420 medium with 5 % fetal bovine serum against the cell sheet. If cells remained 
attached another 10 ml of EX-CELL 420 medium with 5 % fetal bovine serum was added to the 
tissue culture flask and the cells dislodged by gently tapping the side of the tissue culture flask. 
Cell suspensions from both dislodging steps and multiple tissue culture flasks were pooled into a 
sterile container, mixed and a cell count performed using the Vi-CELL XR analyzer as described 
above. New tissue culture flasks (175 cm
2
, BD Falcon, Franklin Lakes, NY) were planted at a 
viable cell density of 1.00 x 10
7
 cells per flask in 100 ml of EX-CELL 420 medium with 5 % 
fetal bovine serum and 50 µg ml
-1
 gentamicin sulfate. The cells were incubated at 27 ± 2 °C in a 
humidified incubator (Nuaire, Plymouth, MN)for seven days before this procedure was repeated. 
 
Planting of 96-Well Tissue Culture Plates 
The 96-well plates (flat bottom, BD Falcon, Franklin Lakes, NY) for the titration assay 
were planted one to four hours before actual initiation of the titrations. The number of plates 
planted depended on the number of assays scheduled. Firstly the same steps as described above 
for the Sf-9 cell stock cultures were performed. Using the determined viable cell count a cell 
suspension with a viable cell density of 5.00 x 10
5
 cells ml
-1
 was prepared in EX-CELL 420 
medium with 50 µg ml
-1
 gentamicin sulfate. The 96-well plates were then planted with 0.1 ml of 
this cell suspension per well and incubated in a humidified incubator at 27 ± 2 °C for up to four 
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hours. This resulted in a 30 – 50 % confluent cell sheet at the time of the titration initiation 
described below. 
 
Titration and Inoculation of 96-Well Tissue Culture Plates 
The samples to be analyzed were retrieved from the -70 °C freezer and thawed at room 
temperature. In the meantime, so-called 96-deep well dilution blocks were prepared by adding 
1350 µl of EX-CELL 420 medium with 50 µg ml
-1
 gentamicin sulfate to each well. 150 µl of 
each sample and a baculovirus concentration reference was then pipetted into the designated 
wells in row A of the dilution blocks. Using a multi-channel pipette a ten-fold dilution series was 
prepared by transferring 150 µl from the wells in row A to row B and so forth down to row H. 
Before each transfer, the contents of each well were mixed by pipetting up and down for five 
times. Pipette tips were changed after each transfer. Once this was accomplished, the 96-well 
tissue culture plates planted earlier were removed from the incubator and inoculated with 0.1 ml 
of the prepared dilutions. Overall one 96-well tissue culture plate was used per sample with ten 
replicate wells (columns 2 to 11) per dilution. Columns 1 and 12 were used as negative controls 
and inoculated with 0.1 ml of EX-CELL 420 medium with 50 µg ml
-1
 gentamicin sulfate. The 
baculovirus concentration reference was run on one separate plate per assay day. The plates were 
then covered with the lid provided and incubated in a humidified incubator at 27 ± 2 °C for six 
days. 
 
Fixing and Staining 
At the end of the six-day incubation, the inoculated 96-well tissue culture plates were 
removed from the incubator and the media of each well discarded. 100 µl of cold 50:50 
methanol/acetone solution was then added to each well and incubated at room temperature for 
10 ± 2 minutes to fix the plates. Subsequently, 50 µl of 1:300 diluted anti-baculovirus envelope 
gp64 protein was added to each well, the plates covered with the accompanying lid and 
incubated in a humidified incubator at 37 ± 2 °C for 50 minutes. At the end of the incubation, the 
plates were removed from the incubator and the antibody solution discarded from each well. 
Each well was then washed with 100 µl of room temperature phosphate buffered saline twice. 
After this 50 µl of the 1:100 diluted fluorescein labeled goat anti-mouse IgG (H + L) antibody 
was added to each well. The plates were covered again and incubated in a humidified incubator 
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at 37 ± 2 °C for 50 minutes. At the end of the incubation, the plates were removed from the 
incubator and the antibody solution discarded from each well. Each well was washed with 100 µl 
of phosphate buffered saline and the liquid discarded. As a last step 50 µl of phosphate buffered 
saline was added to each well, the plates were covered with the lid, wrapped in aluminum foil, 
and transferred to the fluorescent microscope for reading and interpretation. 
 
Reading and Interpretation of Titrations 
Utilizing the fluorescent microscope (Eclipse TE2000U, Nikon Instruments, Melville, 
NY), wells of the 96-well tissue culture plates were observed for positive fluorescence. A well 
was scored positive when immunofluorescent positive cells due to baculovirus were observed in 
any area of the well. The number of positive wells over the ten wells inoculated per dilution was 
recorded. The Reed-Muench 50 % end-point formula was used to calculate the baculovirus 
concentration as log10 TCID50 ml
-1
. For a valid test, two criteria had to be met. Firstly, the 
negative control wells on each 96-well tissue culture plate (columns 1 and 12) showed no 
positive fluorescence typical of baculovirus. Secondly, the reference titer fell within ± 0.5 
log10 TCID50 ml
-1
 of the established average titer for this specific reference. Both criteria were 
met for all performed titrations. Previously established error for this method exhibited is ± 0.5 
log10 TCID50 ml
-1
. 
 
3.10 Quantification of Recombinant PCV2 ORF2 Protein by ELISA 
An indirect-sandwich enzyme-linked immunosorbent assay was utilized to quantify the 
recombinant PCV2 ORF2 protein concentration in bioreactor experiment samples. 
Concentrations were reported as relative potency (RP) to a reference sample with a known (but 
confidential) PCV2 ORF2 protein concentration as calculated by the software RelPot 4.0. Per 
scheduled assay day, 10 samples were analyzed. For buffer compositions, see Appendix A - . 
 
As a first step, the swine anti-PCV2 ORF2 polyclonal antibody (capture antibody) was 
diluted 1:6000 in carbonate coating buffer and 100 µl of this solution was added to all wells of a 
96-well plate (Microlon 600, Greiner Bio-One, Montroe, NC). Up to five plates were coated at a 
time to allow analysis of up to ten samples. The plates were then sealed and stacked. The stack 
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was capped with an empty 96-well plate and incubated at 37 ± 2 °C for 17 to 24 hours, usually 
overnight. 
 
After the initial incubation, all plates were washed three times with 250 µl of washing 
buffer per well utilizing an automated plate washer (ELX 405, BioTek Instruments, Winooski, 
VT). After the last wash, the plates were inverted and tapped onto a paper towel to remove 
residual liquid. 250 µl of blocking solution were then added to each well, the plates sealed and 
incubated at 37 ± 2 °C for 1 hour ± 5 minutes. The plates were not stacked during this or any 
subsequent incubation. 
 
The frozen sample vials as well as the reference and a negative control were retrieved 
from the -70- °C freezer and thawed at room temperature. Separate 96-deep well sample dilution 
plates (polypropylene, Nunc, Roskile, Denkmark) were prepared by addition of 200 µl of diluent 
solution to each well except for columns 1 to 3 in row H and all of row A. The samples, 
references, and controls were diluted 1:30 in diluent solution in separate test tubes and 300 µl of 
this dilution added to the corresponding wells in row A of the previously prepared dilution 
plates. Using a multichannel pipette the contents of row A were then mixed by pipetting up and 
down for five times before 100 µl were transferred to row B. This was continued down to row G 
with changing pipette tips after each transfer. 
 
Following the incubation with the blocking solution step, the plates were washed again as 
described above. Starting at row H 100 µl of each well were then transferred from the prepared 
dilution plates to the corresponding well on the actual 96-well test plates. Pipette tips were 
changed after the first liquid transfer (row H) but the same set of pipette tips were used for all 
subsequent transfers up to row A. Prior to each transfer the contents of each well on the dilution 
plates were mixed by pipetting up and down for three times. The plates were sealed and 
incubated at 37 ± 2 °C for 1 hour ± 5 minutes. 
 
This incubation was followed by another washing step as described above. 100 µl of a 
1:300 dilution of the monoclonal antibody to PCV2 ORF2 (detection antibody) in diluent 
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solution were then added to each well. The plates were sealed and incubated at 37 ± 2 °C for 
1 hour ± 5 minutes. 
 
Following the incubation, the plates were then washed again as described above. 100 µl 
of a 1:10000 dilution of the goat anti-mouse (H+L)-HRP (conjugate antibody) in conjugate 
solution (1 % normal rabbit serum in diluent solution) were added to each well. The plates were 
sealed and incubated at 37 ± 2 °C for 45 ± 5 minutes. 
 
This incubation was followed by another final washing step as described above. Equal 
volumes of the two components (3,3’,5,5’-tetramethylbenzidine and H202) of a microwell 
peroxidase substrate system were mixed immediately prior to use and 100µl of this solution was 
added to each well. The plates were incubated at room temperature for 15 minutes ± 15 seconds. 
The reaction was stopped by addition of 100 µl of a 1 M HCl solution to each well. Subsequently 
the absorption of each well at 450 nm was read with an automated ELISA plate reader 
(WaveX 340, BioTek Instruments, Winooski, VT). For a valid test, three criteria had to be met. 
Firstly, the absorbance of the positive control (wells C1, C2, and C3) had to be ≥ 0.838. 
Secondly, the average absorbance of the negative control (wells H1, H2, and H3) had to be 
≤ 0.200. Thirdly, the analysis with the software RelPot 4.0 (USDA, APHIS) had to result in valid 
co-parallel lines or a valid reported RP value. All three criteria were met for all performed 
analysis. 
 
3.11 Error and Reproducibility Considerations 
Analytical techniques and methods used in the field of cell culture technology have 
considerable variability or errors associated with them. Methods and instruments used in this 
work for example included an automated cell density analyzer (Vi-CELL XR) and a membrane-
based electrochemical biochemistry analyzer for medium component quantification 
(YSI Select 2700), as well as a bioassay for the quantification of a recombinant baculovirus (end-
point dilution assay) or an immunosorbent assay (ELISA) for the quantification of a recombinant 
target protein. Errors of 10 % or higher (e.g. error of ± 0.5 log10 TCID50 ml
-1
for virus 
quantification) are commonly seen with these methods or instruments and are accepted in the 
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field of cell culture technology. While this alone often already poses a significant challenge for 
data interpretation, sample preparation adds another layer of potential variability in addition to 
the assay error. Small variations or delays in the processing of a discrete sample taken from a 
bioreactor can for example change the obtained results significantly, e.g. for cell viability. While 
every effort was made in this work to reduce the variability in sample preparation, the reader 
should be aware that the overall random error generally will exceed the specified 
instrument/assay error. This becomes especially important for cases where specific parameters 
were calculated based on multiple error-associated values, e.g. the specific recombinant protein 
productivity per viable cell. Error propagation was used to capture the impact of multiple error-
prone parameters on a final result as comprehensively as possible. 
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Chapter 4 - Results and Discussion 
4.1 Precultures for Cell Expansion 
The main purpose of the precultures was further cell expansion after the spinner flask 
scale for support of the experiments performed at 15 L working volume. Several off-line 
analyses were performed to evaluate and quantify the Sf-9 clone cell growth process and its 
metabolic behavior under the given conditions. Dielectric spectroscopy was utilized to monitor 
the growth process in-line and in real-time and to establish correlations with the viable 
biovolume and cell density taking into account process and probe variations. Combining both 
eventually allowed a deeper insight into the physiological state of the cells. 
 
As described in Chapter 3.4.2 the 20 L bioreactors were inoculated with a viable cell 
density of approximately 0.50 x 10
6
 cells ml
-1
 at a working volume of 7.5 L. Culture conditions 
were controlled at 27.0 °C, 100 rpm and 40 % dissolved oxygen concentration. The cells were 
allowed to grow for two days with sampling for off-line analyses approximately every 24 hours. 
A total of 13 of cultures was performed. Since the cells grown in these cultures were to be used 
in subsequent experiments they were not allowed to reach the stationary phase in their cell 
growth cycle to avoid potential detrimental effects on those experiments. Raw data collected is 
presented in Appendix B - . 
 
4.1.1 Cell Culture Parameters 
Most of the cultures showed a slightly lower initial planting viable cell density than 
targeted which is probably due to a systematic error in the initial medium addition process, 
despite the use of a scale to verify the amount of medium added to the vessel. Initial viable cell 
densities ranged from 0.33 to 0.50 x 10
6
 cells ml
-1
. Nevertheless, the initial viable cell density 
proved to be very consistent within the 13 precultures and resulted in immediate cell growth 
without any major lag phase, as shown in Figure 4.1. At the end of the two-day cell growth phase 
all precultures had reached a viable cell density of approximately 2.00 x 10
6
 cells ml
-1
 and were 
therefore ready for back dilution and use for subsequent experiments. Additionally, all 13 
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cultures showed viabilities well above 90 % during this two-day cell growth phase (data not 
shown). 
 
 
Figure 4.1. Viable cell density post planting in the 13 precultures. Cells started growing 
without apparent lag-phase immediately post planting and reached a viable cell density of 
approximately 2.00 x 10
6
 cells ml
-1
 after two days of growth. Trendline is intended to guide 
the eye only. 
 
Based on the data for all 13 precultures the average specific growth rate µ and the cell 
doubling time tD were calculated with Equation 8 and Equation 9. The specific growth rate µ was 
estimated to be 0.031 ± 0.002 h
-1
, while the cell doubling time tD was 22.2 ± 1.4 h. These values 
are in accordance with literature available for Sf-9 insect cell cultures, reporting ranges for µ and 
tD of about 0.029 to 0.035 h
-1
 and 20 to 24 h, respectively
118-120
. 
 
Figure 4.2  gives an overview over the mean viable cell diameters profiles for all 13 
precultures. Initial viable cell diameters ranged from 17.00 to 18.66 µm with values stabilizing 
between 17.83 and 18.53 µm at the end of the two-day growth phase. No major changes over 
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time or differences between precultures were observed. This, together with the cell viability 
values, also indicated consistent precultures suitable for the subsequent experiments. 
 
 
Figure 4.2. Mean viable cell diameter post planting in the 13 precultures. Mean viable cell 
diameters were around 18.00 µm but no major change was observed during the two-day 
growth phase and. Trendline is intended to guide the eye only. 
 
Reported literature values for the mean cell diameter of uninfected Spodoptera 
frugiperda insect cells are generally slightly lower than values found in this work and range from 
approximately 12 to 15 µm
13, 15, 120
. These values were mostly obtained for a different cell clone, 
Sf-9, and they were also obtained with a Coulter Counter, which is based on a different (electric) 
analysis principle. It is possible that the Sf-9 clone cell clone used in this work is either simply 
slightly larger in terms of diameter or the different analysis principle of the Coulter Counter 
produced systematically lower values and ―underestimates‖ the cell diameter compared to the 
Vi-CELL XR analysis and the specific image analysis settings used in this work. In addition, 
generally the total mean viable cell diameter is reported in the literature, which takes into 
account viable and dead cells. In this work only the mean viable cell diameter was used and 
reported. It is known to the author that dead cells usually have a slightly smaller cell diameter 
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than viable cells if analyzed with the Vi-CELL XR analyzer. Therefore, the mean total cell 
diameter will usually be lower than the mean viable cell diameter of the same sample but in this 
work the difference was less than 2 % for the case of uninfected Sf-9 clone cells and therefore 
this is probably not the main contributor to the difference observed. 
 
The pH was left uncontrolled during the precultures but it was monitored with an in-line 
probe directly immersed into the cell culture broth. Initial pH values ranged from 6.39 to 6.55 
but generally dropped slightly to 6.21 to 6.39 at the end of the two-day growth phase (see Figure 
4.3). The pH is often left uncontrolled in insect cell cultures because these cells are supposed to 
have a very high buffer capacity themselves
21
. Additionally the EX-CELL 420 medium used in 
this work has a 8.4 mM phosphate buffer system integrated to help keeping the pH in acceptable 
range
121
. The optimum pH range for insect cell cultures is reported to be about 6.2 to 6.9
1
 which 
covers the values observed in this work. 
 
 
Figure 4.3. Culture medium pH post planting in the 13 pre-cultures. Initial pH values 
ranged from approximately 6.4 to 6.5 and decreased slightly to approximately 6.3 during 
the two-day growth phase. Trendline is intended to guide the eye only. 
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The medium concentrations of the four metabolites D-glucose, L-glutamine, L-lactate 
and L-glutamate were measured off-line in whole cell culture broth samples with the YSI 2700 
Select Biochemistry Analyzer. These analyses are prone to an error of 5 % as specified by the 
instrument manufacturer
109
. 
 
Initial medium D-glucose concentrations ranged from 31.42 to 33.86 mmol L
-1
 and 
continuously fell to 28.70 to 31.19 mmol L
-1
 during the two-day growth phase, as can be seen in 
Figure 4.4. The uninfected Sf-9 clone cells used D-glucose during their growth phase but the 
measured decrease this nutrient’s medium concentration was barely significant. 
 
 
Figure 4.4. Medium D-glucose concentration post planting in the 13 pre-cultures. Initial 
D-glucose concentrations were approximately 32.0 mmol L
-1
 and decreased to 
approximately 30.00 mmol L
-1
 during the two-day growth phase. Trendline is intended to 
guide the eye only. 
 
The specific D-glucose utilization rate qGlc was estimated to be 
(-1.38 ±0.29) x 10
-14
 mmol cell
-1
 s
-1
, which is comparable to Sf-9 cell data available in the 
literature where a value of -2.4 x 10
-14
 mmol cell
-1
 s
-1
 is reported
120
. 
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A more significant decrease in medium concentration due to utilization by the uninfected 
Sf-9 clone cells could be observed for L-glutamine. Figure 4.5 shows that initial concentrations 
of this nutrient ranged from 4.05 to 5.83 mmol L
-1
 and continuously decreased to 1.41 to 
3.51 mmol L
-1
 during the two-day growth phase. The significantly lower medium L-glutamine 
concentrations for pre-cultures #11 to #13 can be explained by the fact, that these experiments 
were performed with EX-CELL 420 medium, which had been stored longer before usage. Since 
L-glutamine is instable in a liquid environment, even at 4 °C, it had degraded over the prolonged 
storage time. 
 
 
Figure 4.5. Medium L-glutamine concentration post planting in the 13 pre-cultures. Initial 
L-glutamine concentrations were usually above 5.00 mmol L
-1
 and decreased to 
approximately 2.00 to 3.51 mmol L
-1
. Precultures #11 and 12 showed slightly lower 
L-glutamine concentrations because of older medium used. Trendline is intended to guide 
the eye only. 
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The specific L-glutamine utilization rate qGlc was estimated to be 
(-1.39 ± 0.29) x 10
-14
 mmol cell
-1
 s
-1
, which is comparable to Sf-9 cell data available in the 
literature where values slightly above -1.0 x 10
-14
 mmol cell
-1
 s
-1
 are reported
120, 122
. 
 
In contrast to the first two medium components measured, the two metabolites L-lactate 
and L-glutamate continuously built up as byproducts in the culture medium during the two-day 
growth phase of the pre-cultures. Figure 4.6 gives an overview of the medium L-lactate 
concentration for the 13 pre-cultures. Initial medium L-lactate concentrations ranged from 0.98 
to 1.14 mmol L
-1
 and continuously increased to 1.55 to 2.39 mmol L
-1
 over the course of the two-
day growth phase.  
 
 
Figure 4.6. Medium L-lactate concentration post planting in the 13 pre-cultures. Initial 
L-lactate concentrations were slightly above 1.00 mmol L
-1
 and increased continuously 
during the two-day growth phase to approximately 2.00 mmol L
-1
. Trendline is intended to 
guide the eye only. 
 
The specific L-lactate production rate qLac was estimated to be 
(4.25 ± 0.81) x 10
-15
 mmol cell
-1
 s
-1
. Literature states that L-lactate is generally toxic for insect 
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cell cultures at higher levels but usually does not accumulate during exponential growth of 
Spodoptera frugiperda cells when oxygen limitation is not an issue
120, 123, 124
. This seems to be in 
contrast to the findings of this work but the production rate and the concentrations reached in this 
work are very low and well below any toxic level, respectively. 
 
The same trend could be observed for L-glutamate and is shown in Figure 4.7. Initial 
medium concentrations of this metabolite ranged from 6.64 to 7.46 mmol L
-1
 and continuously 
increased to 8.10 to 8.71 mmol L
-1
 during the two-day growth phase. 
 
 
Figure 4.7. Medium L-glutamate concentration post planting in the 13 pre-cultures. Initial 
concentrations were approximately 7.00 mmol L
-1
 and increased continuously during the 
two-day growth phase to approximately 8.50 mmol L
-1
. Trendline is intended to guide the 
eye only. 
 
The specific L-glutamate production rate qGlu was estimated to be 
(7.13 ± 1.98) x 10
-15
 mmol cell
-1
 s
-1
. Interestingly, available literature usually states that 
L-glutamate is a nutrient rather than a metabolite for Spodoptera frugiperda cell cultures and 
therefore is consumed by the cells at a rate of 1.94 x 10
-15
 mmol cell
-1
 s
-1
 rather than produced. 
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On the other hand L-glutamate can be produced if a carbon source, e.g. D-glucose, and ammonia 
are present in excess
122
, which may be the case here. 
 
Table 4.1 summarizes the findings for the uninfected Sf-9 clone cell growth in the two-
day precultures and values found in the literature. See Appendix C -  for the complete data set. 
 
Table 4.1. Summary of the measured cell culture parameters for uninfected Sf-9 clone cell 
growth in precultures. Given are mean values ± one standard deviation. 
 Estimated Literature Reference 
µ in h
-1 
0.031 ± 0.002 0.029 to 0.035 118-120 
tD in h 22.2 ± 1.4 20 to 24 118-120 
qGlc in mmol cell
-1
 s
-1 
(-1.38 ± 0.29) x 10
-14
 -2.4 x 10
-14
 120 
qGln in mmol cell
-1
 s
-1
 (-1.39 ± 0.29) x 10
-14
 -1.0 x 10
-14
 120, 122 
qLac in mmol cell
-1
 s
-1
 (4.25 ± 0.81) x 10
-15
 No accumulation 120, 123, 124 
qGlu in mmol cell
-1
 s
-1
 (7.13 ± 1.98) x 10
-15
 -1.94 x 10
-15
 122 
 
4.1.2 Dielectric Spectroscopy 
Dielectric spectroscopy was performed with the FOGALE iBiomass 465 instrument 
during the two-day preculture growth phase. These measurements yielded the raw capacitance 
values at 17 frequencies in the range of 300 to 10000 kHz and the three model derived 
ß-dispersion parameters dielectric increment Δε, characteristic frequency fc and Cole-Cole α. 
Additionally the Biomass signal based on a dual frequency measurement and the suspension 
conductivity were obtained. Data was recorded every 30 minutes. Observed major deviations in 
the data could usually be attributed to technical problems. 
 
Initial values for the dielectric increment Δε, obtained after a short stabilization phase due 
to suspension mixing and temperature adjustments, ranged from 2.21 to 4.06 pF cm
-1. Δε then 
immediately and continuously increased nearly exponentially until the end of the two-day growth 
phase, as shown in Figure 4.8. Final values for Δε ranged from 10.92 to 22.35 pF cm-1. It has to 
be noted, that the Δε profile for preculture #9 temporarily deviated from the near exponential 
profile evolution and exhibited more or less constant values for extended periods of time. The 
signal could usually be recovered for limited time after applying a cleaning cycle but this 
improvement was generally not permanent and had to be repeated multiple times until the end of 
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the two-day growth phase. The reason for this behavior is unknown, but an unknown technical 
issue is believed to be the cause for this. 
 
 
Figure 4.8. Dielectric increment Δε post planting in the 13 precultures. Initial values of Δε 
were approximately 3.0 pF cm
-1
 and increased continuously during the two-day growth 
phase to a range from approximately 11.0 to 22.0 pF cm
-1
.  
 
Δε is directly related to the volume fraction of viable cells P (viable biovolume) as 
described in Equation 4 and Equation 5 assuming a spherical cell shape. The general profile of 
Δε can therefore be attributed to the observed cell growth and therefore increase in biovolume 
post planting as described earlier. The data here also supports the assumption made earlier that 
the cultures exhibited only a minor lag phase of a few hours maximum before actually starting to 
grow exponentially. 
 
According to Equation 4 additional parameters possibly affecting Δε are the cell radius r 
and the specific cell membrane capacitance Cm. As shown in Figure 4.2 the mean viable cell 
diameter did only change very slightly during the preculture growth phase and therefore 
probably did not affect Δε much. Cm was not measured directly in this study but can be 
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calculated based on Equation 4 using the viable cell density and size obtained by off-line 
measurements for each sample. Cm profiles obtained by this calculation are shown in Figure 4.9. 
 
 
Figure 4.9. Specific cell membrane capacitance Cm post planting in the 13 precultures. 
Values for Cm generally ranged from approximately 1.0 to 1.5 µF cm
-2
 and did not exhibit 
any major changes during the two-day growth phase. 
 
Calculated initial values for Cm for the uninfected precultures ranged from 0.83 to 
1.41 µF cm
-2
 and generally increased slightly during the experiment. At the end of the growth 
phase Cm ranged from 0.98 to 1.59 µF cm
-2
. The two calculated values for Cm at approximately 
0.6 h and 26 h post planting for precultures #6 and #9, respectively, fall out of these ranges. In 
the case of preculture #6, this can be explained with an unreasonable high Δε observed at a very 
low volume fraction of viable cells, while in case of preculture #9 a technical issue with 
unknown cause caused the Δε signal to be lower than expected for the observed volume fraction 
of viable cells. The specific cell membrane capacitance Cm is generally interpreted to be 
dependent on the level of folding of the cellular membrane
73, 74
 and was originally thought to be 
a cell biological constant with a value of approximately (1.0 ± 0.5 µF cm
-2
)
73, 87, 125, 126
. Recent 
research suggests that this assumption is not entirely true and Cm can indeed be influenced by 
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cell viability, physiological state, virus infection or during overexpression of cation channels. 
Data specifically for Spodoptera frugiperda cells is scarce and only one publication states values 
in the range of 0.8 to 0.9 µF cm
-2
 for uninfected Sf-9 cells
127
, but these values are also not 
obtained directly by measurements on the cells but rather calculated based on dielectric 
spectroscopy measurements and a simplified dielectric cell model. In this work, Cm was found to 
be 1.2 ± 0.2 µF cm
-2
 (mean ± one standard deviation) during the two-day cell growth phase in the 
precultures. Because no major changes in the Cm profiles were observed it can be assumed that 
no major physiological changes have occurred during the two-day preculture growth phase. 
 
The second ß-dispersion parameter provided by the instrument was the characteristic 
frequency fc. Profiles for this parameter are shown in Figure 4.10. Initial values for fc ranged 
from 630 to 787 kHz and overall decreased slightly to 553 to 660 kHz during cell growth. 
 
 
Figure 4.10. Characteristic frequency fc post planting in the 13 precultures. Initial values 
were around 700 kHz and decreased slightly to approximately 600 kHz during the two-day 
growth phase. Deviations from this are generally attributed to technical issues. 
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The characteristic frequency fc did not exhibit major changes during the uninfected 
precultures but seemed to increase slightly immediately post planting before starting to decrease 
again as soon as 12 h post planting. According to Equation 6 fc is directly influenced by the cell 
radius r, specific cell membrane capacitance Cm and the intracellular and medium 
conductivities ζi and ζe, respectively. Since a slight increase in viable cell radius was observed 
during preculture cell growth this may have contributed to the observed slight decrease in fc. 
 
Third and last ß-dispersion parameter obtained with the instrument was the Cole-Cole α. 
Initial values for α ranged from 0.100 to 0.102 and spread out to a range from 0.080 to 0.104 
during cell growth (see Figure 4.11). In addition, most of the values seemed to decrease slightly 
during this period. 
 
 
Figure 4.11. Cole Cole α post planting in the 13 precultures. Initial values of approximately 
0.10 decreased and spread slightly during the two-day growth phase to a range of 
approximately 0.08 to 0.10. 
 
The parameter Cole-Cole α is an empirical value describing the decrease in capacitance 
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between 0 and 1 where 0 describes a very steep and 1 an infinitely shallow fall in capacitance. In 
cell culture applications α is generally interpreted as a measurement of viable cell size 
distribution and believed to increase when the cell size distribution widens
12, 80
 and values 
observed are typically between 0.1 and 0.2
128
. But the physical origin of this parameter is 
continuously disputed and may indeed also be influenced by several other effects including 
morphology of extracellular spaces, the mobility of membranous proteins and the fractal nature 
of dielectric relaxation
128-131. Decreasing and widening values for α observed during the 
uninfected preculture cell growth cannot be explained with changes or trends in the cell size 
distribution since no significant changes were observed in those values (data not shown). 
 
In addition to the three ß-dispersion parameters, two additional parameters were 
measured by the instrument. The first was the Biomass signal, which was based on the dual 
frequency method. The Biomass signal was obtained by measuring the capacitance (permittivity) 
at a frequency close to the specific fc of the cell culture system utilized (here 1000 kHz), the so 
called working frequency, and subtracting the capacitance (permittivity) obtained at a very high 
frequency (here 10000 kHz). The latter adjusts the measurement for changes in the medium 
background capacitance (permittivity) over time
108
. 
 
Profiles for the Biomass signal are shown in Figure 4.12. Initial values, taken after a short 
stabilization phase for suspension mixing and temperature adjustments, ranged from 0.59 to 
1.44 pF cm
-1
 and started to increase in a close to exponential fashion immediately post planting. 
Final values at the end of the growth phase ranged from 2.95 to 5.82 pF cm
-1
. 
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Figure 4.12. Biomass signal post planting in the 13 precultures. Initial values were 
approximately 1.0 pF cm
-1
 and continuously increased to approximately 3.0 to 6.0 pF cm
-1
 
during the two-day growth phase. 
 
The Biomass signal is often used for viable biovolume estimation because due to the 
nature of its measurement, it is believed to be independent, or at least less influenced, by changes 
in viable cell radius. As with Δε, the general Biomass signal increase immediately post planting 
can be attributed to viable cell growth and so increases in the viable biovolume. 
 
The last parameter provided by the instrument was the suspension conductivity ζs for 
which profiles are shown in Figure 4.13. Initial values for ζs, taken after a short stabilization 
phase for suspension mixing and temperature adjustments, ranged from 15.21 to 15.45 mS cm
-1
. 
ζs did not significantly change during two day cell growth ranged from 15.24 to 15.45 mS cm
-1
 
at the end of the precultures. In addition observed shifts in the profiles from process to process 
are generally statistically not significant because the error for this measurement is at least 1 % as 
stated by the manufacturer. Exceptions were phases of small culture medium temperature 
changes and readjustments, as can be seen from approximately 24 to 34 h post planting in 
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precultures #1 and #2. These deviations were generally caused by changes in the room 
temperature and subsequent changes and readjustments of the culture temperature. 
 
 
Figure 4.13. Suspension conductivity ζs post planting in the 13 precultures. Values ranged 
from approximately 15.3 to 15.4 mS cm
-1
 throughout the two-day growth phase. Spikes 
observed could generally be attributed to changes in the culture temperature. 
 
At this point, the intracellular conductivity ζi can be calculated because r and Cm are 
already known and ζe is given by Equation 7. ζi profiles obtained by this calculation are shown 
in Figure 4.14. Generally, the calculated ζi values ranged from 3.66 to 7.11 mS cm
-1
 at the 
beginning of the culture and did not change much during the two-day preculture growth phase. 
Values obtained at the end of the cultures showed nearly the same range, from 3.80 to 6.68 mS 
cm
-1
. Again precultures #6 and #9 showed two values, the same as in the case of Cm, deviating 
from these ranges. This can be explained by the simple fact that Cm directly affects the 
calculation of ζi and deviations in the first will consequently be found in the latter. 
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Figure 4.14. Intracellular conductivity ζi post planting in the 13 precultures. Values 
generally ranged from approximately 4.0 to 7.0 mS cm
-1
 during the two-day growth phase 
and did not exhibit major changes. 
 
ζi is generally interpreted as the ability of the cell’s interior to conduct electrical current 
and changes are presumably due to different ion concentrations within the cell
73, 75
. Until recently 
studies often treat ζi as independent on the physiological state
73, 125, 132, 133
 but it is well known 
that this value can indeed change in apoptotic and necrotic cells, when morphological changes 
are induced or when the cell membrane conductance is increased, i.e. by treatment with 
antibiotics
134-138. To the knowledge of the author, no literature values for ζi in Spodoptera 
frugiperda derived cells have been published. In mammalian cell cultures ζi usually falls 
somewhere in between 2 and 9 mS cm
-1
 with some researchers suggesting an even narrower 
range of 3 to 5 mS cm
-173, 75, 125, 139, 140. Overall ζi was found to be 5.4 ± 1.2 mS cm
-1
 (mean ± one 
standard deviation) during the exponential cell growth phase in uninfected Sf-9 clone cell 
precultures. 
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4.1.3 Use of DS for Real-Time Determination of Viable Biovolume and Cell Density 
 
Traditionally the main use of DS is the determination of viable biovolume or cell density 
in-line and in real-time
5, 45, 57
. Eliminating the need for time-consuming off-line analyses and the 
sterility risk associated with the sampling procedure is a great benefit of the DS application in 
industrial bioprocesses. Specifically for the BEVS system employed in this work, an accurate 
determination of the cell density at the time of infection is rather important to minimize the 
effects of an inconsistent MOI as much as possible. The data DS obtained during the uninfected 
cell growth of Sf-9 clone cells in the thirteen precultures was used to establish calibrations with 
the viable biovolume and cell density as determined by off-line analyses. 
 
Based on the theory the capacitance and permittivity measured correlate linearly to the 
volume fraction of the viable cells P (viable biovolume) in the cell culture suspension. To verify 
this theory the viable cell densities and mean viable cell diameters obtained for every sample 
during the two-day cell growth in the precultures were used to calculate the viable biovolume, 
assuming a spherical cell shape. This value was then paired with its raw capacitance values at 
each of the 16 remaining frequencies after adjusting for the medium background capacitance by 
subtracting the capacitance value measured at 10000 kHz. In addition, Δε and the Biomass signal 
were also used to obtain correlations. The Pearson correlation coefficient r was then calculated 
for each combination to obtain a measure of linearity of the correlation. Results are shown in 
Table 4.2. A total of 44 data points was used in this analysis. 
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Table 4.2. Pearson correlation coefficients for viable biovolume and dielectric spectroscopy 
signals of uninfected Sf-9 clone cells. 
 
 
Generally, capacitance measurements obtained at frequencies below 3000 kHz provided 
reasonable good correlations with the best correlations obtained for Δε and the Biomass signal. 
Estimated Pearson correlation coefficients for these signals were 0.957 and 0.938, respectively. 
The best linear correlation based on the raw capacitance measurements at single frequencies was 
obtained at 720 kHz with a Pearson r of 0.938. Figure 4.15 and Figure 4.16 show the correlations 
obtained for Δε and the Biomass signal versus the viable biovolume. 
 
Signal Pearson r
Delta ε 0.957
Biomass 0.938
C(300 kHz) 0.907
C(373 kHz) 0.923
C(465 kHz) 0.932
C(578 kHz) 0.936
C(720 kHz) 0.938
C(897 kHz) 0.937
C(1117 kHz) 0.935
C(1391 kHz) 0.925
C(1732 kHz) 0.907
C(2156 kHz) 0.868
C(2684 kHz) 0.846
C(3342 kHz) 0.794
C(4161 kHz) 0.709
C(5181 kHz) 0.640
C(6451 kHz) 0.514
C(8031 kHz) 0.407
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Figure 4.15. Linear correlation viable biovolume vs. Δε post planting for uninfected Sf-9 
clone cells. 
 
 
Figure 4.16. Linear correlation viable biovolume vs. Biomass signal post planting for 
uninfected Sf-9 clone cells. 
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The two linear correlations obtained can be described by the equations 
 
                                  
  
  
 
   
  
 
Equation 19 
 
and 
 
                                           
  
  
 
   
  
 
Equation 20 
 
The parameter viable biovolume is generally not used in insect cell culture technology. 
Instead, the parameter viable cell density is usually preferred. Therefore, the same procedure as 
described above was repeated with viable cell density instead of biovolume values. Results of 
this analysis are shown in Table 4.3. 
 
Table 4.3. Pearson correlation coefficients for viable cell density and dielectric 
spectroscopy signals for uninfected Sf-9 clone cells. 
 
 
Signal Pearson r
Delta ε 0.958
Biomass 0.943
C(300 kHz) 0.911
C(373 kHz) 0.926
C(465 kHz) 0.935
C(578 kHz) 0.940
C(720 kHz) 0.942
C(897 kHz) 0.941
C(1117 kHz) 0.939
C(1391 kHz) 0.930
C(1732 kHz) 0.912
C(2156 kHz) 0.875
C(2684 kHz) 0.854
C(3342 kHz) 0.804
C(4161 kHz) 0.716
C(5181 kHz) 0.647
C(6451 kHz) 0.520
C(8031 kHz) 0.412
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Again, capacitance measurements obtained below 3000 kHz generally provided 
reasonable good correlations with the best correlations obtained for Δε and the Biomass signal. 
For these signals the determined Pearson correlation coefficients were 0.958 and 0.943, 
respectively. The best linear correlation based on the raw capacitance measurements at single 
frequencies was once again obtained at 720 kHz with a Pearson r of 0.942. This can be explained 
by the fact, that the viable cell diameter and size distribution did not exhibit any major changes 
during the preculture growth phase. Therefore, the calculated viable biovolume is linearly 
correlated to the viable cell density with very high significance. In fact, the relationship between 
these two values has a Pearson correlation coefficient of 0.998. This fact is also represented in 
the characteristic frequency fc and Cole-Cole α, which are somewhat dependent on the viable cell 
size and size distribution. Both parameters did only shown minor changes during the cell growth 
in the precultures. Figure 4.17 and Figure 4.18 show the correlations obtained for Δε and the 
Biomass signal versus the viable cell density. 
 
 
Figure 4.17. Correlation viable cell density vs. Δε post planting for uninfected Sf-9 clone 
cells. 
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Figure 4.18. Correlation viable cell density vs. Biomass signal post planting for uninfected 
Sf-9 clone cells. 
 
The two linear correlations obtained can be described by the equations 
 
                                     
  
  
 
     
  
 
Equation 21 
 
and 
 
 
                                               
  
  
 
     
  
 
Equation 22 
 
Overall, the obtained correlations between dielectric spectroscopy measurements and 
their respective viable biovolume and cell density values for both probes used in all 13 
precultures are acceptable based on the Pearson correlation analysis and show a good 
reproducibility. 
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This result suggests that the application of dielectric spectroscopy could replace the 
manual sampling for cell density determination in routine insect cell production processes during 
cell expansion. This would eliminate the effort and sterility risks associated with the manual 
sampling process and additionally and very importantly, the estimation of the viable cell density 
at the actual time of infection could be greatly improved. This would subsequently lead to more 
consistent ―real MOI‖ and so recombinant protein expression. Usually in routine production, a 
viable cell density estimated is already outdated for hours once the virus seed is added to the 
bioreactor. This is because of the long procedures performed in between sampling and virus 
addition like thawing of the virus seed, dispensing or sterilization of the addition lines. It has to 
be noted that the obtained correlations for each single probe/amplifier combination are slightly 
different and deviating more the higher the viable biovolume or cell density in the suspension 
(see Figure 4.19). 
 
 
Figure 4.19. Probe/Pre-Amp set dependency of obtained correlation between Δε and the 
viable cell density. Deviations can be observed at higher cell densities of approximately 2.0 
x 10
6
 cells ml
-1
. If cell densities are further increased, an even stronger deviation is 
expected. 
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This was of less impact in the ranges investigates here, shows, could become more 
important when viable biovolume or cell density are increased beyond what was measured here. 
Therefore, the use of different correlation equations for each might be beneficial in terms of 
accuracy. Such a behavior is expected for correlations obtained with the macroscopic and probe 
geometry dependent raw capacitance values, but should ideally not be the case with for the 
intrinsic permittivity data (Δε and the Biomass). On the other hand using different correlation 
equations for each single probe increases the overall complexity in routine production and 
therefore might be abandoned due to the relatively good results even for the overall correlations. 
To the knowledge of the author, the probe/amp combination dependency of the real-time 
determination of viable cell density or biovolume has not been of a big concern in literature. 
 
Another very important fact to consider is that these correlations are based solely on 
viable cell densities between approximately 0.50 x 10
6
 and 2.50 x 10
6
 cells ml
-1
. Strictly 
speaking, the obtained correlations are not valid outside this range but could be extended once 
additional data outside this range is available from additional experiments or even routine 
production processes. In addition, the correlations were obtained with cells in the exponential 
growth phase. It is known from literature and own experiments that the same linear correlations 
fail once the cell culture reaches the stationary phase and later, even if the cell size does not 
change significantly. Most probable explanation for this is a change in the dielectric properties of 
the cells when shifting from exponential growth to the stationary phase and later to the death 
phase. Since insect cell cultures are ideally passaged or infected during the exponential growth 
phase, this should not be an issue in routine industrial application of dielectric spectroscopy. 
 
4.1.4 Conclusions 
The thirteen precultures served as additional cell expansion step between the spinner 
flask scale and the bioreactor experiments performed at the 15 L working volume scale. Off-line 
sampling and analysis of standard cell culture parameters like viable cell density or medium 
nutrient/metabolite concentrations allowed estimation of cell growth related kinetics for 
comparison with literature. Eventually a judgment of the overall robustness of the growth 
process and the health of the cells was possible. The application of DS in these cultures 
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additionally allowed evaluating the applicableness of this technique towards real-time estimation 
of viable biovolume and cell density as well as gaining more insight into the cell’s physiological 
state. 
 
It was found, that the Spodoptera frugiperda Sf-9 clone cell clone used in this work 
overall performed comparably in terms of growth to Sf-21 and Sf-9 cells as reported in the 
literature. Also, D-glucose and L-glutamine were utilized at comparable rates but were never 
depleted during the two-day cell growth in the precultures. Interestingly, L-lactate and 
L-glutamate both accumulated in the culture medium during growth. This is contrary to findings 
in the literature where it was reported, that L-lactate generally does not accumulate under non 
oxygen-limited conditions. Also, L-glutamate was reported to be utilized rather than be 
produced. Overall, the growth process was reproducible and cell health, as determined by 
evaluating the different parameters and kinetics obtained, was deemed acceptable for subsequent 
experiments at the 15 L working volume scale. Table 4.4 summarizes the findings. 
 
Table 4.4. Summary of the measured cell culture parameters for uninfected Sf-9 clone cell 
growth in precultures. Given are mean values ± one standard deviation. 
 This work Literature Reference 
µ in h
-1 
0.031 ± 0.002 0.029 to 0.035 118-120 
tD in h 22.2 ± 1.4 20 to 24 118-120 
qGlc in mmol cell
-1
 s
-1 
(-1.38 ± 0.29) x 10
-14
 -2.4 x 10
-14
 120 
qGln in mmol cell
-1
 s
-1
 (-1.39 ± 0.29) x 10
-14
 -1.0 x 10
-14
 120, 122 
qLac in mmol cell
-1
 s
-1
 (4.25 ± 0.81) x 10
-15
 No accumulation 120, 123, 124 
qGlu in mmol cell
-1
 s
-1
 (7.13 ± 1.98) x 10
-15
 -1.94 x 10
-15
 122 
 
DS was successfully implemented into the Sf-9 clone cell growth process. Combining the 
DS data with the parameters obtained off-line allowed establishing calibrations for the real-time 
estimation of viable biovolume and cell density in-line of subsequent processes without the need 
of sampling. An example of one of the correlations is shown in Figure 4.20. Utilization of 
different probe/pre-amp combinations in multiple processes overall yielded robust results but 
using a specific calibration for each combination may be beneficial in terms of accuracy. It 
should be noted that preparation and the so-called zeroing of the probes have to be done in a 
consistent way and in the culture medium at process temperature, respectively, to avoid 
deviations. 
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Figure 4.20. Correlation viable cell density vs. Δε post planting. 
 
With the obtained calibrations, DS does not only eliminate the contamination risk 
associated with the usually required sampling procedure but also reduces the time and effort 
required to follow cell growth while providing data in real-time and continuously. Infections in 
the large scale could be performed at more consistent ―real MOI‖ because of elimination of the 
delay between initial sampling and medium or virus addition traditionally hours later. This will 
lead to more repeatable recombinant protein production processes, which potentially could have 
a large impact on a variety of important parameters like capacity planning and the overall cost of 
the recombinant protein production. 
 
0.0E+00
5.0E+05
1.0E+06
1.5E+06
2.0E+06
2.5E+06
3.0E+06
0.0 5.0 10.0 15.0 20.0 25.0
V
ia
b
le
 C
e
ll
 D
en
si
ty
 in
 c
el
ls
 m
l-1
Δε in pF cm-1
80 
 
4.2 Infection at Low MOI 
Reports of monitoring of infected insect cells and the BEVS generally focused on 
synchronous infections at a high MOI. This is usually not preferred in the large scale BEVS 
processes due to the large amount of costly virus seed required. The focus on high MOI 
potentially leads to deviations between laboratory work and industrial processes due to the 
significant impact of small changes in parameters like cell to virus ratio or the time of infection
1
. 
Additionally only limited data that links the obtained DS data to the cell’s physiological state, the 
infection progress, and parameters like the medium nutrient limitations is available. Here DS was 
applied to a range of low MOI experiments under standardized conditions to advance the 
technique into this field and to follow or even predict the process and its outcome. 
 
Eleven different experiments according to the experimental plan described in Table 4.5 
were performed. In essence, the only parameter varied in these experiments was the multiplicity 
of infection while efforts were made to keep other parameters unchanged (engineering and 
biological) to assure comparable results. Sf-9 clone cells grown in the precultures described 
earlier (see Chapter 4.1) at a working volume of approximately 7.5 L were diluted back by the 
addition of fresh EX-CELL 420 medium to a target viable cell density of 
1.00 x 10
6
 viable cells ml
-1
 at approximately 15.0 L working volume. Immediately afterwards the 
culture was infected with the appropriate amount of recombinant PCV2 ORF2 baculovirus. To 
cover the range of comparably low MOI usually utilized in industrial scale baculovirus 
expression vector system bioprocesses, the target MOI were 0.01, 0.10 and 1.00. Bioreactor 
parameters post infection were the same as post planting with an agitation rate of 100 RPM, an 
aeration rate of 1.00 SLPM and a dissolved oxygen concentration of 40 %. Experiments were 
performed in triplicates at each MOI to observe repeatability of the process. Additionally all 
experiments were performed in a randomized order to reduce potential bias of undetected factors 
affecting the experiments. One additional culture with no addition of virus seed was performed 
to serve as an uninfected control. 
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Table 4.5. Overview of performed Low MOI experiments and utilized precultures. 
Preculture # Used for Low MOI Experiment # 
1 MOI 0.10 #1 
2 MOI 0.01 #1 
3 MOI 1.00 #1 
4 MOI 0.10 #2 
5 MOI 1.00 #2 
6 MOI 0.01 #2 
8 MOI 0.01 #3 
9 MOI 0.10 #3 
10 MOI 1.00 #3 
11 Uninfected Control 
 
With few exceptions, the data recorded for the three replicate processes performed at 
each MOI was consistent and comparable. Therefore, only one process at each MOI is shown in 
the following plots to ensure clarity of the plots. Additionally, the recorded data for an 
uninfected control culture is shown in each plot for comparison. With few exceptions, the data 
recorded for the three replicate processes performed at each MOI was consistent and comparable. 
Therefore, only one process at each MOI is shown in the following plots to ensure clarity of the 
plots. Plots with the complete set of experiments can be found in Appendix E - . Raw data 
collected is presented in Appendix D - . 
 
4.2.1 Viable Cell Density, Viability and Viable Cell Diameter 
The three parameters viable cell density, viability and mean viable cell diameter were 
determined off-line with the Beckman Coulter Vi-CELL XR analyzer utilizing the ―Sf-9 clone‖ 
or, from day 5 post infection on, ―Sf-9 clone low viability‖ settings as described in Chapter 3.7. 
The latter setting had to be used once samples contained significant amounts of dead cells and 
cell debris to avoid erroneous detection of these as viable cells. 
 
Viable cell density profiles are shown in Figure 4.21. All cultures showed a slightly 
higher viable cell density at the time of infection than targeted. This is probably due to a 
systematic error in the medium addition process, despite utilizing a scale to verify the amount 
added to the vessel. Nevertheless, the viable cell density at the time of infection proved to be 
very consistent at around 1.25 x 10
6
 viable cells ml
-1
. During the first few days post infection the 
viable cell density generally increased significantly. Depending on the MOI, the maximum 
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viable cell density was reached between 24 and 72 h post infection with values ranging from 
1.19 x 10
6
 to 3.72 x 10
6
 viable cells ml
-1
. Generally, the maximum viable cell density observed 
decreased with increasing MOI. The respective maximum was also reached earlier for cultures 
infected at higher MOI. Once this maximum had been reached, the viable cell density 
continuously decreased until the end of the process. In comparison, the uninfected control culture 
showed an even higher maximum viable cell density than all infected cultures with 
4.61 x 10
6
 viable cells ml
-1
 reached after approximately 130 h culture time. 
 
 
Figure 4.21. Viable cell density post infection at the three different MOI compared to an 
uninfected control culture. Initial values were approximately 1.0 x 10
6
 cells ml
-1
. The viable 
cell density increased for up to 72 h post infection depending on the MOI. Decreasing 
maximum viable cell densities were observed with increasing MOI with peak values of 
approximately 3.0, 2.2, and 1.2 x 10
6
 cells ml
-1
 for MOI 0.01, 0.10, and 1.00, respectively. 
Afterwards the viable cell density decreased continuously until the end of the process. 
Trendlines are intended to guide the eye only. 
 
The general differences observed in the viable cell density profiles for the infected Sf-9 
clone cell cultures post infection can directly be explained with the three MOI utilized. Once a 
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Spodoptera frugiperda insect cell is infected by a baculovirus it stops dividing and starts 
replicating the virus, and in this case, additionally expressing the recombinant PCV2 ORF2 
protein
141, 142
. While an MOI of 1.00 at least theoretically ensures enough virus particles to infect 
each cell, this is not the case at the two lower MOI of 0.10 and 0.01. The cells left uninfected 
after the virus seed addition continue to replicate until they are infected during the so-called 
secondary infection by virus particles already produced and released by the relatively few cells 
that had originally been infected during the primary infection. It has been reported that the 
production and release of budded baculovirus peaks at around 17 to 20 h post infection
141
, which 
left significant time for uninfected cells to divide, especially at the two lower MOI in this work. 
This interpretation is supported by flow cytometric analyses performed in this work, where 
significantly different infection kinetics could be observed depending on the MOI. Basically, the 
lower the MOI the longer it took until a complete infection of the culture was achieved (see 
below, Figure 4.30). These differences in the infection kinetics eventually resulted in the 
observed differences in the viable cell density profiles. In contrast to this, the uninfected control 
culture showed a steady increase in viable cell density until approximately 131 h into the 
process. No arrest in cell division due to baculovirus infection occurred here so that this culture 
just went through the normal growth cycle phases. 
 
All cultures showed cell viabilities well above 90 % at the time of infection. The cell 
viability remained stable above 90 % for at least 48 h post infection before starting to decrease, 
as can be seen in Figure 4.22. A viability of 10 % or below, the specified harvest criteria for this 
process, was reached after approximately 186 h post infection (day 7) at MOI 1.00 and 0.10 or 
216 h post infection (day 9) at MOI 0.01. It was found previously that such a harvest criteria 
allowed recovery of more than 90 % of the total produced recombinant PCV2-ORF2 protein 
from the supernatant after simple removal of cells and cell debris
143
. Employing this strategy 
therefore greatly reduces the downstream processing efforts compared to an earlier harvest, 
which would require target protein extraction from the still intact cells in some fashion. On the 
downside, it lengthens the production process by a few days. The uninfected control culture 
showed a much slower decrease in viability with still 49.0 % of the cells remaining viable after 
approximately 216 hours (day 9). A viability of less than 10 % was eventually achieved after 
384 h (day 16, data not shown). 
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Figure 4.22. Cell viability post infection at the three different MOI compared to an 
uninfected control culture. Cell viability dropped continuously from approximately 95 % 
starting after at least 48 h post infection. Cell viabilities below 10 % (the defined harvest 
criterion) were reached after approximately 168 (MOI 1.00 and 0.10) and 192 h (MOI 0.01) 
post infection. Trendlines are intended to guide the eye only. 
 
The first drop in cell viability could usually be observed after all cells had been infected 
by the recombinant PCV2 ORF2 baculovirus (as determined by flow cytometric analysis, see 
Figure 4.30) and cell division had been largely arrested. The lytic nature of the baculovirus is 
likely responsible for the observed accelerated decrease in viability with increasing MOI
19
. With 
more cells initially infected, the subsequent infection kinetics were expected to be faster which 
subsequently led to an earlier onset of the cell lysis. Cell viability remained higher and dropped 
slower in the uninfected control culture because not lytic baculovirus was contributing to cell 
death. 
 
In addition to the observed cell division arrest, another characteristic response of a 
Spodoptera frugiperda insect cell culture to the infection with a (recombinant) baculovirus is the 
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swelling of the viable cells
11, 15, 141
. This response can be easily followed by measuring the mean 
viable cell diameter (here with Vi-CELL XR). Figure 4.23 shows the profiles for the mean viable 
cell diameter post infection. All cultures showed mean viable cell diameters between 17.74 and 
18.35 µm at the time of infection, comparable to the values observed for the uninfected cell in 
the precultures. Immediately post infection the mean viable cell diameter started to increase. 
Maximum values were reached either on day 3 post infection for cultures infected at MOI 1.00 
and 0.10 or on day 4 post infection for cultures infected at MOI 0.01. Maximum values ranged 
from 21.16 to 23.83 µm with higher maximum values generally observed for cultures infected at 
a higher MOI. Afterwards the mean viable cell diameter seemed to decrease again continuously 
until the time of the harvest. The shift in the mean viable cell diameter observed after 
approximately 120 h post infection (day 5) is an artifact due to the switch in image analysis 
settings and not caused by actual changes in the cell culture. While it is not possible to compare 
absolute values from this point in the culture with values obtained before, the continuous 
decrease in the mean viable cell diameter was still detected. The uninfected control culture 
showed a similar initial mean viable cell diameter, which did not increase significantly 
throughout the process. 
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Figure 4.23. Mean viable cell diameter post infection at the three different MOI compared 
to an uninfected control culture. Mean diameters increased continuously from 
approximately 18.0 µm immediately post infection to up to approximately 24.0 µm. The 
higher the MOI the faster the increase occurred and the earlier a peak was reached. 
Afterwards the mean diameter decreased continuously until the end of the process. 
Trendlines are intended to guide the eye only. 
The observed cell swelling is attributed to nuclear hypertrophy and rearrangements 
within the cytoskeleton as well as virus and recombinant protein production directly
11, 15, 141
. The 
mean viable cell diameter changed significantly post infection for cultures infected at all three 
MOI, but time of start and peak of this increase was quite different between the three MOI. 
Usually the lower the MOI, the later the mean viable cell diameter started increasing with the 
peak also occurring later. This goes hand in hand with the slower infection kinetics discussed 
above. With the first significant decreases in cell viability, the mean viable cell diameter also 
decreased. Cells that had undergone an early infection and subsequent cell swelling lysed at this 
point, leaving cells infected later and therefore still early in the swelling process behind, 
therefore decreasing the mean viable cell diameter. 
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Based on the Vi-CELL XR measurements for viable cell density and mean viable cell 
diameter, the viable biovolume per unit of cell suspension was calculated assuming a spherical 
cell shape. Figure 4.24 shows the profiles for this parameter. The initial biovolume at the time of 
infection ranged from 3.46 to 4.53 x 10
9
 µm
3
 ml
-1
 cell suspension and started to increase 
immediately post infection . After reaching a maximum value, which ranged from 8.01 to 
17.43 x 10
9
 µm
3
 ml
-1
depending on the MOI, the viable biovolume decreased continuously until 
the end of the process. Generally, the maximum values observed were the higher the lower the 
MOI but occurred around 72 h post infection for all three MOI. The shift in the viable biovolume 
observed after approximately 120 h post infection (day 5) is an artifact due to the switch in 
image analysis settings and not caused by actual changes in the cell culture. While it is not 
possible to compare absolute values from after this point in the culture with values obtained 
before, the continuous decrease in the viable biovolume was still detected. The uninfected 
control culture showed a similar initial viable biovolume and peaked after approximately 96 h 
(day 4) at 1.29 x 10
10
 µm
3
 ml
-1
 cell suspension. It has to be noted that the error range for this 
parameter is at least 10 % (10 % error for viable cell density estimation plus an unknown error 
for mean viable cell diameter). 
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Figure 4.24. Viable biovolume post infection at the three different MOI compared to an 
uninfected control culture. Initial values were approximately 4.0 x 10
9
 µm
3
 ml
-1
 and 
increased for up to 72 h post infection depending on the MOI. Decreasing maximum viable 
biovolumes were observed with increasing MOI. Afterwards the viable biovolume 
decreased continuously until the end of the process. Trendlines are intended to guide the 
eye only. 
 
The trends observed for the viable biovolume are apparently caused by the same kinetics 
and effects post infection the viable cell density and mean viable cell diameter were subjected to. 
Therefore the observed differences generally go along with the observations and interpretations 
made for those parameters. But interestingly, the peak in viable biovolume occurs at about the 
same time, 72 h (day 3) post infection, despite the fact that the viable cell density and diameter 
profiles had shown significant differences between different MOI. 
 
 
 
0.0E+00
5.0E+09
1.0E+10
1.5E+10
2.0E+10
2.5E+10
0 24 48 72 96 120 144 168 192 216 240
V
ia
b
le
 B
io
vo
lu
m
e
 in
 µ
m
3
m
l-1
Time Post Infection in h
MOI 0.01 #1
MOI 0.10 #1
MOI 1.00 #1
Uninfected Control
89 
 
4.2.2 Physiological Culture Parameters, Nutrients and Metabolites 
The pH was left uncontrolled during the experiments but it was monitored with an in-line 
probe directly immersed into the cell culture broth. Significant changes in pH could be observed 
post infection, as can be seen in Figure 4.25. Initial readings post infection were in the range of 
6.28 to 6.42 and generally slightly higher than before the back dilution with fresh EX-CELL 420 
medium. The pH then dropped slightly during the first one or two days post infection before 
increasing again for the next one or two days. After this, the pH in all cultures started to decrease 
continuously and generally reached its minimum value at the time of harvest. pH values on the 
harvest day ranged from 5.67 to 6.02. The uninfected control culture showed a comparable 
behavior in pH during the first 72 h but afterwards the pH stayed above 6.2 and did not decrease 
as strongly as observed for the infected cultures. 
 
 
Figure 4.25. Culture medium pH post infection at the three different MOI compared to an 
uninfected control culture. Initial pH was approximately 6.3 and decreased slightly during 
the first 24 to 48 h post infection down to 6.2 before increasing again and peaking between 
6.3 and 6.4 at 48 to 96 h post infection. Thereafter the pH decreased continuously until the 
end of the process. Final pH at the time of harvest values decreased with MOI. Trendlines 
are intended to guide the eye only. 
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The pH is often left uncontrolled in insect cell cultures because these cells are said to 
have a very high buffer capacity themselves
21
. Additionally the EX-CELL 420 medium used in 
this work has a 8.4 mM phosphate buffer system integrated to help keeping the pH in acceptable 
range
121
. The observed changes in pH could directly be related to changes in the L-lactate 
concentration in the culture medium. As expected, increasing L-lactate concentrations during the 
experiments led to a decreasing pH and the other way around (also see Figure 4.28). The 
optimum pH range for insect cell cultures is reported to be about 6.2 to 6.9
1
 but cultures in this 
work usually exhibited significantly lower values, especially later in the process during cell lysis. 
The lowest pH could be observed for the highest MOI. Interestingly the cultures did not seem to 
be negatively affected by the lower pH values in terms of recombinant baculovirus and protein 
production (see below), presumably these were observed late in the process after infection, and 
protein production had already been accomplished to a major portion. 
 
Figure 4.26 gives an overview of the D-glucose medium concentrations post infection. 
Initial D-glucose concentrations ranged from 30.69 to 31.75 mmol L
-1
 and generally decreased 
post infection. Final values reached at the end of each process ranged from 6.55 to 
25.81 mmol L
-1
 with generally lower values reached the lower the MOI. Nevertheless, D-glucose 
was not depleted in any infected culture, therefore a limitation of the culture is not likely. The 
uninfected control culture showed a comparable initial D-glucose concentration of 
33.86 mmol L
-1
 but in this case D-glucose was depleted at around 205 h (day 9) into the process, 
during the cultures death phase. 
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Figure 4.26. Medium D-glucose concentration post infection at the three different MOI 
compared to an uninfected control culture. Initial concentrations were approximately 
31.0 mmol L
-1
 and decreased continuously throughout the culture. Decreasing final 
D-glucose concentrations were found with decreasing MOI with values ranging from 
approximately 25.0 to 15.0 mmol L
-1
. Trendlines are intended to guide the eye only. 
 
The observed decrease in medium D-glucose post infection is in line with previous 
reports that describe D-glucose as the main carbon source in Spodoptera frugiperda cells for 
energy production
122, 144, 145
. Based on the measured medium D-glucose concentrations it can be 
assumed, that a limitation in this nutrient did not occur during any of the cultures infected at one 
of the three MOI. In contrast to this, D-glucose was depleted in the uninfected control culture at 
around 205 h (day 9) because there were still significant amounts of viable cells consuming this 
nutrient at that time. 
 
Figure 4.27 shows the medium concentration profiles obtained for L-glutamine. Initial 
concentrations ranged from 3.96 to 4.69 mmol L
-1
 and generally rapidly decreased post infection. 
Due to interference with the EX-CELL 420 medium, the lower detection limit for this analysis is 
about 0.70 mmol L
-1
. Therefore it was assumed that even with analyses never resulting in a 
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measured value of 0.00 mmol L
-1
, L-glutamine was depleted in the media around 48 to 72 h post 
infection, depending on the culture and MOI used. Usually a higher MOI led to a later depletion 
of L-glutamine in the medium. Some cultures showed a slight increase in L-glutamine 
concentration late in the process again, presumably due to cell lysis and release of intracellular 
L-glutamine into the medium, but concentrations always stayed well below 1.50 mmol L
-1
. The 
uninfected control culture showed a significantly lower initial L-glutamine concentration of 
3.07 mmol L
-1
 which was depleted at around 60 h into the process. The lower initial 
concentration in L-glutamine can be attributed to the fact that the medium used for this process 
was stored longer before usage and the instable L-glutamine therefore degenerated slightly 
during this prolonged storage time. 
 
 
Figure 4.27. Medium L-glutamine concentration post infection at the three different MOI 
compared to an uninfected control culture. Initial concentrations were approximately 
4.5 mmol L
-1
 and decreased continuously throughout the culture. Depletion of this nutrient 
was assumed to have occurred approximately between 48 and 72 h post infection, 
depending on the MOI. The detection limit for this analysis is approximately 0.7 mmol L
-1
 
and therefore no concentrations below this level could reliably measured. Trendlines are 
intended to guide the eye only. 
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Like D-glucose, L-glutamine is also a major nutrient in Spodoptera frugiperda insect cell 
cultures and was rapidly consumed in the experiments. The depletion of this nutrient occurred 
with higher MOI, presumably because overall less viable cells were consuming L-glutamine in 
this case than compared to the low MOI experiments, where substantial cell growth occurred 
even after infection. The same was observed for the uninfected control culture, where 
L-glutamine was depleted around 60 h into the process. 
 
Profiles for medium L-lactate concentrations are shown in Figure 4.28. Initial 
concentrations immediately post infection ranged from 1.35 to 1.69 mmol L
-1
. The concentration 
then increased for at least one day before decreasing again to an overall minimum value 
generally below 1.00 mmol L
-1
 on day 3 or 4 post infection, presumably due to oxidization by 
the cells
123
. From this point on the L-lactate concentration increased steadily again until the end 
of each process. Final concentrations ranged from 2.29 to 4.97 mmol L
-1
. The uninfected control 
culture showed a comparable initial L-lactate concentration of 1.11 mmol L
-1
 and also showed a 
slight immediate increase up to concentration of 1.90 mmol L
-1
 after approximately 55 h. From 
that point on the L-lactate concentration decreased until approximately 157 h and 0.03 mmol L
-1
 
before starting to increase again and reaching a concentration of 0.82 mmol L
-1
 after 
approximately 216 h. 
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Figure 4.28. Medium L-lactate concentration post infection at the three different MOI 
compared to an uninfected control culture. Initial concentrations were approximately 
1.5 mmol L
-1
 and increased to up to approximately 2.5 mmol L
-1
 during the first 24 to 48 h 
post infection. This was followed by a decrease lasting until approximately 72 to 96 h post 
infection and another subsequent continuous increase until the end of the process. A lower 
MOI seems to cause a higher final L-lactate concentration. Trendlines are intended to 
guide the eye only. 
 
Initial L-glutamate concentrations ranged from 7.46 to 8.43 mmol L
-1
. Depending on the 
MOI utilized cultures followed slightly different profiles (see Figure 4.29). Cultures infected 
with an MOI of 0.01 showed an initial slight increase in L-glutamate until day 2 post infection. 
Then values decreased again down to a minimum at around day 5 post infection before steadily 
increasing until the end of the process. Cultures infected with an MOI of 0.10 generally showed 
an L-glutamate concentration increase post infection until the end of the experiments without a 
distinguished minimum as described for MOI 0.01 cultures. Cultures infected with an MOI of 
1.00 also showed an increase right from the start but values leveled off at around day 3 post 
infection without any further increase. However, it has to be noted that some of these 
observations are barely significant due to the error associated with this analysis. Final 
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concentrations ranged from 8.12 to 9.57 mmol L
-1
. The uninfected control culture showed a 
comparable initial L-glutamate concentration of 7.83 mmol L
-1
 with values slightly increasing 
during the first 38 h. From that point on the L-glutamate concentration decreased again with a 
final value of 4.39 mmol L
-1
 after approximately 205 h. 
 
 
Figure 4.29. Medium L-glutamate concentration post infection at the three different MOI 
compared to an uninfected control culture. Initial concentrations were approximately 
8.0 mmol L
-1
 and increased to up to approximately 9.0 mmol L
-1
 until the end of the process 
for MOI 0.10 and 1.00. Cultures infected at MOI showed a slightly different profile with a 
slight decrease in L-glutamate during the first 24 h post infection before another increase 
and decrease up to 120 h post infection. Afterwards the L-glutamate concentration 
increased continuously until the end of the process and reached comparable levels to 
cultures infected at MOI 0.10 and 1.00. Trendlines are intended to guide the eye only. 
 
Profiles in medium L-glutamate concentrations for all three MOI seemed to differ slightly 
but differences observed were generally barely significant. Interestingly, the profile for the 
uninfected control culture somewhat resembled the data for the MOI 0.01 experiments, further 
confirming the fact that these cultures behaved mainly like uninfected cultures during the first 
0.0
2.0
4.0
6.0
8.0
10.0
12.0
0 24 48 72 96 120 144 168 192 216 240
L-
gl
u
ta
m
at
e
 in
 m
m
o
l L
-1
Time Post Infection in h
MOI 0.01 #1
MOI 0.10 #1
MOI 1.00 #1
Uninfected Control
96 
 
days post infection due to the very low initial virus concentration. During the later days the 
uninfected control continuously utilized L-glutamate while in the case of any infected culture 
L-glutamate was released into the medium. 
4.2.3 Fraction of Infected Cells 
Figure 4.30 shows the profiles obtained for the fraction of infected cells post infection at 
the different MOI. The percentage of infected cells for each of the three MOI showed different 
profiles but were relatively consistent within each MOI. The first main difference was found to 
be the initial percentages estimated immediately after infection. Generally, a higher MOI meant a 
higher initial percentage of infected cells. Values here ranged from 0.09 at MOI 0.01 to 14.15 % 
at MOI 1.00. While essentially all cells were infected eventually, as defined by percentages 
above 90 %, the time post infection at which this occurred was quite different at each MOI. 
While cultures infected at MOI 0.01 showed a relatively slow increase in the fraction of infected 
cells post infection and were eventually completely infected at around 72 h post infection, a 
faster increase observed at MOI 0.10 and 1.00. In those cases, a complete infection was already 
achieved at around 48 h post infection. Because samples were only analyzed in approximately 
24 h intervals, no further differentiation between the point of complete infection at these two 
MOI could be made. But it is obvious from the profiles, that the culture infected at the higher 
MOI of 1.00 should have reached the point of complete infection earlier, already indicated 24 h 
post infection, where between 32.97 and 52.94 % of the cells were infected, compared to only 
3.89 to 7.25 % in MOI 0.10 cultures. 
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Figure 4.30. Fraction of infected cells post infection at the three different MOI. A higher 
initial MOI resulted in faster infection kinetics and eventually earlier complete infection of 
the culture at approximately 48 to 72 h post infection. 
 
The rate of infection and the fraction of initially infected cells is a direct function of the 
MOI and as expected results obtained in this work showed significantly different profiles for the 
three MOI. Infection at a lower MOI led to lower fractions of infected cells early in the process 
and complete infection of the culture was delayed. The Poisson probability distribution can be 
used to model the baculovirus infection process and predict the fraction of initially infected cells 
as a function of the MOI 
24, 146-148
. Experimental values obtained in this work were compared to 
the theoretical predictions by the Poisson distribution (Equation 23) for the situation that each 
cell was infected by at least one baculovirus. 
 
         
    
  
       
Equation 23 
 
Data used in this comparison was from approximately 24 h (day 1) post infection, since it 
was assumed, that at this time the initially added virus particles had completed infection but no 
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significant subsequent infection by newly produced virus particles (secondary infection) had 
taken place yet
149
. This assumption could be verified by the fact that very little infectious virus 
particles had been produced until 24 h post infection for any MOI (see below, Figure 4.32). 
Results of this comparison are shown in Figure 4.31. Additional data extracted from literature 
and converted to a TCID50-based MOI is added to the plot for comparison
149
. Experimental 
values shown are mean values of the three replicates performed at each MOI ± one standard 
deviation and the assay error for the fraction of infected cells and MOI, respectively. 
 
 
Figure 4.31. Comparison of theoretical Poisson model vs. experimental and literature data 
for the fraction of infected cells at 24 hours post infection (primary infection). 
Experimental data from this work is comparable to the theoretical model as well as 
literature. 
 
Calculated mean experimental values were generally lower than estimated by the Poisson 
model but not significantly different when the 95 % confidence interval was taken into account. 
This was mainly due to the rather large error for the baculovirus titration of ± 0.5 log TCID ml
-1
. 
This caused a wide range of possible ―real MOI‖ around the targeted MOI at which the cultures 
could have actually been infected, as shown with the horizontal error bars. Additionally 
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suboptimal culture conditions at the time of infection could also have influenced the amount of 
infective virus particles available, e.g. by retaining in surface foam or suboptimal pH conditions. 
While it was out of the scope of this work, if desired more sophisticated models can be used if 
one wants to obtain more detailed information about the subsequent infection processes over 
time at the comparably low MOI utilized here. The literature gives several examples of this
149-153
. 
 
In summary, the relationship of MOI and the progress of infection early in the culture 
(24 H) as given by the proposed Poisson model was confirmed here. In industrial practice, a 
tradeoff is often necessary between the use of costly virus and the time required to achieve a 
complete infection and subsequent product formation. 
 
4.2.4 Production of Recombinant PCV2 ORF2 Baculovirus 
Upon infection with a recombinant baculovirus and if the target protein gene is controlled 
under one of the very late promoters, e.g. the polyhedrin promoter, the insect cell initially 
produces new virus particles before eventually shifting to recombinant protein production. To 
follow the baculovirus production kinetics at the different MOI the baculovirus concentration 
was measured in whole culture samples stored at -70 °C with an end-point dilution assay. 
 
Recombinant baculovirus concentrations for all three MOI showed overall similar 
profiles and were consistent within each MOI (see Figure 4.32). Generally, the recombinant 
baculovirus concentration initially remained relatively constant with no significant differences in 
concentration for the first 24 h post infection, but only the data for cultures infected at MOI 1.00 
may indicate a slight increase during this time. Different starting recombinant baculovirus 
concentrations immediately after infection were due to the different MOI used. The recombinant 
baculovirus concentration then continuously increased to reach its specific maximum 
concentration and remained constant within the error range of the assay once this concentration 
was reached. Maximum concentrations ranged from 7.63 to 8.50 log10 TCID50 ml
-1
. Noticeably 
the time of reaching this maximum concentration is different for the three MOI. Generally, the 
maximum recombinant baculovirus concentration was reached earlier the higher the MOI, more 
100 
 
specifically it took approximately 96, 72, and 48 h post infection to reach this point in the 
process for the MOI 0.01, 0.10, and 1.00, respectively. 
 
 
Figure 4.32. Recombinant PCV2 ORF2 baculovirus concentration post infection at the 
three different MOI. A higher initial MOI resulted in earlier recombinant PCV2 ORF2 
baculovirus production. Maximum concentrations were reached at different times ranging 
from approximately 48 to 96 for all MOI at approximately 8.0 log10 TCID50 ml
-1
. 
Trendlines are intended to guide the eye only. 
 
The described differences in the infection kinetics can also explain the observed 
differences in the production of recombinant baculovirus post infection. Generally, the lower the 
MOI cultures were infected with the later the peak in recombinant baculovirus concentration was 
observed. The release of budded virus usually occurs from approximately 6 to 8 h post infection 
and peaks around 17 to 20 h post infection
141
. Lower initial virus concentrations will lead to less 
immediately infected cells - as confirmed above – and therefore less new virus particles will be 
produced early in the process by these cultures. But subsequent infection processes will lead to 
an ever-increasing fraction of infected cells over time, which produce the recombinant 
baculovirus, and eventually lead to a complete infection. Recombinant baculovirus 
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concentrations generally peaked around 24 h after the time point when virtually all cells had 
been infected. This is in agreement with the 17 to 20 h of time needed from the time of infection 
to the peak in virus production. Interestingly no significant differences could be observed 
between the maximum recombinant baculovirus concentrations obtained after infection at the 
three different MOI. 
4.2.5 Production of Recombinant PCV2 ORF2 Protein 
The relative PCV2 ORF2 protein concentration for all three MOI showed overall similar 
profiles and is shown in Figure 4.33. The first time protein was detected at approximately 96, 72, 
and 48 h post infection for cultures infected at MOI 0.01, 0.10, and 1.00, respectively. From this 
point on the protein concentration increased continuously (with some fluctuations due to assay 
variation) to reach a maximum at the end of the process. The final PCV2 ORF2 protein 
concentrations ranged from 2.2 to 4.8 RP. It has to be noted, that even taking the large error 
range of the assay into consideration the PCV2 ORF2 antigen expression seemed to be more 
consistent within each MOI the higher the MOI was. Especially the data for cultures infected at 
MOI 0.01 showed a rather wide spread of the three data sets and significant differences in 
harvest concentrations determined. This spread seemed to narrow for MOI 0.10 and especially 
1.00 (see Appendix E - ). 
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Figure 4.33. Recombinant PCV2 ORF2 protein concentrations post infection at the three 
different MOI. A higher initial MOI resulted in earlier recombinant PCV2 ORF2 protein 
production. Maximum concentrations were generally reached at the end of the process. 
Infection at all MOI was capable of producing PCV2 ORF2 protein at a volumetric yield of 
approximately 4.0 RP after 168 to 216 h post infection but variability increased greatly 
with decreasing MOI (see Appendix E - ). Trendlines are intended to guide the eye only. 
Overall, the same trends could be observed in the profiles for the recombinant 
PCV2 ORF2 protein concentration but a lower MOI generally led to a slower increase in the 
PCV2 ORF2 protein concentration. Because the expression of the PCV2 ORF2 gene is regulated 
under the very late polyhedrin promoter, production started approximately around 15 to 20 h post 
infection
20, 152
. Consequently, the first significant amounts of the PCV2 ORF2 protein could be 
detected approximately 24 h after a major fraction of the cells had been infected. Figure 4.34 
shows the overall trend observed. Harvest PCV2 ORF2 protein concentration seemed to increase 
with MOI but statistical analysis revealed that the differences observed are not significantly 
different (p > 0.05 in all cases, by using a t-test assuming unequal variances, see Appendix F - ). 
Nevertheless, the consistency of PCV2 ORF2 harvest concentrations improves greatly with 
increasing MOI (from 33 to 3 % standard deviation). This behavior is presumably due to the fact 
that even small deviations in the viable cell density and amount of virus added, both together 
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eventually constituting the ―real MOI‖, but also in the time of infection, are amplified in 
situations below MOI 0.10 and may lead to fluctuations
1
. Nevertheless, MOIs as low as 3 x 10
-5
 
have been used to successfully produce recombinant protein with the baculovirus expression 
vector system
154
. 
 
 
Figure 4.34. Dependency of harvest recombinant PCV2 ORF2 protein concentration on 
MOI. Variability in the harvest PCV2 ORF2 concentration decreased greatly with 
increasing MOI. Values shown are mean ± standard deviation based on the three replicates 
performed at each MOI. 
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In addition to the overall volumetric recombinant PCV2 ORF2 protein yield of the 
process, the specific productivity per unit of viable biovolume or cells is an important parameter 
to consider. While eventually the volumetric concentration of recombinant protein at the time of 
harvest may be the most important factor in the routine vaccine production, the specific yield has 
important implications for downstream processes and the overall effectivity of the process in 
terms of yield and cost compared to the raw materials and work invested. To obtain a measure of 
the mean specific yield of a respective culture the harvest PCV2 ORF2 protein concentration was 
divided by the observed maximums of viable biovolume and cell density during that respective 
culture. Figure 4.35 and Figure 4.36 show the calculated specific yields. 
 
 
Figure 4.35. Dependency of the specific recombinant PCV2 ORF2 protein productivity per 
observed maximum viable biovolume on MOI. Mean specific yields were approximately 2.5 
times higher at MOI 1.00 than at 0.01.Values shown are mean ± standard deviation based 
on the three replicates performed at each MOI. 
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Figure 4.36. Dependency of the specific recombinant PCV2 ORF2 protein productivity per 
observed maximum viable cell density on MOI. Mean specific yields were approximately 3 
times higher at MOI 1.00 than at 0.01.Values shown are mean ± standard deviation based 
on the three replicates performed at each MOI. 
 
A rather large discrepancy could also be observed for the specific PCV2 ORF2 protein 
yields for the three different MOI. Generally, a strong dependence of the specific yields on the 
MOI could be observed. It was found (by using a t-test assuming unequal variances, see 
Appendix F - ), that the means at all MOI were statistical significantly different with p < 0.05, 
except between MOI 0.01 and 0.10 (p = 0.09 and 0.07 for the biovolume and cell correlation, 
respectively). Mean specific yields at MOI 1.00 were up to three times higher than at MOI 0.01 
with mean values increasing from 
9.9 to 33.7 x 10
-7
 RP ml µm
3
 or 2.0 to 5.1 x 10
-10
 RP ml cell. This indicates a more effective 
intracellular PCV2 ORF2 production process with increasing MOI. This may be facilitated by 
the fact that the cultures at higher MOI replicate less post infection and therefore all available 
resources, in terms of nutrients and the intracellular apparatus, can be channeled into the 
recombinant baculovirus and eventually protein production. 
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4.2.6 Dielectric Spectroscopy 
With few exceptions, the data recorded for the three replicate processes performed at 
each MOI was consistent and comparable. Therefore, only one process at each MOI is shown in 
the following plots to ensure clarity of the plots. Additionally, the recorded data for an 
uninfected control culture is shown in each plot for comparison. 
 
Figure 4.37 gives an overview of the dielectric increment Δε profiles post infection at the 
three MOI utilized in this work. Initial Δε values ranged from about 5.00 to 8.00 pF cm-1 and 
generally increased immediately post infection for infection at all three MOI, peaked and then 
started to decrease again. Peak values were generally reached earlier the higher the MOI, 
occurring from approximately 48 to 74 h post infection. Interestingly the shape of the increase 
for the three different MOI was also different. Δε values for MOI 0.01 and 0.10 showed a slower 
increase during the first 24 h post infection than observed for MOI 1.00. In addition, MOI 0.01 
data also showed a small plateau phase from around 48 h post infection before increasing again. 
Peak values reached were approximately 42.00, 55.00, and 38.00 pF cm
-1
 for infection at MOI 
0.01, 0.10, and 1.00, respectively. Once Δε had reached its specific peak value, it decreased 
continuously until the culture was terminated. This decrease is relatively slow for another 24 to 
48 h – depending on the experiment - before a drop-off in the signal could be observed and the 
signal then fell rapidly thereafter. Δε for the uninfected control culture was relatively similar to 
the MOI 0.01 process during the first 48 h of the process and also exhibited the mentioned 
plateau in Δε around the same time. But the plateau observed in the uninfected control culture 
was much more prominent and lasted about 24 h longer than in the infected culture. Following 
the plateau Δε started to increase again slowly in the control culture until reaching a secondary 
plateau around 120 h into the process, followed by another but slower subsequent increase. Δε 
never really peaked or exhibited the subsequent decrease observed in the infected cultures. 
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Figure 4.37. Dielectric increment Δε post infection at the three different MOI. Δε increased 
immediately post infection from below 10.0 pF cm
-1
 to values as high as approximately 
55.0 pF cm
-1
 after approximately 48 to 72 h post infection. Highest peak values were 
generally reached at MOI 0.10 but the time of the peak was delayed with decreasing MOI. 
Δε decreased continuously afterwards until the end of the process. 
 
Δε is directly related to the volume fraction of viable cells P or viable biovolume, which 
increased significantly immediately post infection. But other than in the case of the uninfected 
cells described earlier, this time the viable cell diameter also changed during the process and 
therefore additionally affected Δε. In the case of MOI 1.00 cell size changes in the viable cell 
diameter were observed as early as 24 h post infection while it took approximately 48 h until 
significant changes were observed in cultures infected at MOIs 0.10 and 0.01. Therefore, 
significant influences on the viable cell size on Δε can be excluded until these points post 
infection but not thereafter. While the volume fraction of viable cells (viable biovolume) 
determined off-line usually peaked around 72 h post infection, this was not always the case for 
Δε. For MOI 0.10 and 1.00 Δε peaked significantly earlier, approximately 60 and 48 h post 
infection, respectively. This might be rationalized with the influence of the viable cell size on Δε 
as described earlier. In the cases of MOI 0.10 and 1.00, the viable cell size changed and leveled 
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off earlier during the process and therefore may have contributed to this observation. 
Nevertheless, it has to be taken into account, that off-line samples for the determination of the 
viable biovolume were only taken approximately every 24 h so that slight time shifts for the 
respective peaks may be explained by this. Additionally the change in the settings from 
approximately 120 h (day 5) post infection may have lead to deviations in the biovolume 
calculations late in the process because these settings usually estimated the viable cell diameter 
to be higher. 
 
Another factor possibly affecting Δε is the specific cell membrane capacitance Cm. In this 
work, Cm was not measured directly but could be calculated based on Equation 4 using the viable 
cell density and size obtained by off-line measurements (Vi-CELL XR) for each sample point. 
Cm profiles obtained by this calculation are shown in Figure 4.38. 
 
 
Figure 4.38. Specific membrane capacitance Cm post infection at the three different MOI. 
Values ranged from approximately 0.6 to 2.0 µF cm
-2
 during the first 120 h post infection 
but did not show any distinct differences at different MOI. Late in the process, some 
cultures showed strong increases in Cm but it remains unclear if this is indeed a true 
representation of the reality. 
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Calculated values for Cm ranged from 0.61 to 2.03 µF cm
-2
 during the first approximately 
120 h post infection but did not show any distinct differences or trends between the three 
different MOI. After this, some of the cultures showed strong increases in Cm but at this point it 
remains unclear why this is the case. Often it is assumed that cell death goes along with a 
decrease in Cm due a loss in membrane structure and rounding. Such a behavior has been 
reported in the literature
138, 155-157
. But other contradictory literature actually reports an increasing 
Cm during cell death, presumably due to increased folding of the membrane when the cells shrink 
and cell components leak out or other membrane properties change
158, 159
. Trends observed for 
Cm are in accordance with the latter. The switch in the Vi-CELL XR settings after approximately 
120 h (day 5) post infection and the observed changes also seem unreasonable to explain this 
behavior. The specific cell membrane capacitance Cm is generally interpreted to be dependent on 
the level of folding of the cellular membrane
73, 74
 and was originally thought to be a cell 
biological constant with a value of approximately 1.00 ± 0.5 µF cm
-273, 87, 125, 126
. Recent research 
suggests that this assumption is not entirely true and Cm can indeed be influenced by cell 
viability, physiological state, virus infection and release or during overexpression of cation 
channels
12, 73, 139
. Data specifically for Spodoptera frugiperda derived cells is scarce and only one 
publication reports values for Cm in the range of 0.55 to 0.85 µF cm
-2
 for infected Sf-9 cells (no 
MOI given, but presumably higher than in this work due to observed immediate arrest in cell 
division post infection). But these values were also not obtained directly by measurements but 
rather calculated based on dielectric spectroscopy measurements and a simplified dielectric cell 
model
127
. Interestingly, in the work cited the specific membrane capacitance Cm increased during 
the first 20 h post infection and then again dropped later in the process, a behavior that was not 
observed in this work. 
 
The calculations above are assuming that the theoretical relationship stated in Equation 4 
is valid even in the case of cell death. It had been developed based on the so-called single shell 
model, representing the cell as a conductive core surrounded by a non-conductive shell. 
Successful staining of the cells with trypan blue late in the process (by Vi-CELL XR) suggests, 
that the membrane permeability indeed increased, in case of a non-permeable membrane trypan 
blue should not have been able to enter the cell. While usually not done when using DS in cell 
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culture technology, the use of a modified relationship based on a shell model with a highly 
conductive shell is suggested for such situations
87
 and described in Equation 24 
 
   
        
            
 
  
   
 
    
   
  
Equation 24 
 
where Gm is the membrane conductance in S. This modified relationship takes the 
membrane conductance Gm into account and therefore may be better suited to describe the 
behavior of Δε late in the process. An increase in Gm, as suggested by the decreasing viability 
determined with trypan blue staining, would further contribute to a typically observed decrease 
in Δε. Because neither Cm nor Gm was directly measured in this work, no further statement about 
the behavior of those two parameters can be made at this point. Further research is required to 
address this issue. 
 
The second ß-dispersion parameter provided by the instrument was the characteristic 
frequency fc, which is thought to be influenced by the cell radius r, the specific cell membrane 
capacitance Cm, and the intracellular and medium conductivities ζi and ζe, respectively (see 
Equation 6). Profiles for this parameter are shown in Figure 4.39. The characteristic frequency fc 
for the three MOI started at around 600 kHz for all MOI but showed slightly different profiles 
during the process. In the case of infection at MOI 0.01 the signal initially increased slightly for 
about 30 h post infection followed by a decrease and a minimum reached at around 72 h post 
infection. From that point on fc continuously increased until the end of the process. Data for MOI 
0.10 generally also showed a slight increase in characteristic frequency post infection until about 
30 h post infection from which point on a decrease could be observed also. A minimum in fc 
could be observed at around 60 h post infection after which the characteristic frequency started 
to increase again until approximately 100 h post infection. In contrast to the observations for 
MOI 0.01 and 0.10, fc for experiments performed with MOI 1.00 started to decrease immediately 
post infection. Again, a minimum in the signal was reached at approximately 48 h post infection 
and followed by a subsequent increase until the end of the process. Noticeably the increase 
slowed down at around approximately 72 h but picked up again at approximately 96 h post 
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infection. The shift in fc observed at around 120 h post infection for the culture infected at MOI 
1.00 was due to a technical issue and does not represent any actual change in the culture. In 
contrast to the changes observed in case of an infection with the recombinant PCV2 ORF2 
baculovirus, the characteristic frequency in the uninfected control culture remained relatively 
constant during the first 56 h, but then increased slightly during the next 20 h. Afterwards fc 
approximately remained constant until the end of the process. Overall, fc was usually slightly 
higher than in the infected cultures, with exception of the first 30 h where the signal was close to 
the values observed for MOI 0.01. 
 
 
Figure 4.39. Characteristic frequency fc post infection at the three different MOI. fc 
generally decreased slightly from approximately 600 kHz during the first 48 to 72 h post 
infection and was followed by another subsequent increase once a local minimum had been 
reached. The time of the minimum was delayed with decreasing MOI and different 
absolute minimum values were reached. Some of the cultures showed another strong 
increase in fc late in the process but the exact reason for this remains unknown. 
 
In contrast to the uninfected cell growth in the precultures described earlier, the infected 
Sf-9 clone cell cultures all showed significant changes in the characteristic frequency fc post 
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infection. The characteristic frequency fc is, according to Equation 6, directly influenced by the 
cell radius r, the specific cell membrane capacitance Cm and the intracellular and medium 
conductivities ζi and ζe, respectively. The observed early decrease in fc post infection generally 
occurred once the average viable cell diameter started to increase due to cell baculovirus 
infection induced swelling. This decrease occurred delayed for cultures infected at lower MOI 
because of the previously discussed overall slower infection progress and so viable cell diameter 
changes. The same was true for the observed minimum between approximately 48 and 72 h post 
infection. While the decrease in fc due to an increase in the viable cell diameter is in accordance 
with the underlying theories, the minimum observed in the characteristic frequencies did not 
always occur at the same time as the peak observed in viable cell diameter. For example, for 
cultures infected at MOI 0.01 the minima in fc occurred before the actual peak in viable cell 
diameter was observed, at 72 and 96 h post infection, respectively. Additionally the observed 
subsequent increase in fc occurred for all MOI generally earlier than a respective decrease in 
average viable cell diameter was observed. Overall similar values and a similar profile for fc 
during a synchronous infection at a much higher MOI of 10 of Spodoptera frugiperda Sf-9 cells 
was observed before, but deviations in fc from the cell size profile in that study could also not be 
explained conclusively
12
. It has to be mentioned again, that sampling in this work was only 
performed every 24 h and therefore may not be able to represent changes at the exact time they 
happened in the cultures. As stated above, other parameters affecting fc are the specific cell 
membrane capacitance Cm and the intracellular and medium conductivities ζi and ζe respectively. 
As shown before Cm did not change significantly during the first 120 h post infection, and 
therefore presumably did not have a great influence on fc during this time. 
 
The suspension conductivity profiles for each MOI were relatively similar and are shown 
in Figure 4.40. Generally, immediately after infection and after a short stabilization phase due to 
the medium addition and subsequent temperature adjustments, the suspension conductivity 
started to decrease. At some point during the process, ζs then reached a minimum with values 
ranging from 15.16 to 15.36 mS cm
-1
. The time of occurrence of this minimum varied from 
approximately 84 h to 72 h post infection for MOI 0.01 to 1.00, respectively. From this point on 
ζs started to increase again until the end of the specific process. Observed spikes in the profiles 
were generally due to slight temperature changes of the culture, which in turn were caused by 
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changes in the room temperature. In contrast to this, the suspension conductivity profile for the 
uninfected control cultured showed a constant decrease during the process while flattening out 
after approximately 150 h. The temporary decrease observed between 150 h and 180 h appears to 
be an artifact and could not be related to a culture medium temperature decrease within this time. 
 
 
Figure 4.40. Suspension conductivity ζs post infection at the three different MOI. Initial 
values measured for ζs were approximately 15.4 mS cm
-1
 and generally decreased post 
infection until a minimum was reached at approximately 72 to 84 h post infection. This was 
followed by an increase in ζs until the end of the process. 
 
Most probable explanation for the observed suspension conductivities profiles are the 
increase, and later decrease, in viable biovolume. As cells divided and swell post infection, the 
fraction of volume they take up in each unit of the suspension, the viable biovolume, increased. 
Because the viable biovolume essentially hinders the conduction of charges throughout its 
fraction due to the non-conductive cell membrane, former conductive ―material‖ was replaced by 
non-conductive ―material‖ and the measured ζs decreased. The opposite was true later in the 
process when ζs increased again. The viable biovolume decreased significantly and caused a 
decrease in non-conductive material per unit volume of cell suspension. Therefore, ζs increased 
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again. Additionally the take up and release of charged particles from the medium by the cells 
could have theoretically contributed to the observed changes. Calculated profiles for ζe, using 
Equation 7, only showed minor variations and therefore this can be assumed to only have had 
minor effect on ζs (data not shown). The same is true for the effect on the characteristic 
frequency fc. But the latter can also be affected by the intracellular conductivity ζi and while ζi 
was not measured directly in this work, at this point it can be calculated using and Equation 6. 
Obtained profiles can be seen in Figure 4.41. 
 
 
Figure 4.41. Intracellular conductivity ζi post infection at the three different MOI. Initial 
values determined for ζi ranged from approximately 3.0 to 5.0 mS cm
-1
 but no major 
changes were observed during the first 72 h post infection. Late in the process, some 
cultures showed strong increases in ζi but it remains unclear if this is indeed a true 
representation of the reality. 
 
Generally, the calculated ζi values ranged from 2.79 to 5.44 mS cm
-1
 immediately post 
infection and seemed to slightly increase for most of the cultures over time. Approximately from 
72 h post infection significant differences in the profiles could be observed with some cultures 
showing a rather strong further increase, while a few remained relatively constant before 
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
0 24 48 72 96 120 144 168 192 216
In
tr
ac
e
ll
u
la
r 
co
n
d
u
ct
iv
it
y 
in
 m
S 
cm
-1
Title
MOI 0.01 MOI 0.10 MOI 1.00 Uninfected Control
115 
 
eventually also strongly increasing very late in the process. The switch in the Vi-CELL XR 
settings after approximately 120 h (day 5) post infection may explain the observed unreasonable 
strong increases thereafter. ζi is generally interpreted as the ability of the cell’s interior to 
conduct electrical current and changes are presumably due to different ion concentrations within 
the cell
73, 75. Until recently studies often treat ζi as independent on the physiological state
73, 125, 
132, 133
 but it is well known that this value can indeed change in apoptotic and necrotic cells, when 
morphological changes are induced and when cell membrane conductance is increased, i.e. by 
treatment with antibiotics
134-138
. To the knowledge of the author, no literature values for ζi in 
Spodoptera frugiperda cells have been published. In mammalian cell cultures ζi usually falls 
somewhere in between 2 and 9 mS cm
-1
 with some researchers suggesting an even narrower 
range of 3 to 5 mS cm
-173, 75, 125, 139, 140
. Values calculated in this work fell in this range for the 
majority of the time but especially extreme values observed late in the processes seem to be 
rather unreasonable. They were caused by very high values obtained for the characteristic 
frequency fc late in these processes but the reason for this behavior in fc is not fully understood at 
this point. None of the investigated parameters affecting fc, mainly the viable cell radius r, Cm, 
and ζe, supported this kind of increase. 
 
The Cole-Cole α showed slightly different profiles for infections at the three MOI, as 
shown in Figure 4.42. Immediately post infection α dropped slowly from slightly below 0.10 to 
about 0.08 for infection at all three MOI. After am minimum was reached between 24 and 36 h 
post infection α increased again to a peak of about 0.11 between 54 to 84 h post infection. This 
peak was generally reached the earlier the higher the MOI. Subsequently α decreased before 
increasing once again to another local peak. After this secondary peak was reached α 
continuously decreased until the end of the process at all three MOI. The shift in α around 120 h 
post infection is due to a technical issue and not cell culture related. The uninfected control 
culture showed a different profile for the Cole-Cole α. While starting at approximately the same 
value immediately post infection, α increased up to around 0.11 at about 50 h post infection and 
then continuously decreased until the end of the process to approximately 0.08, showing less of 
the observed changes than the infected cultures. 
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Figure 4.42. Cole-Cole α post infection at the three different MOI. α decreased immediately 
post infection from slightly below 0.10 to approximately 0.80 during the first 24 to 36 h post 
infection for all MOI. Afterwards a strong increase up to approximately 0.11 between 54 to 
84 h post infection was detected which generally occurred the earlier the higher the MOI. 
Afterwards α first decreased again, which was followed by another increase up to a local 
peak. Thereafter α eventually continuously decreased until the end of the process. 
 
The parameter Cole-Cole α is an empirical value describing the decrease in capacitance 
measured with increasing frequency. The parameter α can assume values between 0 and 1 where 
0 describes a very steep and 1 an infinitely shallow fall in capacitance. In cell culture 
applications α is generally interpreted as a measurement of viable cell size distribution and shape 
believed to increase when the cell size distribution widens
12, 80
 with values observed typically 
between 0.1 and 0.2
128
. But the physical origin of this parameter is continuously under discussion 
and may indeed also be influenced by several other effects including morphology of extracellular 
spaces, the mobility of membranous proteins and the fractal nature of dielectric relaxation
128-131
. 
Vi-CELL XR data for the viable cell size distribution did not support the observed changes in α. 
The measurements performed may have been to insensitive but also other factors, as discussed 
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above, could have caused the changes in Cole-Cole α. Overall the Cole-Cole α was judged to be 
inconclusive in this work. 
 
In addition to the three ß-dispersion parameters and the suspension conductivity, the 
Biomass signal, based on the dual frequency method, was recorded by the instrument. The 
Biomass signal was obtained by measuring the capacitance (permittivity) at a frequency close to 
the specific fc of the cell culture system utilized (here 1000 kHz), the so called working 
frequency, and subtracting the capacitance (permittivity) obtained at a very high frequency (here 
10000 kHz). The latter adjusts the measurement for changes in the medium background 
capacitance (permittivity) over time
108
. Figure 4.43 shows the Biomass signal evolution post 
infection. 
 
The Biomass signal, thought to be a cell size independent measure of the viable 
biovolume, generally increased immediately post infection for all MOI but peak values reached 
were different and shifted in time. More specifically, initial Biomass values observed were 
around 2.00 pF cm
-1
 and peak values were generally higher but reached later the lower the MOI. 
For example, in experiments utilizing a MOI of 1.00 the maximum value of about 8.00 pF cm
-1
 
was reached around 72 h post infection, while this was the case at 80 and 100 h post infection for 
MOI 0.10 and 0.01, respectively. In these two cases, the maximum values observed were about 
10.00 and 12.00 pF cm
-1
. Interestingly the shape of the increase for the three different MOI was 
also quite different, indicating different evolutions in the viable biovolume. The signal for MOI 
0.01 showed a rapid increase directly from the beginning but at around 50 h post infection a 
distinct plateau could be observed. The signal for MOI 0.10 also showed a plateau at around the 
same time but it was generally less prominent. In the case of MOI 1.00, there was no real plateau 
phase detectable and the signal increased at a more or less constant rate to the specific peak 
value. Once the Biomass signal had reached its specific peak value it decreased continuously 
until the end of the process. While the signals for MOI 0.01 and 0.10 first showed a comparably 
fast decrease before slowing down, the decrease for MOI 1.00 was relatively constant until the 
end of the process. The Biomass signal recorded for the uninfected control culture resembled the 
MOI 0.01 profile somewhat, especially during the first 96 h of the process. In addition, the same 
distinct plateau in the signal could be observed around 48 h into the process. From 96 h into the 
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process the signal for the uninfected control culture continued to increase without ever peaking 
during the process but also showed a secondary plateau around 120 h into the process. After 
about 205 h a Biomass value of approximately 16.00 pF cm
-1
 was reached. 
 
 
Figure 4.43. Biomass signal post infection at the three different MOI. The Biomass signal 
increased immediately post infection from approximately 2.5 pF cm
-1
 up to a maximum 
value of approximately 12.0 pF cm
-1
. Generally, decreasing maximum Biomass signals were 
observed for increasing MOI and the peak occurred earlier. Distinct plateau phases could 
be observed in especially the MOI 0.01 culture. After the respective peak, the Biomass 
signal decreased continuously until the end of the process. 
 
The Biomass signal is often used for viable biovolume estimation because due to the 
nature of its measurement, it is believed to be independent, or at least less influenced, by changes 
in cell size. As with Δε, the general increase in the Biomass signal starting immediately post 
infection can be attributed to an increase in the volume fraction of viable cells (viable 
biovolume). Interestingly the Biomass signal also showed some plateaus during the initial 
increase up the respective peaks. These plateaus were particularly visible for experiments at MOI 
0.01 but still detectable at MOI 0.10. In both cases the plateau phase started at around 48 h post 
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infection. In the case of MOI 1.00, no plateau was observed. Since no samples were taken 
during, immediately before, and after these plateaus, no specific explanation for their occurrence 
can be given at this point. Assuming the Biomass signal to be a true representation of the viable 
biovolume, possible explanations include a temporarily leveling-off of the viable cell count, 
viable cell diameter or both. The peak in the Biomass signal generally occurred approximately at 
the same time as the peak in the calculated viable biovolume. Some deviations from this could be 
observed in the case of MOI 0.01 where the peak in the Biomass signal occurred delayed, up to 
approximately 24 h, compared to the viable biovolume. But again, due to the sampling frequency 
data at the actual sampling point may not represent the real maxima actually achieved during the 
process and therefore slightly differ.  
 
The dielectric spectroscopy measurements obtained by the FOGALE iBiomass 465 
instrument were used to generate correlations to estimate cell culture related variables on-line 
and in real-time. Based on the theory, the capacitance and permittivity measured correlate 
linearly to the volume fraction of the viable cells (viable biovolume) in the cell culture 
suspension. To verify this theory the viable cell densities and mean viable cell diameters 
obtained for every sample during cell growth were used to calculate the viable biovolume, 
assuming a spherical cell shape. This value was then paired with its raw capacitance values at 
each of the 16 frequencies adjusted for the medium background capacitance by subtracting the 
value measured at 10000 kHz. In addition, the polarization adjusted Biomass and Δε signals were 
also used. The Pearson correlation coefficient r was then calculated for each combination to 
obtain a measure of linearity of the correlation. Therefore the data of all nine processes, a total of 
78 data points, was used in this analysis. Results are given in Table 4.6. 
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Table 4.6. Pearson correlation coefficients for viable biovolume and dielectric spectroscopy 
signals in infected cultures. 
 
 
Generally, signals at frequencies below 3000 kHz provided reasonable good correlations. 
Determined Pearson correlation coefficients for the Δε and Biomass signals were 0.902 and 
0.904, respectively and the obtained correlations are shown in Figure 4.44 and Figure 4.45. The 
best linear correlation based on the raw capacitance measurements at single frequencies was 
obtained at 720 kHz with 0.907. As expected with the observed viable cell size changes, the 
correlation based on the cell size independent Biomass signal provided better slightly better 
results than the correlation with the Δε signal. Nevertheless, the latter is still quite acceptable. 
The correlations obtained for these infected cultures are of a slightly lower quality than for the 
uninfected cells in the precultures (Pearson correlation coefficient of 0.957 and 0.938). In 
addition to the added variability due to viable cell size changes, the cells presumably underwent 
changes in their dielectric properties due to infection, virus, and recombinant protein production, 
and cell lysis later in the process. Additionally cells that might be determined as ―dead‖ with off-
line measurements like the trypan blue staining in the Vi-CELL RX, may still contribute to the 
dielectric signals measurements. Such a behavior was described earlier in the literature and also 
seems to be apparent here 
7, 46
. 
 
Signal Pearson r
Delta ε 0.902
Biomass 0.904
C(300 kHz) 0.853
C(373 kHz) 0.878
C(465 kHz) 0.894
C(578 kHz) 0.903
C(720 kHz) 0.907
C(897 kHz) 0.905
C(1117 kHz) 0.900
C(1391 kHz) 0.890
C(1732 kHz) 0.879
C(2156 kHz) 0.867
C(2684 kHz) 0.834
C(3342 kHz) 0.804
C(4161 kHz) 0.780
C(5181 kHz) 0.751
C(6451 kHz) 0.705
C(8031 kHz) 0.625
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Figure 4.44. Linear correlation viable biovolume vs. Δε post infection. 
 
 
Figure 4.45. Linear correlation viable biovolume vs. Biomass signal post infection. 
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The two linear correlations obtained can be described by the equations 
 
                                  
  
  
 
   
  
 
Equation 25 
 
and 
 
                                           
  
  
 
   
  
 
Equation 26 
 
Correlations with the viable cell density were of much lower quality in general. 
Correlations obtained for the Δε and Biomass signals had Pearson correlation coefficients of 
0.684 and 0.714, respectively, while the best correlation at a single frequency was again obtained 
at 720 kHz with a Pearson correlation coefficient of 0.707. Therefore, a use of these for the 
estimation of viable cell density post infection is not suggested. 
 
Overall, the results obtained are of significantly lower quality than for the uninfected 
cells in the precultures. For the viable biovolume the observed changes in viable cell diameter 
significantly reduced the quality of the linear correlation with Δε, as was expected based on the 
theoretic dielectric cell model. For the correlation with the Biomass signal a lesser reduction in 
quality was found, which may still be acceptable. Therefore, the claim of better representation of 
the ―true‖ volume fraction of viable cells P (viable biovolume) seems to be justified. However, 
while it had been possible to estimate viable cell densities directly with a linear relationship 
during the uninfected cell growth, this is not possible anymore with a sufficient accuracy post 
infection. Reasons for this are the change in viable cell diameter post infection and presumably 
changes in the dielectric properties of the cells. Samples late in the process may also suffer from 
less accurate estimations of viable cell density and mean viable cell diameter. Overall, the quality 
of the correlations is not high enough for the reliable use in routine vaccine production. 
Therefore, a multivariate modeling approach was taken to account for the changes in multiple 
variables. While such a model will be more complicated in terms of the equation(s) obtained, it 
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should provide estimations for more variables at the same time, e.g. also viable cell diameter, 
and provide these with a lower error. More details on this approach are given in Chapter 4.2.9. 
 
4.2.7 Detection of Culture Events in Real-Time by Dielectric Spectroscopy 
The infection of Spodoptera frugiperda insect cell cultures at MOIs below 1.00 generally 
means that the process is strongly dependent on subsequent (secondary) infection by newly 
produced virus particles and shows significant differences in regards to kinetics and yields 
achieved post infection. This was confirmed by the experiments performed in this work. While 
the infection at MOIs between 0.01 and 1.00 also led to significantly different profiles in the 
dielectric spectroscopy signals depending on the MOI, specific observations in the dielectric 
spectroscopy signals could be related to important events in the cultures throughout the whole 
range of investigated MOI making them a potentially very useful tool for the routine monitoring 
of industrial scale bioprocesses utilizing the baculovirus expression vector system. 
 
The dielectric increment Δε increased immediately post infection, presumably due to the 
increase in viable biovolume through an increase of viable cell density and in the individual cell 
volume. At some point post infection Δε peaked and decreased again subsequently. The time of 
the peak ranged from approximately 48 to 74 h post infection and occurred the earlier the higher 
the MOI. Off-line analyses showed, that at approximately the same time the culture was 
―completely‖ infected with fractions of infected cells around 95 %, signaling the end of the 
infection process in the cultures. This is shown in Figure 4.46. Slight deviations could be 
observed for cultures infected at MOI 0.10, where the peak in Δε occurred slightly later than the 
detected ―complete‖ infection, but the difference was only a few hours. Additionally, because 
samples for off-line analyses were only taken approximately every 24 h, the precise time of 
complete infection in the cultures may not coincide with the time of sampling. 
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Figure 4.46. Comparison of Δε with the time of complete infection in the culture at the 
three different MOI. Complete infection was detected around the peak in Δε and is 
indicated by the red vertical lines. 
 
Another dielectric spectroscopy signal, the Biomass signal, could also be used to detect 
another specific event in the cultures. Like Δε, the Biomass signal increased immediately post 
infection, but peaks were reached slightly later at approximately 72 to 100 h post infection, 
depending on the MOI. The Biomass signal generally tracked the viable biovolume post 
infection and peaked at the same time as this with some minor deviations observed and described 
earlier. In addition, the peak in the Biomass signal also coincidenced with the recombinant 
baculovirus concentration reaching its maximum value in the specific process before leveling off 
thereafter. This comparison is shown in Figure 4.47. Again, slight deviations caused by the 
sampling frequency need to be considered. 
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Figure 4.47. Comparison of Biomass Signal with the time of peak recombinant baculovirus 
concentration at the three MOI. The peak in recombinant baculovirus concentration was 
achieved at approximately the occurrence of the peak in the Biomass signal and is indicated 
by the red vertical lines. 
 
The agreement in these two parameters can be explained with the changes and processes 
in a Spodoptera frugiperda insect cell post infection. Once the cell is infected, it starts replicating 
the recombinant baculovirus and production thereof peaks around 17 to 20 h post infection. The 
cell also starts swelling. Therefore, the peak in baculovirus concentration can reasonable be 
expected approximately 20 h after the culture was completely infected. Additionally at this time 
approximately the peak in viable biovolume should be reached due to the induced cell swelling 
before significant amounts of the cells have died due to cell lysis. 
 
Especially the connection of the Biomass signal and the baculovirus concentration could 
be very useful in the routine monitoring and operation of industrial scale baculovirus expression 
vector system processes. Working seed stocks of the recombinant baculovirus have to be 
produced regularly for subsequent recombinant protein production. Production of high quality 
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MOI below 0.10. As already mentioned earlier, the process becomes prone to fluctuations at 
these low MOI and therefore optimal harvest time to achieve maximum baculovirus titer may 
shift considerably. With the use of the dielectric spectroscopy, the time of harvest could be 
detected in-line and in real-time without the need of sampling the reactor or relying on pre-
established fixed harvest time criteria, which may result in premature harvest with sub-optimum 
baculovirus concentration. On the other hand, a harvest too late may also affect baculovirus 
quality in terms of infectivity and recombinant protein expression capability and could be 
avoided when using the dielectric spectroscopy as a real-time monitoring device. Obviously, and 
maybe even more importantly, the same approach could also be applied in bioprocesses where 
the baculovirus itself is the desired product and not some recombinant protein. It should be noted 
that validity of these statements should be checked for each specific application and 
(downstream) procedure. In cases where the produced baculovirus seed is not directly harvested 
and frozen without further processing to remove any cells but rather filtered or centrifuged, the 
extracellular only baculovirus concentration may peak slightly delayed. Nevertheless, even in 
such a case a criterion based on dielectric spectroscopy could be developed. 
 
An additional observation made during the low MOI experiments was the occurrence of a 
plateau region in the Biomass signal, which was especially prominent in the cases of an infection 
at MOI 0.01 and 0.10. While the exact cause for this plateau could not be identified due to the 
limited sampling frequency for off-line analysis, it occurred at approximately the same time as 
the L-glutamine depletion in the cultures. Since the Biomass signal is supposedly, and confirmed 
by experimental data in this work, a measurement of the volume fraction of viable cells (viable 
biovolume) it seems appropriate to say that the increase in biovolume leveled off during the time 
of the observed plateau phase. The fact that the plateau was nearly invisible in MOI 1.00 cultures 
may be explained by the fact that the depletion in L-glutamine occurred later in these cultures 
when the Biomass signal already had reached its peak and was starting to decrease again, 
therefore being somehow being overlayed. Interestingly such a plateau could also be observed in 
the uninfected control culture indicating it was not necessarily limited to infected cultures and 
the accompanying changes in the cell’s physiological and dielectric properties. Even in this case 
the plateau coincided with the depletion of L-glutamine in the medium. These observations 
triggered another subset of feeding experiments, which are described in Chapter 4.3. 
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4.2.8 Recombinant PCV2 ORF2 Protein Yield Prediction 
It was shown earlier, that the recombinant PCV2 ORF2 protein harvest concentration was 
prone to significant variations, especially at the lowest MOI. These variations were presumably 
due to the less reproducible process at the lower MOI but daily samples and accompanying off-
line analyses were not able to explain the observed differences in recombinant PCV2 ORF2 
protein production. The dielectric spectroscopy measurements on the other hand were performed 
very frequently (every 30 minutes) and potentially also give more insight into the cell’s 
physiological state. It was proposed that this information might lead to a better understanding of 
the process state, and while it may not always be completely clear if and how the cell’s dielectric 
properties changed during the early phases of the process, the obtained dielectric spectroscopy 
signals still represent the cell cultures state at the time of measurement. It was suggested that this 
could be used to predict the recombinant PCV2 ORF2 protein harvest concentration early in the 
process, since the late stage protein expression phase is generally dependent on the early 
infection phase in the cell culture and deviations in the latter will carry on into the former. 
 
While due to the approximately 24 h sampling interval no samples were taken exactly at 
the time of the observed peak in the Biomass signal, it was found that the maximum Biomass 
signal obtained at the actual sampling points (which generally occurred right before the peak in 
this signal) correlated with the obtained recombinant PCV2 ORF2 protein yield. This was 
usually approximately the point of maximum viable biovolume in the respective process and 
occurred approximately 24 h after the infection of the culture was completed. This also meant 
that the peak in budded baculovirus production occurred at this time and that the expression of 
recombinant PCV2 ORF2 protein had just started, usually 72 to 96 h (day 3 to 4) post infection. 
Additionally, only a minor fraction of the cells was determined as dead by the Vi-CELL XR 
trypan blue staining at this time. Assuming each unit of viable biovolume or viable cell 
contributes the same mean amount to both, the Biomass signal at the time of sampling and the 
overall recombinant PCV2 ORF2 protein yield, it should be possible to establish a linear 
correlation between these two parameters. The obtained correlations are shown in Figure 4.48 
and Figure 4.49. 
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Figure 4.48. Correlation specific recombinant PCV2 ORF2 yield vs. specific Biomass signal 
at the time of signal peak based on viable biovolume. 
 
 
Figure 4.49. Correlation specific recombinant PCV2 ORF2 yield vs. specific Biomass signal 
at the time of signal peak based on viable cell density. 
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The obtained correlations show, that a higher specific PCV2 ORF2 protein productivity 
usually was indicated by a higher specific Biomass signal. Interestingly the correlation based on 
the viable cell count is much better than the one based on the viable biovolume and can be 
described by Equation 27. Knowing the cell concentration at the time of the Biomass signal 
peak, either by sampling and off-line analyses or estimation through the DS data, would then 
allow a prediction of the final harvest PCV2 ORF2 protein concentration. 
 
                                        
                                               
     
  
  
  
     
      
    
    
 
Equation 27 
 
The viable biovolume based correlation is of a lower quality and may be explained with 
the assumption, that the calculated parameter viable biovolume is prone to a larger error than the 
viable cell density alone. This may have led to the less accurate correlation. Nevertheless, since 
the Biomass signal overall reflects the viable biovolume, and a higher specific Biomass signal 
per cell therefore means a larger mean volume of this cell, the obtained correlations basically 
indicate, that a larger cell was equal to a higher specific PCV2 ORF2 protein production. A 
similar behavior was observed before for the production of other recombinant proteins in insect 
cells and confirms the observations made in this work
142, 160
. Interestingly the correlation 
obtained was valid over the whole range of utilized MOI from 0.01 to 1.00 and was even able to 
predict the observed variations in the specific yield at MOI 0.01. It is expected that the 
correlation would become better if samples were taken at the actual peak in the Biomass signal. 
The obtained correlations could be very useful in the routine industrial scale recombinant protein 
production utilizing the baculovirus expression vector system. Obtaining a reliable prediction for 
the yield early in the process would allow early judgment about the success of a specific 
production run and may allow decisions and planning for the subsequent downstream processing 
procedures, including any concentration or dilution steps, before the specific process is even 
finished. With current technology, the first measurement of the recombinant PCV2 ORF2 protein 
concentration is not obtained until days after the end of the process. 
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4.2.9 Infection Phase Modeling with Dielectric Spectroscopy Data 
As described earlier, the infection of insect cell cultures at low MOIs in the range from 
0.01 to 1.00 generally means that the infection is non-synchronous and therefore the process is 
strongly dependent on subsequent (secondary) infections by newly produced virus particles. This 
led to significant variations in various cell parameters kinetics and even recombinant baculovirus 
and protein yields between, but also sometimes within, each MOI. The dielectric spectroscopy 
performed with the FOGALE iBiomass 465 instrument allowed to follow the process during the 
infection phase in terms several cell culture parameters by utilizing a multivariate modeling 
approach. A multivariate approach was chosen because the two other types of models generally 
proposed, linear and Cole-Cole, were not suitable for this application. The first is only valid as 
long as the viable cell size does not change, which was clearly the case in these cultures post 
infection with the recombinant PCV2 ORF2 baculovirus. The Cole-Cole model can only be used 
to calculate viable cell density and viable cell size when one can assume a constant specific cell 
membrane capacitance Cm and intracellular conductivity ζi during the process. It has been shown 
that this assumption is not valid in a variety of situations, one of them virus infection and 
release
12, 73, 139
. 
 
The multivariate models developed were based on partial least squares (PLS) regression 
and built using the software JMP 8 (SAS Institute Inc). While PLS is commonly used to analyze 
spectroscopic data in a variety of applications
88
, several studies used PLS regression models 
specifically for the analysis of dielectric spectroscopy data in cell culture processes involving 
mammalian or yeast cell cultures
77, 88, 161
 but no application in insect cell cultures has been 
reported. This technique builds a model based on linear combinations to find the fundamental 
relations between the independent variables and responses. In this case, the capacitance spectra 
at 16 frequencies (corrected by subtracting the background capacitance at 10000 kHz) as 
provided by the FOGALE iBiomass 465 instrument were the independent variables. All 
measurements obtained off-line were the dependent parameters, or so called responses. These 
included cell parameters like volume fraction of viable cells, viable cell density, or average cell 
size. 
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The peak in the Biomass signal served as the end point of the infection and therefore 
modeling phase, because at this time (day 3 or 4 post infection depending on the MOI) generally 
all cells were infected, the baculovirus concentration did not change significantly anymore 
thereafter and no significant amounts of the PCV2 ORF2 protein had been produced. 
Additionally off-line analyses performed with the Vi-CELL XR analyzer became less accurate 
after this point therefore compromising the model quality. Model calibration was performed 
using the data generated during the low MOI experiments. Dielectric spectroscopy data 
generated in experiment MOI 1.00 #3 and a few other data points were excluded due to apparent 
issues during those sampling points. Overall, the calibration set for the infection phase contained 
35 data points. To avoid over-fitting a standard cross validation procedure was performed by the 
software. Cross validation is a standard procedure in PLS modeling and would also allow 
estimation of the predictive power of the model for new data even in the absence of an 
independent validation data set
162
. Details on the obtained models can be found in Appendix G - . 
 
The performance of the calibration models was evaluated by calculating the root mean 
standard error of calibration RMSEC according to Equation 28: 
 
       
         
 
   
 
 
Equation 28 
 
The RMSEC for each variable is given in Table 4.7. The given percent error of 
calibration (PEC) was calculated by diving the RMSEC by the mean of the respective data set 
77, 
88, 128
. 
 
Table 4.7. Performance of calibration models. 
 
 
P
Viable Cell Density
in cells ml-1
Average Cell
Diameter in µm
Medium Glutamine
Concentration in mmol L-1
Baculovirus Produced
in log10 TCID50 ml
-1
RMSEC 0.0009 3.25E+05 0.70 0.47 0.45
PEC 9.5 15.8 3.5 21.0 22.0
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Clearly, the developed PLS model fit well for the volume fraction of viable cells P 
(viable biovolume) and the average cell diameter with 9.5 and 3.5 % error, respectively. The 
error for the viable cell density was slightly higher with 15.8 %. The ―indirectly‖ related 
variables medium L-glutamine concentration and baculovirus produced had model calibration 
errors of 21.0 and 22.0 %, respectively. It is not surprising that these values are higher, because 
they can only be related indirectly to the dielectric spectroscopy measurements through the 
measured cell’s dielectric properties. 
 
While the PRESS statistic as calculated by the cross-validation principally gives an 
estimation of the predictive power for the developed PLS models, an additional validation 
experiment was performed to verify the models with an independent data set. Target viable cell 
density at the time of infection was 1.00 x 10
6 
cells ml
-1
 and the MOI 0.10. It has to be noted that 
the experiment performed was slightly different. Specifically a different lot of Sf-9 clone cells 
and recombinant PCV2 ORF2 baculovirus seed we used. Additionally the cells to be infected 
were not grown in a preculture as described before, but instead scaled up externally in spinner 
flasks to allow a so-called concurrent infection directly at 15 L working volume. Raw data 
collected is presented in Appendix H - . 
 
Figure 4.50 to Figure 4.53 compare the experimental results of the validation experiment 
with the model-predicted values for several variables. 
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Figure 4.50. Model validation for volume fraction of viable cells P. 
 
 
Figure 4.51. Model validation for viable cell density. 
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Figure 4.52. Model validation for average cell diameter. 
 
 
Figure 4.53. Model validation for medium glutamine concentration. 
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The predictive power of the models was evaluated by calculating the root mean standard 
error of prediction RMSEP according to Equation 29: 
 
       
         
 
   
 
 
Equation 29 
 
The RMSEP for each variable is given in Table 4.8. The given percent error of prediction 
(PEP) was calculated by diving the RMSEP by the mean of the respective data set
77, 88, 128
. 
 
Table 4.8. Model predictive power (RMSEP). 
 
 
Again, the volume fraction of viable cells P and the average cell diameter were predicted 
best by the respective PLS model with errors of 16.5 and 2.9 %, respectively. These values are 
acceptable and allow reasonable estimation of these variables by the developed PLS models for 
independent data sets. The error for the viable cell density increased strongly compared to the 
calibration data set and was calculated to be 25.2 %. This is a rather higher error and reasonable 
estimation of the viable cell density with the developed PLS model may be not very accurate. 
The same is true for the prediction of the medium L-glutamine concentration with an error of 
29.8 %. While these two models could still give good estimations of the general trend in the 
culture, the predicted absolute values should be treated with caution. 
 
While an increase in the errors is not surprising if one uses independent data, one reason 
for the particular large changes for some of the variables may be the slightly different process in 
this case. While the target MOI was chosen to be 0.10 and therefore well within the range used 
for model calibration, the process behaved slightly different. More specifically the viable cell 
density leveled off after already one day post infection and cells starting dying earlier than 
observed for the same MOI in the low MOI experiments described earlier. The cells also 
P
Viable Cell Density
in cells ml-1
Average Cell
Diameter in µm
Medium Glutamine
Concentration in mmol L-1
RMSEP 0.0013 4.16E+05 0.58 0.78
% Error 16.5 25.2 2.9 29.8
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consumed L-glutamine slightly faster and therefore the predicted values were generally higher 
than the experimentally determined ones (except the initial measurement). 
 
While the errors observed seem rather large at first sight one needs to remember that the 
techniques used to analyze off-line samples generally do not provide much better estimations 
with errors of at least 10 % for the parameters investigated here. Therefore, application of such 
PLS models to obtain real-time information about the process state without the need of sampling, 
and so reducing the risk of contamination and labor required, should still be considered a very 
useful and acceptable alternative. In addition, the PLS models developed in this work are based 
on a calibration data set for infection at a wide range of MOI from 0.01 to 1.00. While it was the 
goal of this work to obtain a ―universal‖ model valid over the whole MOI range to account for 
substantial variations in the process due to ―real MOI‖ deviations, an industrial process would 
generally be performed at an optimized MOI. This should result in a less variable process and 
therefore a more accurate prediction. 
 
4.2.10 Conclusions 
Industrial scale bioprocesses based on the BEVS are preferably performed under low 
MOI conditions. While this saves costly virus seed, it makes the process also dependent on 
subsequent production of new virus particles and subsequent infection processes to completely 
infect the culture and induce recombinant protein expression in all the cells. Small deviations in 
cell density, virus to cell ratio or time of infection may be amplified under such situations 
causing variability in the processes and yields. It was hypothesized that DS could be a useful tool 
for real-time on-line monitoring of such cultures allowing detection of culture events and may 
even serve as a predictive tool for process success and eventually yield. DS was applied to a total 
of nine multi-liter bioreactor cultures focusing on process behavior at three different low MOI, 
0.01, 0.10 and 1.00, and DS data was related to information obtained by off-line sample 
analyses. 
 
Cultures infected at the three different MOI showed significantly different profiles and 
kinetics post infection for several parameters. Generally the process was delayed with decreasing 
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MOI in terms of infection kinetics, cell related parameters like growth, swelling and lysis, 
recombinant virus and eventually PCV2 ORF2 protein production. 
 
Increasing MOI generally led to decreasing cell growth and eventually lower maximum 
viable cell densities post infection when compared to the uninfected control culture. This 
behavior could qualitatively be explained with the amount of virus particles added to the culture 
at the time of infection and the subsequent infection kinetics as summarized in Figure 4.54 and 
Figure 4.55. A baculovirus infected cell stops dividing. The more virus particles were added 
initially at the time of infection, the more were produced by the cells primarily infected early in 
the process, the quicker secondary infections were facilitated and eventually the earlier the stop 
in cell division due to infection outlasted the cell division. Determined initial infection rates for 
the specific recombinant baculovirus used in this work were comparable to theoretical values 
(Poisson distribution) and reports in the literature. 
 
 
Figure 4.54. Viable cell density post infection at the three different MOI compared to an 
uninfected control culture. Initial values were approximately 1.0 x 10
6
 cells ml
-1
. The viable 
cell density increased for up to 72 h post infection depending on the MOI. Decreasing 
maximum viable cell densities were observed with increasing MOI with peak values of 
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approximately 3.0, 2.2, and 1.2 x 10
6
 cells ml
-1
 for MOI 0.01, 0.10, and 1.00, respectively. 
Afterwards the viable cell density decreased continuously until the end of the process. 
Trendlines are intended to guide the eye only. 
 
 
Figure 4.55. Fraction of infected cells post infection at the three different MOI. A higher 
initial MOI resulted in faster infection kinetics and eventually earlier complete infection of 
the culture at approximately 48 to 72 h post infection. Trendlines are intended to guide the 
eye only. 
 
Despite the fact that recombinant PCV2 ORF2 protein production could be achieved at 
all three MOI, results indicated that mean PCV2 ORF2 harvest concentrations increased with the 
MOI (see Figure 4.56). While differences observed were not always statistically significant at the 
α = 0.95 level, the trend described seems reasonable. Maybe even more importantly, variations in 
the yield were greatly reduced, when the MOI was increased, indicating lower variability in the 
process under those conditions. Interestingly, the specific productivity in terms of recombinant 
PCV2 ORF2 protein per cell also greatly varied with MOI (see Figure 4.57). Overall, an 
increasing specific productivity per biovolume or cell was observed with increasing MOI. This 
may be due to the fact that more of the resources available to the culture (nutrients, but also cell 
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apparatus) were channeled into the production of recombinant PCV2 ORF2 protein instead used 
up for cell growth purposes. 
 
 
Figure 4.56. Dependency of harvest recombinant PCV2 ORF2 protein concentration on 
MOI. Variability in the harvest PCV2 ORF2 concentration decreased greatly with 
increasing MOI. Values shown are mean ± standard deviation based on the three replicates 
performed at each MOI. 
 
 
0.0
1.0
2.0
3.0
4.0
5.0
6.0
0.00 0.01 0.10 1.00 10.00
H
ar
ve
st
 R
e
co
m
b
in
an
t 
P
CV
2 
O
R
F-
2
 P
ro
te
in
 
C
o
n
ce
n
tr
at
io
n
 in
 R
P
MOI
141 
 
 
Figure 4.57. Dependency of the specific recombinant PCV2 ORF2 protein productivity per 
observed maximum viable cell density on MOI. Mean specific yields were approximately 3 
times higher at MOI 1.00 than at 0.01.Values shown are mean ± standard deviation based 
on the three replicates performed at each MOI. 
 
DS was used to monitor the cultures infected in the low MOI range in-line and in real-
time. DS proved to be able to distinguish between the different MOI conditions by providing 
significantly different profiles for the specific DS signals (Δε, fc, α, Biomass, ζs). The differences 
could generally be explained with the MOI dependent progress of the culture in terms of culture 
parameters like viable cell density or diameter, but late in the process deviations occurred. 
Nevertheless, DS allowed detecting of important culture events and even early prediction of 
recombinant protein production seems to be possible based on the real-time data. The peak in the 
Biomass signal for example occurred at approximately the same time as the maximum 
recombinant baculovirus concentration was achieved (see Figure 4.58). This would allow real-
time initiation of the harvest procedure in baculovirus seed expansion. 
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Figure 4.58. Comparison of Biomass Signal with the time of peak recombinant baculovirus 
concentration at the three MOI. The peak in recombinant baculovirus concentration was 
achieved at approximately the occurrence of the peak in the Biomass signal and is indicated 
by the red vertical lines. 
 
Based on the assumption, that a larger cell was equal to a higher specific PCV2 ORF2 
protein production
142, 160
, a linear correlation could be obtained between the specific Biomass 
signal per viable cell at the time of the signal peak, indicating an increasing volume of the cell 
with an increasing specific PCV2 ORF2 protein yield per viable cell (see Figure 4.59). The 
correlation obtained was valid over the whole range of MOI from 0.01 to 1.00 and was even able 
to predict the observed large variations in the specific yield at MOI 0.01. The obtained 
correlations could be very useful in the routine industrial scale recombinant protein production 
with the BEVS. Obtaining a reliable prediction for the yield early in the process would allow 
early judgment about the success of a specific production run and may allow decisions and 
planning for the subsequent downstream processing procedures, including any concentration or 
dilution steps, before the specific process is even finished. With current technology, the first 
measurement of the recombinant PCV2 ORF2 protein concentration is not obtained until hours 
to days after the end of the process. 
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Figure 4.59. Correlation specific recombinant PCV2 ORF2 yield vs. specific Biomass signal 
at the time of signal peak based on viable cell density. 
 
A multivariate model was developed to follow the infection process in the cultures within 
the MOI range investigated here. Using the data from the low MOI study as a calibration data set 
allowed developing PLS models (one for each response) for the estimation of several variables in 
real-time based on the DS data. The obtained models were successfully validated in an 
independent experiment (MOI 0.10). Figure 4.60 and Figure 4.61 as well as Table 4.9 summarize 
the findings and model quality in terms of its predictive power. 
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Figure 4.60. Model validation for volume fraction of viable cells P. 
 
 
Figure 4.61. Model validation for average cell diameter. 
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Table 4.9. Model predictive power (RMSEP). 
 
 
While the models developed here were based on calibration experiments in the range of 
MOI 0.01 to 1.00 to cover all potential process variations due to inconsistent ―real MOI‖, an 
industrial bioprocess based on the BEVS would generally performed at an optimized MOI. 
Ideally, this should result in a process with a smaller range of ―real MOI‖ than used here, and 
therefore a further improvement of the predictive power of the model can be expected. To the 
authors knowledge this is the first time PLS modeling has been successfully applied to a 
bioprocess based on the BEVS for the production of a recombinant protein. With a better 
understanding of the processes late in the cultures, it should also be possible to extend the PLS 
model throughout the whole culture until the time of harvest. With the knowledge obtained, 
potentially otherwise unidentified causes for observed problems in the large scale and under 
different vessel configurations, e.g. an insufficient infection early in the process, could be 
identified and therefore tackled. 
 
P
Viable Cell Density
in cells ml-1
Average Cell
Diameter in µm
Medium Glutamine
Concentration in mmol L-1
RMSEP 0.0013 4.16E+05 0.58 0.78
% Error 16.5 25.2 2.9 29.8
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4.3 Medium Supplementation for Uninfected Sf-9 Clone Cell Growth 
During the uninfected control culture, it was observed, that a specific nutrient, namely 
L-glutamine, was rapidly depleted in the culture medium. With L-glutamine being a major 
carbon and energy source for insect cells and this depletion happening relatively early in the 
processes, usually after approximately 48 h, it was proposed that this could potentially have a 
significant negative impact on the cultures in terms of cell growth and achievable maximum cell 
densities
163
. Interestingly, DS signals recorded showed specific behavior around the time of 
L-glutamine depletion. Both, the dielectric increment Δε and the Biomass signal, showed a 
distinct plateau phase at approximately the time L-glutamine was depleted (see Figure 4.62, 
compare Figure 4.27 for time of L-glutamine depletion). In case of the Δε signal the plateau 
lasted about 24 h before another subsequent increase was observed, but the Biomass signal 
plateau lasted only about 12 h. Since samples had only been taken approximately every 24 h 
from the culture with none taken during the plateau phase, no immediate explanation for these 
plateaus in the signals could be found. 
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Figure 4.62. Δε and Biomass signal from the uninfected control culture in the low MOI 
study. The first plateau occurred at approximately the same time L-glutamine was depleted 
in the culture medium. 
 
Based on the theoretical dielectric cell model, several factors could have influenced these 
signals. Δε is dependent on the volume fraction of viable cells P and the cell radius, but also the 
specific cell membrane capacitance Cm. P increased from the sample taken immediately prior the 
plateau phase to the first sample after, but it was not clear how P behaved during the actual 
plateau phase. Because the cell size independent Biomass signal also showed the same plateau, 
even though it was only about half as long, it was speculated that a change in viable cell radius 
alone was probably not the cause for the observed plateaus. In fact, no significant cell size 
change could be observed for the samples taken immediately prior to and after the observed 
plateau phase, but again, data during the plateau phase was not available. Assuming an 
increasing P during the plateau phase the only factor left potentially influencing the signals could 
have been Cm. To cause the changes in the signal as observed, Cm would have had to decrease 
during the plateau phase. Since the characteristic frequency is also dependent on Cm, changes in 
the latter should have also been reflected there with an increasing fc. A significant increase in fc 
was observed approximately from 60 h into the process but this change came much later than the 
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initial onset of the plateau phases in both, Δε and the Biomass signal, making it unlikely that this 
alone caused the plateaus. Additionally the values for fc were still much lower than the working 
frequency for the Biomass signal (1000 kHz), which would ideally mean, that the latter would 
not have been influenced much by the increase in fc. 
 
To get more insight into the plateau phase and its possible causes and also to investigate 
the effect of L-glutamine depletion, two more uninfected cell growth experiments were 
performed in parallel, utilizing precultures #12 and #13. One culture was a repetition of the 
uninfected control culture while the second culture was fed multiple times with a 200 mM 
L-glutamine solution in order to prevent depletion. This culture was supplemented every time the 
L-glutamine concentration in the media had dropped below approximately 2.0 mmol L
-1
 and 
L-glutamine levels were brought back up to approximately 6.0 mmol L
-1
. Care was taken not to 
exceed this level to avoid any other potential side effects on cell metabolism. Samples were 
taken from the culture approximately every 8 h starting from approximately 24 h into the process 
to obtain more information about changes in the culture during the plateau phase accompanying 
the L-glutamine depletion. Raw data collected is presented in Appendix I - . 
 
Figure 4.63 and Figure 4.64 below illustrate the results of these experiments. Significant 
differences in the Δε and Biomass profiles between the control and feeding culture were 
observed. In general the L-glutamine fed culture showed a faster increase in the respective 
signals even early in the process after around 24 h when L-glutamine depletion had not yet 
occurred in the control culture. Interestingly the plateau phase was not observed during the 
L-glutamine supplemented culture and the values of the measured parameters Δε and Biomass 
were about twice as high in the supplemented culture at around this time. In contrast to the 
control culture, the supplemented culture reached its respective maximum values and leveled off 
relatively soon after this, at approximately 66 h into the process, while the control culture 
showed slow but steady increases until eventually leveling off at around 114 h into the process. 
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Figure 4.63. Comparison of the Biomass signal for a L-glutamine supplemented culture 
with a control culture without any supplementation. The supplemented culture does not 
show the same plateau phase as the control culture around 48 h post planting. 
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Figure 4.64. Comparison of Δε for a L-glutamine supplemented culture with a control 
culture without any supplementation. 
 
While the supplementation of the uninfected Sf-9 clone cell culture with L-glutamine 
seems to be the fundamental cause for the differences in the Δε and Biomass signals, the off-line 
analyses of the samples revealed why these differences were observed. Figure 4.65 shows the 
profile for the viable cell density during the two processes, as determined with the Vi-CELL XR 
instrument. The L-glutamine supplemented culture exhibited significantly higher values in both 
parameters from approximately 48 h into the process, indicating that the observed L-glutamine 
depletion indeed slowed down, but did not cease, cell growth. The depleted culture seemed to 
switch its metabolism to a more D-Glucose and L-glutamate based consumption and continued 
growing at a slower rate and in a non-exponential fashion. Regarding the plateau phase, itself 
observed at the time of L-glutamine depletion, it seems reasonable to explain this with a slow-
down in the cell propagation during the metabolic switch. The off-line data for the volume 
fraction of viable cells and viable cell density seems to support this theory but a complete stop in 
the growth was not detected. One has to keep in mind though, that the sampling was still only 
performed at approximately every 8 h and while the values obtained during this phase seem to 
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indicate a continuous increase the values are not necessarily significantly differently based on the 
instruments error. 
 
 
Figure 4.65. Comparison of the viable cell density for an L-glutamine supplemented culture 
with a control culture without any supplementation. The supplemented culture shows 
increased cell growth reaching an approximately 45 % higher maximum viable cell density 
at 72 h post planting. Trendlines are intended to guide the eye only. 
 
According to Equation 4 the viable cell radius r and the specific cell membrane 
capacitance Cm also have an influence on Δε. Off-line data supported the assumption made 
earlier, that cell size changes did not cause the plateau observed. While the changes in the viable 
cell size were very small and probably not even significant (data not shown), the trend was a 
conflictive increase of the cell size during this time. Cm could not be measured directly in this 
work and therefore its potential influence is unknown at this point. Based on these observations it 
seems reasonable to say, that the plateau phase in Δε and the Biomass signal seems to be mainly 
caused by a temporary stop in cell propagation during a metabolic switch due to a depletion of a 
main nutrient, namely L-glutamine. Once the switch was completed, the culture started growing 
again, but at a slower pace. 
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While the supplementation of the uninfected Spodoptera frugiperda cell culture with 
L-glutamine significantly accelerated growth and increased the achieved cell densities even early 
in the process, it remains unclear what caused this culture to enter the stationary phase at around 
66 h into the process. L-glutamine was still left in sufficient quantities in the supplemented 
growth media but other media nutrients not measured in this work may have been depleted 
around this time. It is also possible that undetected byproducts of the cell culture had 
accumulated to inhibiting levels at this point but at least one research found that this is usually 
not a problem in insect cell culture
164
. At around 53 h into the process, the dissolved oxygen 
concentration in the culture dropped to 0 % for a few seconds due to a backpressure problem in 
the vessel during one of the L-glutamine addition steps. While the dissolved oxygen 
concentration completely recovered eventually over the next 2 hours this may have caused or 
contributed to the subsequent stop in cell propagation. Additional experiments would be needed 
to investigate and eventually confirm or reject these hypotheses. 
 
In general, the cell densities achieved in this work, even with feeding of L-glutamine, are 
still well below values reported earlier for comparable Spodoptera frugiperda insect cell 
cultures. Depending on the specific feeding strategy utilized (one time addition, multiple feeds) 
cell densities in fed-batch cultures reached ranged from 1.2 to 5.2 x 10
7
 cells ml
-1
 for Sf-9 and 
Sf-21 cell cultures
13, 123, 165
. Cultures in perfusion mode yielded approximately the same cell 
densities between 1.5 to 5.5 x 10
7
 cells ml
-1
 for the same two cell lines
166, 167
. 
 
Therefore, further investigation in both, feeding components and alternative process 
modes, should be considered. Especially in the industrial production environment one would 
have to weigh the potential benefits of a higher cell yield with the disadvantages of a more 
complex process and control strategy. But it is reasonable to assume, that a significant 
improvement in the cell yield could lead to a reduction in time and cost of the large-scale cell 
production. The proposed potential feeding or media replacement strategies could be improved 
and controlled very accurately by utilizing the available real-time DS data. Based on the on-line 
estimation of the viable cell density within the culture, together with knowledge about the 
specific consumption or production rates of e.g. L-glutamine, would allow to automatically 
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calculate and control the optimal rate of feeding or perfusion to keep the concentrations of the 
nutrients and metabolites in question at acceptable levels. Figure 4.66 sketches such a control 
strategy. 
 
 
 
Figure 4.66. Schematic of a proposed feed-rate control based on DS measurements in-line 
of a bioreactor. 
 
While this approach of a controlled continuous feeding would definitively be more 
cumbersome than a simple one-time addition at the beginning of the process or pulse additions 
during the process, it may also be very beneficial. It has been shown that feeding strategies based 
on step additions often lead to significant changes in the media osmolality which could be not 
only be attributed to decreases in the maximum achieved viable cell density in uninfected 
cultures but also recombinant protein productivity of infected cells, when compared to cultures 
with a semi-continuous feed
13, 168
. 
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4.3.1 Conclusions 
During the uninfected control culture it was observed, that a specific nutrient, namely 
L-glutamine, was rapidly depleted in the culture medium. It was proposed that this could have 
had a significant negative impact on cell growth because of the fact that L-glutamine is a major 
nutrient in insect cell culture. DS data, specifically Δε and the Biomass signal, exhibited distinct 
plateaus from approximately the time of L-glutamine depletion in the culture medium lasting 
approximately 12 and 24 h. A set of two experiments including a non-fed control culture and a 
second culture supplemented with L-glutamine to avoid depletion of this nutrient was conducted. 
It was found, that the depletion in L-glutamine indeed had a significant negative impact on Sf-9 
clone cell growth. An improvement of approximately 45 % in viable cell density after 72 h, 
approximately the beginning of the stationary phase in the supplemented culture, was achieved 
when L-glutamine was fed to the culture. At this point it is still unclear what eventually caused 
the supplemented culture to enter the stationary phase with sufficient L-glutamine still available 
in the medium. DS data reflected the observed large differences in terms of viable cell density 
and growth. Based on these results it was proposed to use DS as a tool to control either feed or 
perfusion rates in more sophisticated process modes, potentially yielding even higher cell yields. 
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Chapter 5 - Conclusion and Outlook 
This PhD research project focused on the application of DS in an industrial bioprocess at 
the multi-liter scale utilizing Spodoptera frugiperda derived Sf-9 clone cells and the BEVS with 
a recombinant baculovirus to produce a protein of the VLP class that serves as the 
immunostimulating agent in a vaccine. A newly developed DS instrument specialized for the use 
in the biopharmaceutical field was used together with a range of off-line sample analyses to 
quantify key process parameters. It was proposed that the use of DS as an on-line tool would 
allow insight into intricate processes within the cultures under low MOI conditions, allowing not 
only evaluation of the current state of a process but also prediction of the success of production 
formation already at an early stage. 
 
DS could successfully be implemented into the growth process of uninfected cells. 
Developed linear correlations now allow the real-time estimation of viable biovolume and cell 
density on-line without the need for sampling. This greatly eliminates the contamination risk 
associated with the sampling procedure itself but also greatly reduces the time and effort usually 
required to perform the discrete sampling and any subsequent off-line analysis. Having such a 
tool has the potential to improve the repeatability of subsequent baculovirus infection and 
recombinant protein production processes because of more consistent ―real MOI‖. 
 
DS proved also to be able to monitor and differentiate cultures infected in the low MOI 
range (0.01 to 1.00). Significantly different profiles for DS related parameters were obtained at 
the different MOI, allowing the qualitative monitoring of the infection and recombinant protein 
production process. Differences in the DS data could generally be explained with the different 
behavior of culture parameters like viable cell density or cell diameter, but some questions 
remain, especially late in the process. Nevertheless, DS did not only allow detection of important 
culture events in real-time, e.g. the peak in baculovirus production/concentration, but also seems 
to be able to serve as a predictive tool for the overall recombinant protein yield early in the 
process. Additionally, PLS models were developed to follow the infection phase in the low MOI 
range quantitatively for specific culture parameters. The obtained models provide information 
about the progress in viable biovolume, cell diameter, and even L-glutamine concentration in the 
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culture medium with a sufficient accuracy. It is expected that the quality of the models can be 
further improved when an optimized, narrower MOI range is utilized, which is usually the case 
in an industrial application. A potential extension of the model to include the lysis phase of the 
cultures should also be investigated. To the knowledge of the author, this is the first time PLS 
modeling has been successfully applied to a BEVS based bioprocess. 
 
During the experiments performed in this work it was observed, that a specific nutrient, 
namely L-glutamine, was depleted early in the process in both, uninfected and infected, cultures. 
This depletion was accompanied by a significant plateau in some of the DS signals. Additional 
supplementation experiments identified the L-glutamine depletion as ultimately causing those 
plateaus by temporarily ceasing cell growth before a switch in the cells metabolism had 
occurred. An improvement of approximately 45 % in maximum viable cell density was achieved 
by a simple feeding strategy. It is proposed that more sophisticated processed modes like 
continuous fed-batch or even perfusion will allow further improvement of the cell yield but 
further research is required to identify potentially limiting nutrients or inhibiting metabolites. DS 
would allow implementation of an adequate control of the feed or perfusion rate to ensure 
optimum process conditions by providing real-time information about the viable cell density. 
 
A similar depletion of the same nutrient was observed for the case of baculovirus infected 
cultures, regardless of the virus concentration added used. Preliminary experiments with a one-
time addition of an L-glutamine and L-cystein feed at the beginning of the culture gave 
promising results in terms of increased yield but DS data also showed distinct differences 
compared to a non-supplemented control culture (see Figure 5.1) . In general, the DS data 
seemed to indicate an extended culture, despite the fact that off-line analysis showed a 
comparable drop in cell viability. This again indicates that ―dead‖ cells (as determined by trypan 
blue) may still contribute significantly to the DS signals in some cases. Further research is 
required to investigate the effect of medium specific nutrient supplementation and its effects on 
the PCV2 ORF2 production process and yield. DS could be a valuable tool in those 
investigations providing additional data and insight into the culture’s progress. 
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Figure 5.1. Comparison of Biomass signals for a supplemented infected culture (MOI 0.10, 
L-glutamine and L-cystein supplementation) with a control culture without any 
supplementation. The supplemented culture seems to be extended slightly and exhibits a 
higher Biomass signal peak. 
 
Summarized, DS along with the information derived in this work will contribute to 
satisfy the increased requirements for on-line process monitoring as delineated in the PAT 
initiative by the FDA. It allows non-invasive and non-destructive continuous monitoring of 
suspension as well as adherent cell cultures but continuous research is required. The influence of 
all the cells dielectric properties like the specific membrane capacitance or the intracellular 
conductivity is not fully understood yet and dedicated research in this area could potentially 
greatly improve the understanding of DS data and its application. Additionally, improved 
methods to estimate the biovolume from a cell size distribution taking into account more than 
just one representative parameter like the mode or mean should be considered
169
. Nevertheless, 
routine process monitoring to follow culture parameters by PLS models, detection of deviations 
from the normal and specific events in the culture’s progress as well as yield prediction have 
been successfully established in this work. Transfer of the DS technology into the multi-m
3
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routine production has the potential to greatly improve process understanding in the production 
scale as well as to simplify but also increase repeatability of the processes. 
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Appendix A - Composition of PCV2 ORF2 ELISA Buffers 
Carbonate Coating Buffer, 0.05 M, pH 9.6 
 
2.93 g NaHCO3 
1.59 g Na2CO3 
100  ml Deionized Water 
 
PCV2 10x D-PBS, pH 7.3 
 
80.0 g NaCl 
11.5 g Na2HPO4 
2.0 g KCl 
2.0 g KH2HPO4 
QS to 1000 ml with Deionized Water 
 
Blocking Solution, pH 7.3 
 
50.0 g Non-Fat Dry Milk 
0.5 ml Tween 20 
100 ml 10x D-PBS, pH 7.3 
QS to 1000 ml with Deionized Water 
 
Wash/Diluent Solution, pH 7.3 
 
1000 ml 10x D-PBS, pH 7.3 
5 ml Tween 20 
8995 ml Deionized Water 
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Appendix B - Precultures – Raw Data 
 
Table B.1. Raw data precultures – off-line analyses. 
 
Preculture #
Time Post 
Planting
in h pH
Total Cell 
Density
in cells ml-1
Viable Cell 
Density
in cells ml-1
Viability
in %
Mean 
Average 
Cell 
Diameter
 in µm
Mean 
Viable Cell 
Diameter
in µm
D-glucose
in mmol L-1
L-lactate
in mmol L-1
L-glutamine
in mmol L-1
L-glutamate
in mmol L-1
1 0.89 6.41 5.1E+05 4.7E+05 92.3 17.4 17.8 32.64 1.12 5.24 6.64
27.95 6.37 1.2E+06 1.1E+06 96.0 18.0 18.2 31.92 1.23 4.71 7.76
49.18 6.27 2.2E+06 2.1E+06 97.2 18.2 18.3 30.03 1.90 3.31 8.35
2 2.01 6.39 4.8E+05 4.5E+05 93.6 17.7 17.8 32.42 1.13 5.68 7.01
27.48 6.37 1.0E+06 9.8E+05 96.8 18.5 18.7 31.86 1.33 4.97 8.01
49.39 6.25 2.2E+06 2.1E+06 96.9 18.2 18.3 29.81 2.00 3.51 8.20
3 0.76 6.53 4.6E+05 4.4E+05 95.8 17.9 18.0 31.42 1.07 5.46 7.25
25.23 6.48 8.2E+05 7.9E+05 96.2 18.3 18.5 31.25 1.12 5.13 7.40
49.80 6.32 2.0E+06 1.9E+06 96.9 18.2 18.3 30.03 1.65 3.33 8.19
53.70 6.29 2.4E+06 2.3E+06 97.0 18.2 18.3 28.70 1.70 2.88 8.41
4 0.89 6.51 4.7E+05 4.5E+05 94.8 17.2 17.4 31.53 1.12 5.48 6.85
25.33 6.46 8.9E+05 8.4E+05 94.6 18.3 18.6 31.08 1.14 5.11 7.36
50.68 6.31 1.9E+06 1.8E+06 95.7 18.3 18.5 29.86 1.77 3.80 8.00
53.71 6.27 2.3E+06 2.3E+06 96.8 18.3 18.5 29.09 1.89 3.29 8.18
5 0.53 6.51 4.6E+05 4.3E+05 94.4 17.2 17.3 31.75 1.11 5.81 6.77
26.01 6.42 1.0E+06 9.9E+05 96.5 17.9 18.1 31.92 1.15 5.11 7.70
47.20 6.27 1.8E+06 1.7E+06 96.5 17.9 18.1 29.20 1.55 2.78 8.63
6 0.57 6.49 4.4E+05 4.0E+05 92.0 16.9 17.3 32.14 1.14 5.80 6.96
26.15 6.43 1.2E+06 1.2E+06 95.5 17.9 18.1 31.31 1.17 4.80 7.49
47.34 6.28 2.1E+06 2.0E+06 96.5 17.9 18.0 29.31 1.85 2.60 8.68
7 0.59 6.53 3.6E+05 3.3E+05 92.3 17.5 17.9 32.58 1.13 5.83 7.14
30.56 6.45 6.9E+05 6.6E+05 94.8 18.0 18.3 32.75 1.22 4.85 7.67
52.47 6.30 1.7E+06 1.6E+06 96.6 17.9 18.0 30.86 1.84 3.43 8.10
8 0.71 6.52 5.3E+05 4.8E+05 90.2 17.5 17.9 31.58 1.14 5.62 7.24
30.64 6.41 9.7E+05 8.8E+05 91.7 17.6 18.0 31.75 1.33 4.18 7.82
52.73 6.23 2.2E+06 2.1E+06 96.6 17.8 18.0 28.75 2.23 2.53 8.52
9 0.58 6.48 5.0E+05 4.7E+05 93.4 16.8 17.1 32.47 1.10 5.40 7.25
25.50 6.41 8.3E+05 7.8E+05 93.9 17.7 17.9 32.53 1.08 4.44 7.62
50.74 6.25 2.2E+06 2.2E+06 96.5 17.7 17.8 30.08 1.83 2.57 8.71
10 0.69 6.55 3.9E+05 3.6E+05 90.3 17.9 18.3 32.53 0.98 5.40 7.13
25.67 6.53 9.8E+05 9.1E+05 93.7 17.8 18.1 32.19 1.05 4.44 7.79
50.92 6.39 2.3E+06 2.2E+06 96.0 18.0 18.1 29.70 1.79 2.71 8.47
11 0.72 6.50 3.7E+05 3.3E+05 87.8 16.8 17.3 33.86 1.11 4.79 7.46
23.05 6.44 5.7E+05 5.4E+05 94.4 17.6 17.9 32.69 1.10 3.94 7.64
48.95 6.29 1.6E+06 1.5E+06 95.2 17.8 18.0 30.36 1.62 2.76 8.37
55.46 6.24 2.1E+06 2.0E+06 95.1 18.0 18.2 30.20 1.90 2.12 8.51
12 0.60 6.55 4.3E+05 4.0E+05 92.9 17.5 17.9 33.58 1.07 4.05 7.19
22.32 6.47 7.3E+05 7.0E+05 95.5 17.8 17.9 33.03 1.09 3.49 7.33
48.67 6.29 1.7E+06 1.6E+06 96.2 18.0 18.1 31.42 1.72 2.02 7.98
53.81 6.24 2.1E+06 2.0E+06 95.2 18.0 18.2 31.19 1.95 1.72 8.34
13 0.74 6.51 5.3E+05 5.0E+05 92.9 17.7 17.9 32.92 1.09 4.06 7.15
22.45 6.43 9.2E+05 8.7E+05 95.2 18.0 18.2 33.19 1.27 3.46 7.78
48.81 6.25 1.9E+06 1.8E+06 96.5 18.1 18.2 31.19 2.21 1.77 7.98
53.95 6.21 2.4E+06 2.3E+06 95.8 17.9 18.1 31.03 2.39 1.41 8.15
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Table B.2. Raw data precultures – dielectric spectroscopy. 
 
Preculture #
Time Post 
Planting
in h
Biomass 
(1000 kHz)
in pF cm-1
Suspension 
Conductivity
in mS cm-1
Δε
in pF cm-1
fc
in kHz
alpha
in -
C(300kHz)
in pF
C(373kHz)
in pF
C(465kHz)
in pF
C(578kHz)
in pF
C(720kHz)
in pF
C(897kHz)
in pF
C(1117kHz)
in pF
C(1391kHz)
in pF
C(1732kHz)
in pF
C(2156kHz)
in pF
C(2684kHz)
in pF
C(3342kHz)
in pF
C(4161kHz)
in pF
C(5181kHz)
in pF
C(6451kHz)
in pF
C(8031kHz)
in pF
C(10000kHz)
in pF
1 0.89 1.04 15.38 3.10 760 0.102 3.77 3.27 2.93 2.54 2.16 1.88 1.59 1.35 1.14 0.98 0.85 0.75 0.69 0.61 0.56 0.51 0.47
27.95 2.19 15.54 7.62 677 0.099 6.87 6.27 5.61 4.92 4.22 3.57 2.97 2.45 2.01 1.60 1.37 1.17 1.04 0.85 0.82 0.77 0.69
49.18 4.38 15.33 19.14 554 0.104 14.45 12.90 11.16 9.42 7.77 6.30 5.00 3.88 2.95 2.23 1.68 1.27 0.98 0.81 0.58 0.44 0.35
2 2.01 0.69 15.44 2.22 702 0.100 2.43 2.34 2.13 1.96 1.75 1.56 1.38 1.25 1.13 0.98 0.90 0.86 0.82 0.77 0.75 0.74 0.69
27.48 1.77 15.59 7.01 606 0.094 6.06 5.57 4.93 4.32 3.69 3.13 2.60 2.19 1.81 1.43 1.25 1.12 1.00 0.90 0.87 0.84 0.79
49.39 3.79 15.45 15.80 590 0.088 13.57 11.89 10.31 8.66 7.14 5.79 4.57 3.56 2.84 1.99 1.61 1.21 0.99 0.89 0.70 0.59 0.53
3 0.76 0.84 15.32 2.57 768 0.100 2.37 2.14 1.87 1.63 1.38 1.14 0.93 0.73 0.57 0.43 0.32 0.21 0.17 0.12 0.09 0.07 0.05
25.23 1.92 15.24 6.24 720 0.099 6.54 5.71 4.89 4.20 3.53 2.91 2.37 1.91 1.52 1.15 0.93 0.75 0.60 0.44 0.42 0.39 0.33
49.80 4.32 15.27 16.46 627 0.098 18.05 14.99 12.36 10.11 8.17 6.46 5.06 3.86 2.89 2.06 1.52 1.10 0.77 0.54 0.38 0.27 0.19
53.70 4.90 15.27 18.93 614 0.099 20.45 16.95 13.98 11.38 9.13 7.23 5.62 4.28 3.19 2.26 1.66 1.16 0.81 0.57 0.36 0.23 0.14
4 0.89 0.80 15.45 2.63 704 0.100 2.11 1.99 1.73 1.53 1.29 1.08 0.89 0.70 0.51 0.39 0.31 0.25 0.18 0.12 0.11 0.10 0.07
25.33 1.80 15.36 6.57 658 0.094 5.02 4.67 4.17 3.67 3.10 2.56 2.11 1.68 1.29 0.92 0.72 0.60 0.45 0.34 0.31 0.30 0.27
50.68 3.20 15.39 16.16 521 0.085 10.75 9.75 8.35 6.98 5.68 4.49 3.45 2.57 1.87 1.18 0.85 0.55 0.34 0.19 0.12 0.07 0.03
53.71 3.55 15.40 15.88 568 0.077 12.18 10.80 9.26 7.70 6.23 4.96 3.82 2.83 1.95 1.30 0.94 0.61 0.37 0.22 0.12 0.07 0.04
5 0.53 0.97 15.32 3.24 680 0.102 2.96 2.59 2.22 1.85 1.53 1.22 0.97 0.73 0.55 0.39 0.27 0.19 0.10 0.07 0.01 -0.02 -0.04
26.01 2.08 15.34 7.71 634 0.100 7.53 6.40 5.40 4.48 3.65 2.91 2.28 1.75 1.31 0.91 0.69 0.47 0.32 0.21 0.13 0.08 0.04
47.20 4.33 15.31 16.78 609 0.104 15.77 13.47 11.36 9.44 7.67 6.15 4.85 3.72 2.82 2.01 1.52 1.08 0.76 0.52 0.37 0.26 0.17
6 0.57 1.23 15.38 4.06 696 0.102 3.63 3.27 2.84 2.43 2.07 1.68 1.38 1.10 0.81 0.65 0.51 0.36 0.29 0.22 0.16 0.12 0.10
26.15 2.10 15.41 7.69 651 0.096 6.02 5.50 4.88 4.22 3.56 2.90 2.35 1.86 1.34 1.03 0.80 0.58 0.45 0.33 0.25 0.21 0.18
47.34 3.51 15.39 13.15 639 0.092 10.04 9.25 8.16 7.06 5.96 4.85 3.90 3.06 2.23 1.67 1.30 0.96 0.73 0.54 0.42 0.34 0.28
7 0.59 0.59 15.21 2.21 635 0.100 1.68 1.51 1.29 1.11 0.92 0.73 0.55 0.41 0.29 0.19 0.12 0.06 0.02 0.01 -0.03 -0.05 -0.06
30.56 1.26 15.27 4.68 648 0.097 3.35 3.08 2.77 2.38 2.03 1.64 1.29 0.99 0.73 0.46 0.37 0.24 0.14 0.08 0.05 0.03 0.01
52.47 2.95 15.24 10.92 644 0.095 8.42 7.63 6.75 5.76 4.81 3.91 3.08 2.37 1.75 1.20 0.91 0.60 0.40 0.26 0.16 0.09 0.04
8 0.71 0.80 15.35 2.73 684 0.100 2.38 2.13 1.87 1.59 1.35 1.10 0.88 0.70 0.55 0.40 0.31 0.22 0.16 0.12 0.10 0.07 0.06
30.64 1.65 15.35 6.79 606 0.096 4.54 4.23 3.81 3.31 2.75 2.23 1.76 1.38 1.06 0.68 0.50 0.34 0.24 0.16 0.13 0.08 0.06
52.73 3.74 15.32 14.58 633 0.084 11.59 10.44 9.12 7.75 6.44 5.19 4.05 3.11 2.29 1.56 1.15 0.78 0.53 0.37 0.26 0.17 0.12
9 0.58 1.14 15.27 3.20 788 0.101 3.90 3.24 2.77 2.27 1.93 1.53 1.20 1.00 0.74 0.54 0.43 0.32 0.23 0.15 0.10 0.06 0.04
25.50 0.98 15.35 2.13 1087 0.098 0.36 0.71 0.92 0.94 0.95 0.86 0.74 0.61 0.40 0.25 0.19 0.07 -0.01 -0.08 -0.08 -0.11 -0.13
50.74 4.54 15.25 18.19 608 0.094 17.90 14.97 12.44 10.14 8.14 6.38 4.86 3.61 2.54 1.67 1.19 0.92 0.35 0.10 -0.04 -0.11 -0.18
10 0.69 0.92 15.41 2.77 770 0.101 2.62 2.32 2.06 1.73 1.46 1.19 0.97 0.75 0.64 0.43 0.31 0.22 0.15 0.10 0.06 0.03 0.02
25.67 1.77 15.40 5.85 708 0.098 5.29 4.63 4.09 3.49 2.91 2.38 1.89 1.46 1.13 0.78 0.59 0.41 0.29 0.19 0.13 0.09 0.04
50.92 3.85 15.37 13.91 660 0.094 12.02 10.59 9.23 7.88 6.50 5.25 4.15 3.19 2.40 1.69 1.25 0.87 0.60 0.42 0.26 0.15 0.09
11 0.72 0.69 15.31 2.29 710 0.100 2.35 2.06 1.77 1.53 1.30 1.05 0.87 0.70 0.57 0.44 0.36 0.28 0.24 0.17 0.17 0.15 0.13
23.05 1.36 15.41 4.50 706 0.100 4.35 3.80 3.28 2.81 2.33 1.91 1.53 1.22 0.94 0.65 0.53 0.38 0.29 0.20 0.17 0.13 0.09
48.95 3.18 15.41 11.73 638 0.102 10.10 8.89 7.63 6.44 5.30 4.28 3.39 2.60 1.93 1.33 1.02 0.69 0.46 0.31 0.18 0.09 0.02
55.46 4.02 15.41 14.41 656 0.102 12.60 11.12 9.58 8.15 6.74 5.45 4.35 3.37 2.52 1.78 1.36 0.95 0.67 0.46 0.29 0.18 0.08
12 0.60 0.96 15.37 3.00 733 0.101 2.81 2.50 2.17 1.87 1.58 1.28 1.04 0.82 0.64 0.48 0.37 0.26 0.19 0.14 0.10 0.07 0.05
22.32 1.63 15.36 5.86 655 0.100 5.68 4.86 4.12 3.41 2.80 2.24 1.75 1.34 1.00 0.69 0.51 0.34 0.21 0.14 0.07 0.03 0.00
48.67 4.39 15.33 17.12 608 0.104 15.75 13.54 11.44 9.50 7.77 6.23 4.89 3.76 2.83 2.02 1.52 1.08 0.75 0.52 0.35 0.24 0.16
53.81 5.27 15.32 20.78 604 0.103 19.14 16.37 13.84 11.50 9.39 7.47 5.85 4.50 3.38 2.41 1.82 1.28 0.88 0.61 0.40 0.26 0.16
13 0.74 1.44 15.36 3.02 1009 0.112 5.70 5.04 4.47 3.97 3.55 3.18 2.85 2.59 2.37 2.19 2.04 1.93 1.83 1.72 1.61 1.49 1.31
22.45 2.64 15.41 6.69 854 0.129 9.90 8.73 7.65 6.76 5.93 5.22 4.60 4.05 3.61 3.25 2.96 2.72 2.55 2.36 2.18 1.98 1.74
48.81 5.09 15.39 17.64 636 0.145 18.03 15.75 13.74 11.90 10.14 8.65 7.30 6.15 5.21 4.44 3.84 3.36 3.01 2.68 2.42 2.13 1.85
53.95 5.82 15.37 22.35 564 0.152 20.35 17.77 15.43 13.29 11.35 9.60 7.73 6.73 5.64 4.77 4.07 3.50 3.11 2.75 2.45 2.14 1.86
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Appendix C - Precultures - Kinetics 
Table C.1. Kinetics precultures. 
 
1 0.031 22.3 -1.37E-14 -1.02E-14 4.09E-15 9.01E-15
2 0.033 21.1 -1.42E-14 -1.18E-14 4.70E-15 6.46E-15
3 0.031 22.1 -1.27E-14 -1.20E-14 2.94E-15 5.40E-15
4 0.031 22.7 -1.15E-14 -1.03E-14 3.59E-15 6.24E-15
5 0.030 23.1 -1.62E-14 -1.92E-14 2.82E-15 1.18E-14
6 0.034 20.1 -1.69E-14 -1.91E-14 4.24E-15 1.03E-14
7 0.030 22.9 -1.15E-14 -1.60E-14 4.75E-15 6.41E-15
8 0.028 24.4 -1.37E-14 -1.50E-14 5.28E-15 6.21E-15
9 0.030 22.9 -1.20E-14 -1.42E-14 3.67E-15 7.32E-15
10 0.036 19.1 -1.53E-14 -1.45E-14 4.38E-15 7.25E-15
11 0.032 21.4 -2.04E-14 -1.49E-14 4.39E-15 5.84E-15
12 0.030 22.8 -1.25E-14 -1.22E-14 4.65E-15 6.02E-15
13 0.029 24.2 -8.38E-15 -1.18E-14 5.76E-15 4.44E-15
Mean 0.031 22.2 -1.38E-14 -1.39E-14 4.25E-15 7.13E-15
STDEV 0.002 1.4 2.88E-15 2.85E-15 8.10E-16 1.98E-15
qGlu
in mmol cell-1 s-
µ
in h-1Preculture #
tD
in h
qGlc
in mmol cell-1 s-1
qGln
in mmol cell-1 s-1
qLac
in mmol cell-1 s-1
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Appendix D - Infection at Low MOI - Raw Data 
Table D.1. Raw data infection at low MOI – off-line analyses (1 of 2). 
 
 
Process ID
Time Post 
Planting
in h pH
Total Cell 
Density
in cells ml-1
Viable Cell 
Density
in cells ml-1
Viability
in %
Mean 
Average Cell 
Diameter
 in µm
Mean 
Viable Cell 
Diameter
in µm
D-glucose
in mmol L-1
L-lactate
in mmol L-1
L-glutamine
in mmol L-1
L-glutamate
in mmol L-1
PCF2 ORF2 
Concentration
in RP
Baculovirus 
Concentration
in log10 TCID50 ml
-1
Fraction of 
Infected Cells
in %
MOI 0.10 #1 0.90 6.32 1.28E+06 1.23E+06 95.6 18.1 18.3 31.47 1.44 4.69 7.87 0.0 3.7 1.3
21.50 6.26 1.84E+06 1.78E+06 96.7 18.3 18.4 27.31 1.71 3.55 8.07 0.0 4.2 7.3
43.12 6.23 2.46E+06 2.36E+06 95.8 21.8 21.9 26.59 1.79 1.65 7.93 0.0 6.4 94.9
69.59 6.27 2.43E+06 2.14E+06 88.0 23.2 23.4 24.64 0.67 0.97 8.19 0.5 8.5 98.3
92.56 6.29 2.21E+06 1.37E+06 62.1 21.5 23.2 22.92 0.77 0.82 8.38 1.8 8.0 83.4
112.80 6.07 2.44E+06 7.40E+05 30.3 21.2 25.4 21.43 1.27 1.09 8.44 3.3 8.2 90.3
140.61 5.96 2.44E+06 2.90E+05 12.0 18.3 22.5 20.20 2.15 0.34 9.50 2.6 8.5 -
164.05 5.92 2.46E+06 1.70E+05 7.1 16.5 19.2 20.09 2.51 0.44 9.57 3.9 7.8 -
MOI 0.01 #1 1.00 6.33 1.23E+06 1.19E+06 96.7 18.1 18.3 31.75 1.47 4.66 7.70 0.0 2.7 0.1
21.57 6.27 1.97E+06 1.92E+06 97.7 18.4 18.5 29.75 2.11 3.75 7.00 0.0 2.6 0.5
43.09 6.23 2.91E+06 2.80E+06 96.4 19.7 19.8 26.87 2.63 1.69 8.33 0.0 4.6 55.4
69.56 6.35 3.23E+06 3.03E+06 94.0 22.1 22.2 24.15 1.02 0.72 8.08 0.1 7.5 91.3
92.53 6.35 2.89E+06 2.48E+06 85.8 22.3 22.6 21.15 0.75 0.81 7.78 0.7 8.4 87.5
113.06 6.27 3.12E+06 1.87E+06 60.0 22.4 24.4 17.71 1.09 1.03 7.52 1.8 8.8 98.3
140.75 6.17 3.23E+06 8.60E+05 26.7 19.4 23.1 15.10 2.50 0.30 8.49 3.2 8.3 -
164.16 6.16 3.15E+06 4.90E+05 15.7 17.0 21.1 13.88 3.41 0.44 8.93 4.3 8.4 -
186.04 6.05 3.03E+06 3.00E+05 10.0 15.7 19.1 12.99 3.82 0.33 8.89 6.0 8.0 -
209.34 6.02 3.07E+06 1.70E+05 5.5 14.4 16.8 12.71 4.12 0.40 8.96 4.3 8.0 -
MOI 1.00 #1 0.76 6.33 1.24E+06 1.20E+06 96.2 18.2 18.3 30.75 1.38 4.58 7.46 0.0 5.4 14.2
21.27 6.28 1.38E+06 1.32E+06 95.9 20.3 20.4 29.47 1.61 3.07 8.20 0.0 6.0 52.9
42.66 6.30 1.43E+06 1.33E+06 92.7 23.0 23.1 28.14 1.34 1.91 8.64 0.2 7.6 96.9
67.00 6.28 1.47E+06 1.27E+06 86.0 23.5 23.8 26.64 0.79 1.53 8.73 1.2 7.8 95.6
89.78 6.11 1.36E+06 8.00E+05 58.7 21.5 23.4 26.14 0.94 1.05 9.11 2.4 8.4 86.3
117.54 5.91 1.80E+06 4.80E+05 26.4 20.2 24.4 25.53 1.62 1.22 9.25 5.3 8.6 -
138.38 5.86 1.82E+06 2.60E+05 14.4 18.8 22.6 24.98 2.01 1.10 9.33 5.1 8.0 -
162.69 5.84 1.75E+06 1.80E+05 10.2 17.6 19.6 25.03 2.29 1.30 9.14 4.8 8.6 -
MOI 0.10 #2 0.95 6.33 1.20E+06 1.14E+06 95.0 18.2 18.4 30.69 1.59 4.68 7.58 0.0 3.6 1.4
21.42 6.24 1.87E+06 1.80E+06 96.5 18.3 18.4 29.81 1.99 3.65 7.84 0.0 3.5 4.8
42.92 6.28 2.32E+06 2.17E+06 93.8 20.8 21.1 27.59 2.16 2.09 8.08 0.0 5.8 94.1
67.29 6.36 2.20E+06 1.99E+06 90.2 23.1 23.3 25.26 1.20 1.11 8.39 0.5 7.8 97.5
90.02 6.34 2.34E+06 1.57E+06 67.0 21.8 23.4 24.03 0.95 0.85 8.44 2.7 8.8 93.3
117.70 6.08 2.23E+06 6.30E+05 28.2 20.2 25.1 22.70 1.78 0.72 8.62 6.0 8.3 -
138.54 6.00 2.47E+06 3.80E+05 15.6 17.9 22.5 21.76 2.48 0.95 8.80 5.2 8.5 -
163.65 5.95 2.54E+06 2.10E+05 8.2 16.2 19.3 21.43 2.90 1.23 8.65 4.4 8.2 -
MOI 1.00 #2 0.75 6.28 1.32E+06 1.27E+06 96.3 18.0 18.1 31.14 1.42 3.96 8.43 0.0 4.7 12.0
22.97 6.07 1.44E+06 1.38E+06 95.9 19.4 19.5 29.53 1.74 2.48 8.61 0.0 5.0 38.4
46.66 6.23 1.74E+06 1.63E+06 93.8 22.4 22.5 26.81 1.09 0.68 9.14 0.1 7.6 96.5
71.91 6.02 1.96E+06 1.67E+06 85.4 22.6 23.0 25.37 0.52 0.19 9.43 1.0 7.7 96.0
96.24 5.81 1.78E+06 1.12E+06 62.6 21.4 22.8 24.20 1.13 0.60 8.80 2.2 8.6 91.4
117.27 5.73 2.03E+06 8.00E+05 39.2 21.5 24.4 22.76 1.85 0.59 8.70 3.9 7.6 76.1
147.09 5.68 2.10E+06 3.70E+05 17.4 18.8 22.1 21.43 2.91 0.81 8.86 4.4 7.8 -
170.39 5.67 2.18E+06 2.10E+05 9.8 17.3 19.1 21.43 3.33 0.80 8.74 4.5 7.5 -
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Table D.2. Raw data infection at low MOI – off-line analyses (2 of 2). 
 
 
 
MOI 0.01 #2 0.87 6.30 1.17E+06 1.13E+06 96.5 17.9 18.0 31.25 1.48 4.02 8.13 0.0 2.7 0.2
23.11 6.17 2.34E+06 2.26E+06 96.9 17.7 17.8 29.25 2.13 2.84 8.34 0.0 2.7 0.4
46.81 6.15 3.58E+06 3.38E+06 94.6 18.8 19.0 25.42 2.34 0.50 8.53 0.0 5.5 47.3
72.05 6.28 3.46E+06 3.26E+06 94.1 20.4 20.5 23.31 0.83 0.16 8.25 0.0 7.5 95.3
96.40 6.27 3.02E+06 2.73E+06 90.6 21.0 21.2 19.21 0.57 0.61 7.68 0.4 8.3 96.9
117.39 6.29 3.07E+06 1.97E+06 64.0 20.8 22.7 15.04 0.94 0.53 7.76 1.3 8.3 97.4
147.19 6.04 3.39E+06 1.23E+06 36.3 18.8 22.3 11.60 2.40 0.67 7.84 2.8 8.3 -
170.49 6.05 3.38E+06 8.40E+05 25.0 16.9 21.3 9.99 3.54 0.75 8.07 4.0 8.3 -
190.47 6.02 3.48E+06 5.80E+05 16.6 15.3 20.1 8.88 4.02 0.79 8.18 3.1 8.8 -
214.54 5.89 3.46E+06 3.40E+05 9.8 13.9 18.6 8.44 4.61 0.96 8.39 3.2 8.2 -
MOI 0.01 #3 0.67 6.32 1.61E+06 1.55E+06 96.3 17.6 17.7 31.14 1.69 4.10 7.83 0.0 2.6 0.1
21.51 6.19 1.99E+06 1.94E+06 97.5 18.0 18.1 29.81 2.31 3.10 7.87 0.0 2.7 0.4
45.43 6.20 3.71E+06 3.61E+06 97.2 18.8 18.9 26.03 2.74 0.68 8.14 0.0 5.6 42.4
69.50 6.33 3.93E+06 3.72E+06 94.8 20.3 20.4 23.04 0.90 0.32 7.64 0.0 7.5 92.3
93.16 6.32 3.71E+06 3.35E+06 90.5 21.0 21.2 18.93 0.62 0.39 7.53 0.4 8.4 94.7
117.66 6.25 3.97E+06 2.40E+06 60.4 20.2 22.3 13.99 1.15 0.32 7.46 0.9 7.8 95.3
138.36 6.25 3.93E+06 1.70E+06 43.2 18.8 22.2 11.05 2.03 0.39 7.61 1.1 8.3 -
165.28 6.05 4.09E+06 1.11E+06 27.2 16.9 21.8 8.55 3.43 0.51 7.90 2.1 8.4 -
190.81 6.07 3.91E+06 6.30E+05 16.0 15.0 20.1 7.33 4.34 0.54 8.09 2.5 8.0 -
216.18 5.93 4.01E+06 4.60E+05 4.0 13.8 19.1 6.55 4.97 0.67 8.12 2.2 8.5 -
MOI 0.10 #3 0.86 6.29 1.25E+06 1.19E+06 95.5 17.9 18.1 31.42 1.47 4.17 8.04 0.0 4.4 0.7
22.43 6.22 2.01E+06 1.93E+06 96.0 18.0 18.2 29.92 1.73 2.94 8.08 0.0 4.5 3.9
50.16 6.25 2.60E+06 2.42E+06 93.3 21.8 22.0 26.09 1.32 1.07 7.68 0.0 7.4 -
72.47 6.28 2.72E+06 2.41E+06 88.8 22.2 22.2 24.70 0.63 0.78 8.00 0.4 8.4 -
94.87 6.23 2.69E+06 1.82E+06 67.6 21.4 22.3 22.31 0.74 0.51 8.67 1.3 8.5 95.4
118.45 6.13 2.77E+06 1.00E+06 36.2 20.2 23.5 20.09 1.15 0.41 8.69 2.5 8.7 -
140.93 6.03 2.89E+06 5.80E+05 20.0 17.8 21.8 18.59 1.92 0.54 8.81 3.1 8.0 -
167.79 5.98 2.86E+06 3.10E+05 11.0 15.7 18.7 18.04 2.42 0.55 9.13 3.9 8.5 -
MOI 1.00 #3 0.86 6.42 1.26E+06 1.19E+06 94.6 17.9 18.1 31.14 1.35 4.31 7.95 0.0 4.7 6.7
22.53 6.32 1.28E+06 1.19E+06 93.3 19.7 19.9 29.97 1.84 3.11 8.16 0.0 5.7 33.0
50.16 6.36 1.21E+06 1.04E+06 86.1 22.8 23.0 28.03 1.63 1.79 8.72 0.2 7.8 -
72.60 6.33 1.48E+06 1.19E+06 80.4 23.0 23.4 27.42 1.27 1.02 8.94 1.5 8.2 -
94.98 6.15 1.40E+05 7.20E+05 51.0 21.0 22.8 26.75 1.69 1.01 9.16 2.6 8.4 95.2
118.55 5.95 1.65E+06 4.30E+05 26.0 19.8 24.2 25.98 2.69 0.88 9.08 3.0 7.7 -
141.01 5.89 1.60E+06 2.50E+05 15.4 18.4 22.0 25.64 3.42 0.90 9.15 3.6 8.3 -
168.03 5.86 1.79E+06 1.60E+05 8.7 16.7 18.0 25.81 3.77 0.83 9.35 4.6 7.8 -
Uninfected 0.52 6.34 1.16E+06 1.10E+06 95.3 17.9 18.1 30.58 1.48 3.07 7.83 - - -
Control 12.58 6.06 1.43E+06 1.36E+06 95.4 18.0 18.1 32.25 1.80 2.64 7.87 - - -
37.55 6.19 2.83E+06 2.71E+06 95.7 17.4 17.6 28.86 1.84 1.22 8.25 - - -
60.28 6.33 3.60E+06 3.43E+06 95.5 17.8 18.0 26.20 0.98 0.48 8.02 - - -
83.92 6.31 4.55E+06 4.22E+06 92.6 17.8 18.0 23.26 0.56 0.46 7.34 - - -
107.76 6.28 5.16E+06 4.11E+06 79.6 17.6 17.9 17.76 0.54 0.43 6.99 - - -
131.76 6.25 5.94E+06 4.61E+06 77.7 18.0 18.3 12.77 0.36 0.66 6.47 - - -
156.84 6.22 5.71E+06 4.07E+06 71.2 17.9 18.3 7.44 0.30 1.13 5.66 - - -
179.55 6.21 5.50E+06 3.22E+06 58.5 17.8 18.4 3.33 0.48 0.78 5.16 - - -
205.01 6.27 5.34E+06 2.62E+06 49.0 17.5 17.5 0.08 0.82 0.58 4.39 - - -
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Table D.3. Raw data infection at low MOI – dielectric spectroscopy (1 of 2). 
 
 
Process ID
Time Post 
Planting
in h
Biomass 
(1000 kHz)
in pF cm-1
Suspension 
Conductivity
in mS cm-1
Δε
in pF cm-1
fc
in kHz
alpha
in -
C(300kHz)
in pF
C(373kHz)
in pF
C(465kHz)
in pF
C(578kHz)
in pF
C(720kHz)
in pF
C(897kHz)
in pF
C(1117kHz)
in pF
C(1391kHz)
in pF
C(1732kHz)
in pF
C(2156kHz)
in pF
C(2684kHz)
in pF
C(3342kHz)
in pF
C(4161kHz)
in pF
C(5181kHz)
in pF
C(6451kHz)
in pF
C(8031kHz)
in pF
C(10000kHz)
in pF
MOI 0.10 #1 0.90 2.05 15.54 8.11 603 0.095 6.59 5.91 5.23 4.48 3.75 3.08 2.49 1.98 1.54 1.13 0.96 0.76 0.64 0.56 0.46 0.40 0.34
21.50 4.14 15.32 16.72 602 0.091 14.07 12.33 10.73 9.03 7.44 6.03 4.76 3.65 2.76 2.00 1.56 1.18 0.89 0.75 0.54 0.41 0.32
43.12 8.14 15.28 42.68 500 0.083 33.66 28.91 24.25 19.84 15.91 12.47 9.58 7.23 5.66 4.11 2.96 2.16 1.61 1.50 0.90 0.70 0.54
69.59 10.07 15.23 49.70 501 0.111 37.70 32.66 27.75 23.05 18.74 14.95 11.75 9.07 6.93 5.13 3.99 3.02 2.31 1.79 1.36 1.04 0.80
92.56 9.45 15.26 37.05 609 0.098 29.98 26.71 23.51 20.03 16.65 13.55 10.77 8.42 6.49 4.83 3.81 2.94 2.28 1.79 1.41 1.13 0.89
112.80 5.61 15.41 22.67 581 0.110 16.91 15.25 13.52 11.60 9.71 7.94 6.38 5.04 3.92 2.91 2.40 1.86 1.47 1.24 0.93 0.72 0.55
140.61 2.80 15.50 6.26 1034 0.118 6.18 5.85 5.51 5.04 4.51 3.98 3.47 2.99 2.57 2.01 1.87 1.59 1.36 1.17 0.97 0.81 0.66
164.05 1.58 15.57 2.67 1540 0.108 2.95 2.86 2.84 2.69 2.49 2.28 2.10 1.90 1.69 1.32 1.34 1.18 1.03 0.92 0.76 0.64 0.51
MOI 0.01 #1 1.00 1.63 15.68 7.91 528 0.089 6.15 5.44 4.73 4.02 3.35 2.70 2.17 1.73 1.38 0.97 0.85 0.68 0.61 0.60 0.50 0.46 0.44
21.57 3.59 15.45 14.48 606 0.085 12.75 11.17 9.67 8.17 6.71 5.31 4.32 3.37 2.69 1.84 1.49 1.13 0.93 0.84 0.64 0.55 0.49
43.09 7.03 15.42 29.14 593 0.083 26.11 22.62 19.29 16.06 13.13 10.49 8.20 6.31 4.83 3.41 2.66 1.96 1.51 1.24 0.95 0.76 0.63
69.56 10.59 15.37 56.50 485 0.098 44.48 38.00 31.86 26.03 20.94 16.47 12.72 9.78 7.43 5.39 4.17 3.13 2.41 1.92 1.47 1.17 0.95
92.53 11.89 15.38 50.35 572 0.101 41.84 36.65 31.59 26.54 21.79 17.55 13.90 10.83 8.32 6.19 4.86 3.73 2.90 2.30 1.81 1.46 1.18
113.06 10.17 15.47 40.96 593 0.101 33.49 29.66 25.70 21.86 18.12 14.68 11.63 9.10 7.03 5.17 4.07 3.09 2.41 1.97 1.48 1.15 0.93
140.75 4.82 15.58 15.72 699 0.114 14.55 13.09 11.59 10.07 8.63 7.25 5.99 4.94 4.11 3.06 2.66 2.18 1.84 1.58 1.34 1.17 1.02
164.16 3.07 15.65 8.28 838 0.112 9.75 8.58 7.57 6.59 5.71 4.88 4.14 3.54 3.00 2.26 2.09 1.76 1.54 1.37 1.18 1.04 0.92
186.04 1.66 15.73 3.95 954 0.104 5.80 5.07 4.50 3.97 3.50 3.06 2.69 2.39 2.11 1.60 1.59 1.43 1.29 1.18 1.08 1.01 0.91
209.34 1.02 15.81 3.54 978 0.104 4.00 3.51 3.11 2.75 2.47 2.22 2.03 1.90 1.77 1.30 1.38 1.28 1.20 1.11 1.05 1.00 0.92
MOI 1.00 #1 0.76 2.30 15.56 9.17 604 0.097 12.67 9.92 7.83 6.13 4.79 3.71 2.80 2.09 1.51 1.00 0.74 0.50 0.31 0.21 0.10 0.04 0.00
21.27 4.34 15.27 19.86 549 0.090 23.08 18.48 14.78 11.71 9.19 7.07 5.37 4.01 2.95 2.04 1.52 1.07 0.74 0.52 0.36 0.26 0.19
42.66 6.32 15.20 37.41 447 0.101 33.65 27.21 21.89 17.31 13.49 10.38 7.86 5.90 4.35 3.10 2.33 1.71 1.21 0.89 0.62 0.44 0.31
67.00 7.83 15.17 33.14 569 0.105 33.23 27.68 22.90 18.66 15.01 11.92 9.25 7.09 5.33 3.85 2.93 2.18 1.59 1.17 0.85 0.62 0.45
89.78 6.86 15.22 27.58 595 0.103 27.57 23.07 19.23 15.83 12.77 10.14 7.91 6.09 4.56 3.26 2.49 1.82 1.31 0.98 0.65 0.44 0.29
117.54 4.21 15.31 17.20 619 0.127 21.89 17.13 13.47 10.52 8.16 6.20 4.63 3.32 2.28 1.33 0.92 0.37 -0.05 -0.35 -0.57 -0.79 -0.87
138.38 2.88 15.36 10.58 706 0.131 18.10 13.68 10.47 8.01 6.07 4.57 3.41 2.48 1.72 0.97 0.74 0.30 -0.02 -0.31 -0.45 -0.64 -0.71
162.69 1.80 15.43 6.05 834 0.120 15.06 10.92 8.00 5.84 4.26 3.06 2.18 1.51 0.95 0.38 0.29 -0.05 -0.30 -0.50 -0.63 -0.80 -0.84
MOI 0.10 #2 0.95 1.24 15.69 12.64 349 0.074 4.40 4.17 3.48 2.81 2.19 1.62 1.16 0.76 0.38 0.09 0.02 -0.09 -0.16 -0.16 -0.19 -0.19 -0.17
21.42 2.85 15.42 14.37 525 0.081 9.17 8.41 7.26 6.04 4.92 3.90 2.97 2.20 1.58 0.91 0.64 0.38 0.21 0.11 0.03 -0.01 -0.02
42.92 5.97 15.37 29.00 534 0.077 21.92 19.32 16.37 13.54 10.89 8.56 6.54 4.88 3.60 2.36 1.71 1.16 0.77 0.50 0.33 0.23 0.15
67.29 8.29 15.33 45.45 481 0.090 32.47 28.22 23.85 19.58 15.67 12.25 9.44 7.13 5.29 3.74 2.82 2.04 1.47 1.05 0.75 0.54 0.38
90.02 8.56 15.34 36.43 578 0.091 26.88 24.37 21.18 17.95 14.83 11.93 9.33 7.14 5.38 3.75 2.86 2.06 1.50 1.08 0.77 0.55 0.40
117.70 4.03 15.47 18.76 536 0.096 12.16 11.26 9.92 8.48 7.06 5.71 4.55 3.53 2.71 1.86 1.55 1.18 0.91 0.71 0.56 0.45 0.35
138.54 1.80 15.55 7.24 584 0.108 4.18 4.30 3.94 3.51 3.02 2.58 2.17 1.81 1.51 1.00 0.97 0.82 0.69 0.56 0.50 0.44 0.37
163.65 0.41 15.64 - - - 0.06 0.62 0.69 0.66 0.61 0.56 0.52 0.48 0.42 0.16 0.33 0.29 0.27 0.28 0.22 0.20 0.17
MOI 1.00 #2 0.75 2.75 15.55 10.45 626 0.101 10.87 9.08 7.50 6.19 4.98 3.93 3.06 2.32 1.73 1.19 0.89 0.61 0.39 0.24 0.13 0.07 0.01
22.97 5.15 15.32 21.24 589 0.099 20.79 17.42 14.43 11.84 9.47 7.49 5.80 4.35 3.21 2.22 1.64 1.12 0.72 0.48 0.26 0.12 0.02
46.66 7.97 15.24 49.02 428 0.107 37.51 31.15 25.37 20.32 15.98 12.32 9.38 7.01 5.19 3.67 2.73 1.94 1.34 0.94 0.58 0.35 0.18
71.91 9.60 15.18 43.64 524 0.121 37.29 31.59 26.42 21.78 17.62 14.02 10.99 8.46 6.44 4.70 3.61 2.65 1.92 1.38 0.98 0.69 0.46
96.24 8.67 15.29 36.34 559 0.126 30.85 26.53 22.50 18.79 15.41 12.40 9.82 7.67 5.89 4.32 3.37 2.51 1.84 1.35 0.97 0.69 0.46
117.27 7.21 15.36 27.00 609 0.136 24.38 20.98 17.90 15.10 12.48 10.18 8.18 6.48 5.06 3.76 3.03 2.29 1.71 1.26 0.92 0.67 0.44
147.09 4.44 15.46 12.74 788 0.138 15.23 12.85 10.85 9.15 7.63 6.31 5.18 4.24 3.42 2.56 2.17 1.69 1.31 1.00 0.74 0.54 0.36
170.39 2.78 15.52 6.05 1078 0.121 10.27 8.37 6.92 5.79 4.82 4.05 3.35 2.80 2.32 1.72 1.55 1.24 0.96 0.75 0.55 0.41 0.26
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Table D.4. Raw data infection at low MOI – dielectric spectroscopy (2 of 2). 
 
 
MOI 0.01 #2 0.87 1.35 15.81 5.11 616 0.095 2.43 2.63 2.48 2.26 2.01 1.67 1.37 1.09 0.74 0.54 0.45 0.33 0.26 0.19 0.14 0.13 0.11
23.11 3.11 15.43 10.15 713 0.093 6.54 6.52 6.00 5.34 4.66 3.90 3.16 2.48 1.85 1.29 1.00 0.68 0.49 0.37 0.23 0.16 0.11
46.81 7.12 15.39 26.36 643 0.095 20.28 18.52 16.33 14.10 11.77 9.55 7.61 5.92 4.46 3.18 2.40 1.69 1.22 0.89 0.59 0.42 0.30
72.05 9.73 15.32 39.71 589 0.102 31.08 27.75 24.09 20.49 16.95 13.67 10.85 8.46 6.33 4.70 3.59 2.65 1.99 1.46 1.09 0.83 0.62
96.40 11.56 15.32 39.86 673 0.109 30.52 28.14 25.19 21.94 18.65 15.40 12.46 9.84 7.57 5.62 4.35 3.22 2.40 1.78 1.30 0.97 0.71
117.39 10.44 15.36 32.98 733 0.099 24.33 23.09 21.24 18.85 16.28 13.63 11.07 8.84 6.78 5.05 3.94 2.94 2.23 1.67 1.23 0.91 0.67
147.19 5.60 15.53 14.75 867 0.104 10.74 10.59 10.08 9.26 8.23 7.09 5.94 4.91 3.87 2.88 2.39 1.84 1.45 1.12 0.84 0.66 0.50
170.49 3.98 15.60 9.31 982 0.109 6.49 6.72 6.56 6.19 5.64 4.98 4.30 3.64 2.92 2.23 1.94 1.53 1.24 0.99 0.77 0.61 0.48
190.47 2.69 15.68 5.67 1106 0.104 4.02 4.27 4.26 4.14 3.84 3.43 3.03 2.66 2.18 1.64 1.52 1.24 1.04 0.85 0.70 0.59 0.49
214.54 1.62 15.74 3.21 1168 0.097 2.80 2.72 2.69 2.62 2.45 2.17 1.96 1.72 1.39 1.00 1.01 0.84 0.73 0.62 0.52 0.46 0.39
MOI 0.01 #3 0.67 0.99 15.34 5.52 500 0.088 2.74 2.64 2.44 2.09 1.75 1.40 1.08 0.82 0.58 0.31 0.25 0.17 0.12 0.08 0.09 0.08 0.08
21.51 3.13 15.36 11.49 662 0.085 8.76 8.07 7.19 6.22 5.22 4.28 3.39 2.63 1.98 1.31 1.01 0.71 0.50 0.35 0.28 0.22 0.16
45.43 7.44 15.29 24.14 725 0.067 25.05 21.53 18.60 15.62 12.87 10.33 8.10 6.19 4.63 3.22 2.38 1.54 1.15 0.74 0.56 0.34 0.35
69.50 10.01 15.26 39.17 620 0.088 35.48 30.64 26.31 22.03 17.97 14.34 11.19 8.61 6.50 4.61 3.45 2.48 1.79 1.29 0.93 0.66 0.47
93.16 12.17 15.26 40.95 700 0.090 36.76 32.54 28.62 24.59 20.53 16.71 13.31 10.34 7.91 5.72 4.35 3.16 2.31 1.68 1.21 0.86 0.61
117.66 8.98 15.34 26.60 785 0.083 24.49 21.95 19.74 17.23 14.68 12.15 9.76 7.70 5.96 4.32 3.36 2.49 1.86 1.37 1.03 0.76 0.57
138.36 6.18 15.40 17.37 814 0.086 16.09 14.42 13.12 11.52 9.82 8.21 6.67 5.32 4.14 2.94 2.36 1.77 1.33 0.99 0.76 0.57 0.43
165.28 3.50 15.51 8.91 913 0.092 8.34 7.54 7.02 6.28 5.53 4.68 3.89 3.17 2.57 1.78 1.52 1.17 0.92 0.72 0.57 0.43 0.33
190.81 1.70 15.61 3.63 1111 0.094 3.64 3.22 3.13 2.93 2.65 2.30 1.97 1.69 1.46 0.89 0.90 0.72 0.60 0.49 0.42 0.34 0.28
216.18 0.57 15.71 1.11 1271 0.097 1.13 0.88 0.99 1.02 0.95 0.89 0.79 0.72 0.60 0.28 0.41 0.36 0.32 0.28 0.26 0.23 0.20
MOI 0.10 #3 0.86 1.72 15.78 8.65 532 0.086 9.01 7.05 5.54 4.19 3.12 2.26 1.57 0.95 0.48 0.03 -0.11 -0.32 -0.45 -0.50 -0.56 -0.57 -0.56
22.43 4.09 15.30 17.60 580 0.086 17.75 14.59 11.80 9.38 7.35 5.62 4.15 2.97 1.96 1.11 0.68 0.22 -0.08 -0.27 -0.41 -0.46 -0.50
50.16 8.96 15.23 45.04 521 0.082 40.05 33.41 27.38 22.06 17.24 13.22 9.92 7.26 5.11 3.36 2.33 1.40 0.76 0.33 0.02 -0.16 -0.29
72.47 9.30 15.23 44.55 524 0.101 38.65 32.43 26.84 21.74 17.21 13.46 10.22 7.66 5.50 3.75 2.67 1.70 1.00 0.50 0.17 -0.04 -0.20
94.87 9.29 15.24 37.92 591 0.098 33.83 28.85 24.30 20.01 16.15 12.68 9.79 7.37 5.31 3.57 2.57 1.61 0.93 0.44 0.11 -0.12 -0.28
118.45 6.13 15.33 23.98 617 0.092 22.04 18.77 15.78 12.98 10.46 8.21 6.28 4.69 3.31 2.10 1.53 0.86 0.40 0.09 -0.13 -0.27 -0.35
140.93 3.22 15.46 10.97 685 0.100 11.70 9.74 8.17 6.78 5.45 4.29 3.33 2.60 1.87 1.12 0.94 0.56 0.30 0.10 -0.01 -0.08 -0.15
167.79 1.67 15.54 5.18 719 0.104 6.34 5.17 4.25 3.39 2.77 2.13 1.67 1.31 0.94 0.48 0.49 0.28 0.13 0.04 -0.07 -0.11 -0.16
MOI 1.00 #3 0.86 1.42 15.86 4.62 731 0.096 4.00 3.49 3.13 2.72 2.24 1.83 1.42 1.09 0.87 0.48 0.38 0.24 0.14 0.07 0.01 -0.03 -0.04
22.53 2.95 15.40 11.66 615 0.091 10.01 8.68 7.56 6.35 5.19 4.14 3.25 2.48 1.88 1.25 0.97 0.68 0.48 0.35 0.23 0.16 0.11
50.16 4.77 15.37 24.13 500 0.103 18.74 16.05 13.61 11.19 8.97 7.07 5.50 4.21 3.20 2.23 1.73 1.27 0.93 0.68 0.48 0.33 0.23
72.60 5.75 15.34 21.88 629 0.103 17.04 15.33 13.58 11.69 9.72 7.91 6.27 4.88 3.89 2.66 2.09 1.53 1.13 0.83 0.59 0.40 0.28
94.98 4.79 15.41 15.91 701 0.101 12.12 11.17 10.30 9.07 7.70 6.41 5.14 4.11 3.27 2.30 1.87 1.43 1.08 0.83 0.62 0.45 0.34
118.55 2.94 15.48 7.15 950 0.101 5.39 5.24 5.13 4.81 4.29 3.72 3.13 2.61 2.17 1.52 1.34 1.06 0.83 0.65 0.49 0.37 0.29
141.01 1.60 15.54 2.73 1572 0.099 1.13 1.48 1.88 2.05 2.02 1.94 1.79 1.63 1.47 1.03 1.02 0.86 0.72 0.59 0.48 0.40 0.32
168.03 0.67 15.57 1.00 5367 0.097 -1.47 -0.93 -0.29 0.15 0.43 0.64 0.76 0.82 0.85 0.55 0.67 0.59 0.51 0.44 0.34 0.28 0.23
Uninfected 0.52 1.99 15.14 7.09 654 0.101 5.92 5.32 4.63 3.92 3.28 2.67 2.15 1.68 1.26 0.85 0.70 0.50 0.35 0.25 0.18 0.12 0.06
Control 12.58 3.08 15.44 10.25 700 0.101 9.43 8.36 7.29 6.28 5.24 4.31 3.49 2.79 2.15 1.55 1.25 0.93 0.72 0.52 0.43 0.35 0.26
37.55 5.88 15.35 19.39 703 0.105 17.77 15.66 13.64 11.66 9.74 7.99 6.41 5.03 3.87 2.77 2.14 1.55 1.11 0.78 0.57 0.40 0.26
60.28 7.91 15.27 26.33 695 0.105 24.17 21.25 18.53 15.78 13.21 10.79 8.69 6.83 5.23 3.79 2.93 2.13 1.56 1.11 0.82 0.60 0.41
83.92 10.41 15.24 29.84 801 0.103 28.03 25.20 22.23 19.37 16.58 13.83 11.31 8.99 7.01 5.16 4.00 2.92 2.17 1.55 1.17 0.87 0.62
107.76 12.96 15.21 37.71 792 0.102 35.00 31.45 27.89 24.20 20.69 17.23 14.06 11.23 8.68 6.39 4.90 3.57 2.64 1.89 1.41 1.05 0.75
131.76 14.25 15.17 39.76 830 0.092 38.86 34.68 30.63 26.67 22.74 18.90 15.43 12.22 9.35 6.85 5.20 3.77 2.71 1.91 1.37 0.97 0.65
156.84 15.09 15.07 41.95 830 0.084 39.99 36.09 32.06 28.19 24.02 20.04 16.32 12.93 9.95 7.30 5.56 4.06 2.96 2.11 1.61 1.22 0.88
179.55 16.03 15.02 44.32 831 0.082 42.27 38.23 34.03 29.81 25.46 21.30 17.30 13.73 10.54 7.76 5.88 4.29 3.18 2.28 1.74 1.35 1.00
205.01 16.61 15.15 45.71 830 0.081 44.02 39.52 34.91 30.46 25.98 21.52 17.29 13.60 10.38 7.47 5.53 3.92 2.71 1.86 1.25 0.83 0.51
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Appendix E - Infection at Low MOI – Complete Plots 
 
Figure E.1. Viable cell density post infection. 
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Figure E.2. Viability post infection. 
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Figure E.3. Mean viable cell diameter post infection. 
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Figure E.4. Viable biovolume post infection. 
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Figure E.5. pH post infection. 
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Figure E.6. D-glucose post infection. 
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Figure E.7. L-glutamine post infection. 
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Figure E.8. L-lactate post infection. 
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Figure E.9. L-glutamate post infection. 
 
0.0
2.0
4.0
6.0
8.0
10.0
12.0
0 24 48 72 96 120 144 168 192 216 240
L-
gl
u
ta
m
at
e
 in
 m
m
o
l L
-1
Time Post Infection in h
MOI 0.10 #1
MOI 0.01 #1
MOI 1.00 #1
MOI 0.10 #2
MOI 1.00 #2
MOI 0.01 #2
MOI 0.01 #3
MOI 0.10 #3
MOI 1.00 #3
Uninfected Control
190 
 
 
Figure E.10. Fraction of infected cells post infection. 
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Figure E.11. Recombinant PCV2 ORF2 baculovirus concentration post infection. 
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Figure E.12. Recombinant PCV2 ORF2 protein concentration post infection. 
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Figure E.13. Δε post infection. 
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Figure E.14. fc post infection. 
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Figure E.15. Cole-Cole α post infection. 
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Figure E.16. Biomass signal post infection. 
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Appendix F - Infection at Low MOI - Tests for Statistical 
Significance 
Table F.1. t-test for parameter RP. 
 
MOI 0.01 MOI 0.10
Mean 3.231111111 4.043333333
Variance 1.148692593 0.086877778
Observations 3 3
Hypothesized Mean Difference 0
df 2
t Stat -1.265615405
P(T<=t) one-tail 0.166563587
t Critical one-tail 2.91998558
P(T<=t) two-tail 0.333127175
t Critical two-tail 4.30265273
MOI 0.01 MOI 1.00
Mean 3.231111111 4.613333333
Variance 1.148692593 0.0223
Observations 3 3
Hypothesized Mean Difference 0
df 2
t Stat -2.212388663
P(T<=t) one-tail 0.078716075
t Critical one-tail 2.91998558
P(T<=t) two-tail 0.15743215
t Critical two-tail 4.30265273
MOI 0.10 MOI 1.00
Mean 4.043333333 4.613333333
Variance 0.086877778 0.0223
Observations 3 3
Hypothesized Mean Difference 0
df 3
t Stat -2.987915821
P(T<=t) one-tail 0.029113726
t Critical one-tail 2.353363435
P(T<=t) two-tail 0.058227452
t Critical two-tail 3.182446305
t-Test: Two-Sample Assuming Unequal Variances
Parameter RP
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Table F.2. t-test for parameter specific RP per viable biovolume. 
 
 
 
MOI 0.01 MOI 0.10
Mean 1.98612E-10 2.94889E-10
Variance 3.62971E-21 1.1007E-21
Observations 3 3
Hypothesized Mean Difference 0
df 3
t Stat -2.42457056
P(T<=t) one-tail 0.046892181
t Critical one-tail 2.353363435
P(T<=t) two-tail 0.093784362
t Critical two-tail 3.182446305
MOI 0.01 MOI 1.00
Mean 1.98612E-10 5.08038E-10
Variance 3.62971E-21 5.58198E-21
Observations 3 3
Hypothesized Mean Difference 0
df 4
t Stat -5.584028734
P(T<=t) one-tail 0.002522013
t Critical one-tail 2.131846782
P(T<=t) two-tail 0.005044026
t Critical two-tail 2.776445105
MOI 0.10 MOI 1.00
Mean 2.94889E-10 5.08038E-10
Variance 1.1007E-21 5.58198E-21
Observations 3 3
Hypothesized Mean Difference 0
df 3
t Stat -4.516144385
P(T<=t) one-tail 0.010147025
t Critical one-tail 2.353363435
P(T<=t) two-tail 0.02029405
t Critical two-tail 3.182446305
t-Test: Two-Sample Assuming Unequal Variances
Parameter Specific RP per Viable Biovolume
199 
 
Table F.3. t-test for parameter specific RP per viable cell. 
 
 
 
 
MOI 0.01 MOI 0.10
Mean 9.85552E-07 1.75397E-06
Variance 1.78635E-13 5.37397E-14
Observations 3 3
Hypothesized Mean Difference 0
df 3
t Stat -2.760975259
P(T<=t) one-tail 0.035047556
t Critical one-tail 2.353363435
P(T<=t) two-tail 0.070095113
t Critical two-tail 3.182446305
MOI 0.01 MOI 1.00
Mean 9.85552E-07 3.37314E-06
Variance 1.78635E-13 3.56482E-13
Observations 3 3
Hypothesized Mean Difference 0
df 4
t Stat -5.653222493
P(T<=t) one-tail 0.002411952
t Critical one-tail 2.131846782
P(T<=t) two-tail 0.004823903
t Critical two-tail 2.776445105
MOI 0.10 MOI 1.00
Mean 1.75397E-06 3.37314E-06
Variance 5.37397E-14 3.56482E-13
Observations 3 3
Hypothesized Mean Difference 0
df 3
t Stat -4.378697451
P(T<=t) one-tail 0.011023742
t Critical one-tail 2.353363435
P(T<=t) two-tail 0.022047484
t Critical two-tail 3.182446305
t-Test: Two-Sample Assuming Unequal Variances
Parameter Specific RP per Viable Cell
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Appendix G - Infection at Low MOI – PLS Model Details 
PLS for Variable P 
 
Number of Latent Factors 
 
1 to max=10 
6 
 
X-Y Scores Plots 
 
 
Percent Variation Explained 
 
Number X X Cumulative X Y Y Cumulative Y 
1 97.16  97.16 84.28  84.28 
2 1.631  98.79 4.082  88.36 
3 0.965  99.76 2.713  91.08 
4 0.088  99.85 3.685  94.76 
5 0.1  99.94 0.894  95.66 
6 0.047  99.99 0.421  96.08 
7 0.003  100 0.79  96.87 
8 0.002  100 0.533  97.4 
9 3e-4  100 0.615  98.02 
10 0.001  100 0.224  98.24 
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Cross Validation 
 
Number Prediction 
RMSE 
1 0.412 
2 0.37 
3 0.345 
4 0.271 
5 0.255 
6 0.252 
7 0.348 
8 0.464 
9 0.635 
10 0.664 
Press Residuals 
P 
0.0001964 
-0.000931 
0.0020402 
0.001109 
-0.000416 
-0.000339 
-0.000478 
0.0020219 
-0.002192 
0.0009853 
-0.00031 
0.0006626 
-0.001119 
-0.000871 
-0.00095 
-0.001185 
0.000149 
0.000376 
-0.001727 
-0.000557 
-0.000519 
0.0007641 
0.0015208 
0.0014021 
0.0013628 
-0.001755 
0.001161 
-0.000158 
-1.57e-6 
0.0017469 
-0.000301 
-9.319e-5 
-0.000659 
-0.001111 
0.0015752 
 
202 
 
Model Coefficients for Centered and Scaled Data 
 
Coefficient P P 
Intercept 0  
C (300 kHz) -1.7479  
C (373 kHz) -0.345821  
C (465 kHz) 0.6265049  
C (578 kHz) 1.0187633  
C (720 kHz) 1.2186472  
C (897 kHz) 0.9978556  
C (1117 kHz) 0.6347587  
C (1391 kHz) 0.6952059  
C (1732 kHz) 0.3973477  
C (2156 kHz) -0.301553  
C (2684 kHz) -0.927319  
C (3342 kHz) -1.551418  
C (4161 kHz) -0.402807  
C (5181 kHz) -0.003541  
C (6451 kHz) 0.5536649  
C (8031 kHz) 0.0085567  
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PLS for Variable Viable Cell Density 
 
Number of Latent Factors 
 
1 to max=12 
4 
 
X-Y Scores Plots 
 
 
Percent Variation Explained 
 
Number X X Cumulative X Y Y Cumulative Y 
1 97.16  97.16 38.86  38.86 
2 0.556  97.71 36.84  75.7 
3 2.01  99.72 1  76.7 
4 0.142  99.87 5.52  82.22 
5 0.088  99.95 1.667  83.89 
6 0.038  99.99 0.737  84.63 
7 0.002  99.99 3.324  87.95 
8 0.003  100 0.984  88.94 
9 0.001  100 0.953  89.89 
10 5e-4  100 0.818  90.71 
11 4e-4  100 0.336  91.04 
12 0.001  100 0.054  91.1 
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Cross Validation 
 
Number Prediction 
RMSE 
1 0.809 
2 0.628 
3 0.548 
4 0.505 
5 0.525 
6 0.674 
7 0.785 
8 0.817 
9 1.255 
10 1.374 
11 1.314 
12 1.279 
 
Press Residuals 
 
Viable cell 
density 
99491.596 
33806.557 
-633685.1 
-12989.71 
-222019.5 
-19971.41 
503511.04 
685422.31 
-280186.1 
129698.04 
-22415.98 
122390.75 
-497055.4 
-450337.6 
-170970.2 
-265688.4 
-231076.7 
68094.863 
-358198.3 
48731.204 
-262400.6 
-154775.1 
362327.59 
687165.66 
621186.46 
-963300.2 
400155.57 
306267.16 
-375701.9 
925156.16 
-202407.2 
-296228.3 
71894.711 
-97732.39 
-124090.2 
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Model Coefficients for Centered and Scaled Data 
 
Coefficient Viable cell 
density 
Viable cell density 
Intercept 0  
C (300 kHz) -1.666674  
C (373 kHz) -0.787904  
C (465 kHz) -0.061355  
C (578 kHz) 0.4400162  
C (720 kHz) 0.773084  
C (897 kHz) 0.8551709  
C (1117 kHz) 0.8556998  
C (1391 kHz) 0.9254709  
C (1732 kHz) 1.0222318  
C (2156 kHz) 0.3857822  
C (2684 kHz) -0.126361  
C (3342 kHz) -0.955815  
C (4161 kHz) -0.603821  
C (5181 kHz) 0.9613898  
C (6451 kHz) -0.61458  
C (8031 kHz) -0.89811  
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PLS for Variable Mean Cell Diameter 
 
Number of Latent Factors 
 
1 to max=10 
3 
 
X-Y Scores Plots 
 
 
Percent Variation Explained 
 
Number X X Cumulative X Y Y Cumulative Y 
1 97.16  97.16 72.81  72.81 
2 1.807  98.97 9.253  82.06 
3 0.801  99.77 5.31  87.37 
4 0.107  99.87 0.762  88.13 
5 0.088  99.96 0.353  88.48 
6 0.015  99.98 1.84  90.32 
7 0.019  100 0.982  91.31 
8 0.002  100 1.685  92.99 
9 0.001  100 0.529  93.52 
10 3e-4  100 0.76  94.28 
 
Cross Validation 
 
Number Prediction 
RMSE 
1 0.541 
2 0.466 
3 0.391 
4 0.486 
5 0.594 
6 0.588 
7 0.524 
8 0.625 
9 0.898 
10 0.986 
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Press Residuals 
Average cell 
diameter 
-0.070888 
-0.740546 
0.0916772 
0.8672353 
0.1718468 
-0.197373 
-0.855563 
-1.31983 
-0.444092 
-0.738003 
-0.009591 
1.0598301 
1.9181619 
0.6912232 
0.3740192 
1.1706226 
1.6345426 
-0.736536 
-0.491167 
-0.246605 
0.4185478 
0.6090689 
0.1574571 
-0.36931 
-0.616984 
0.9093612 
0.1308802 
-0.099146 
0.6971393 
-1.224755 
-0.268862 
-0.27814 
-1.277148 
-0.723341 
0.266387 
 
Model Coefficients for Centered and Scaled Data 
 
Coefficient Average cell 
diameter 
Average cell diameter 
Intercept 0  
C (300 kHz) 0.6804086  
C (373 kHz) 0.5232333  
C (465 kHz) 0.3383111  
C (578 kHz) 0.1672908  
C (720 kHz) 0.0217488  
C (897 kHz) -0.093554  
C (1117 kHz) -0.193314  
C (1391 kHz) -0.268585  
C (1732 kHz) -0.297474  
C (2156 kHz) -0.262377  
C (2684 kHz) -0.265311  
C (3342 kHz) -0.063878  
C (4161 kHz) -0.089672  
C (5181 kHz) 0.0582055  
C (6451 kHz) 0.1354934  
C (8031 kHz) 0.5355391  
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PLS for Variable L-glutamine 
 
Number of Latent Factors 
 
1 to max=8 
3 
 
X-Y Scores Plots 
 
 
Percent Variation Explained 
 
Number X X Cumulative X Y Y Cumulative Y 
1 97.16  97.16 85.69  85.69 
2 1.679  98.84 3.26  88.95 
3 0.926  99.77 1.827  90.78 
4 0.126  99.89 0.245  91.02 
5 0.052  99.94 0.291  91.31 
6 0.038  99.98 0.39  91.7 
7 0.014  100 0.597  92.3 
8 0.002  100 0.58  92.88 
 
Cross Validation 
 
Number Prediction 
RMSE 
1 0.394 
2 0.361 
3 0.347 
4 0.409 
5 0.464 
6 0.469 
7 0.428 
8 0.422 
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Press Residuals 
 
Glutamine 
concentration 
0.5406117 
0.3197288 
0.1040153 
0.1340126 
0.41418 
0.3889714 
-0.319224 
0.325476 
0.8475678 
0.8001815 
0.2072992 
-0.265232 
-0.053673 
0.4904067 
0.1749101 
-0.095197 
-0.27612 
0.249237 
-0.169731 
-0.951199 
-0.799602 
-0.380194 
-0.780813 
-1.394838 
-0.703022 
0.8523726 
-0.427587 
-0.500207 
-0.427079 
-0.231552 
0.9464956 
0.2922589 
0.1135739 
0.4549265 
0.2861434 
 
Model Coefficients for Centered and Scaled Data 
Coefficient Glutamine 
concentration 
Glutamine 
concentration 
Intercept 0  
C (300 kHz) 0.1900551  
C (373 kHz) 0.0881619  
C (465 kHz) 0.0115509  
C (578 kHz) -0.066452  
C (720 kHz) -0.130567  
C (897 kHz) -0.179867  
C (1117 kHz) -0.2244  
C (1391 kHz) -0.257632  
C (1732 kHz) -0.245928  
C (2156 kHz) -0.244673  
C (2684 kHz) -0.238004  
C (3342 kHz) -0.133028  
C (4161 kHz) -0.138653  
C (5181 kHz) 0.2006627  
C (6451 kHz) 0.1118749  
C (8031 kHz) 0.3615769  
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Appendix H - Infection at Low MOI – Raw Data PLS Model Validation 
 
Table H.1. Raw data PLS model validation – off-line analyses. 
 
 
Table H.2. Raw data PLS model validation – dielectric spectroscopy. 
 
 
Process ID
Time Post 
Planting
in h pH
Total Cell 
Density
in cells ml-1
Viable Cell 
Density
in cells ml-1
Viability
in %
Mean 
Average Cell 
Diameter
 in µm
D-glucose
in mmol L-1
L-lactate
in mmol L-1
L-glutamine
in mmol L-1
L-glutamate
in mmol L-1
Model 4.12 6.53 1.09E+06 1.02E+06 93.6 17.4 31.52753 1.276643 4.65 7.53
Validation 22.69 6.47 2.04E+06 1.92E+06 94.3 18.2 30.08437 1.054618 2.66 8.15
48.54 6.42 2.04E+06 1.90E+06 93.0 22.5 27.03153 0.943606 0.52 8.99
75.34 6.44 2.20E+06 1.75E+06 79.4 22.5 - - - -
Process ID
Time Post 
Planting
in h
Biomass 
(1000 kHz)
in pF cm-1
Suspension 
Conductivity
in mS cm-1
Δε
in pF cm-1
fc
in kHz
alpha
in -
C(300kHz)
in pF
C(373kHz)
in pF
C(465kHz)
in pF
C(578kHz)
in pF
C(720kHz)
in pF
C(897kHz)
in pF
C(1117kHz)
in pF
C(1391kHz)
in pF
C(1732kHz)
in pF
C(2156kHz)
in pF
C(2684kHz)
in pF
C(3342kHz)
in pF
C(4161kHz)
in pF
C(5181kHz)
in pF
C(6451kHz)
in pF
C(8031kHz)
in pF
C(10000kHz)
in pF
Model 4.12 1.772037 15.3906231 6.91599 613 0.1 6.618226 5.581463 4.66713 3.782806 3.081171 2.426299 1.8574311 1.3789051 0.9847919 0.6892858 0.4732932 0.2895484 0.1469247 0.094945 -0.022048 -0.086472 -0.0928525
Validation 22.69 3.520216 15.3432503 14.6308 585 0.1 13.13961 11.23397 9.474277 7.829559 6.369656 5.052717 3.9275022 2.9870319 2.1929705 1.5756511 1.1776362 0.8144739 0.5455471 0.3693789 0.2290637 0.1335092 0.06996669
48.54 8.369818 15.2468033 47.0937 468 0.1 34.74996 29.72658 24.82864 20.27864 16.15495 12.55817 9.611393 7.2206907 5.3465462 3.8561835 2.8636558 2.0535946 1.4513317 1.0276656 0.7158355 0.4905789 0.32089767
75.34 9.605576 15.2318602 43.99 532 0.11 33.64694 29.32894 25.21212 20.99023 17.1005 13.65582 10.69285 8.1572828 6.1612539 4.4845371 3.4139037 2.481256 1.7880591 1.2813509 0.8961675 0.6105601 0.39529347
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Appendix I - Medium Supplementation for Uninfected Sf-9 Clone Cell Cultures – Raw Data 
Table I.1. Raw data medium supplementation for uninfected Sf-9 clone cell cultures – off-line analyses. 
 
 
Table I.2. Raw data medium supplementation for uninfected Sf-9 clone cell cultures – dielectric spectroscopy. 
 
 
Process ID
Time Post 
Planting
in h pH
Total Cell 
Density
in cells ml-1
Viable Cell 
Density
in cells ml-1
Viability
in %
Mean 
Average Cell 
Diameter
 in µm
D-glucose
in mmol L-1
L-lactate
in mmol L-1
L-glutamine
in mmol L-1
L-glutamate
in mmol L-1
PCF2 ORF2 
Concentration
in RP
Control 4.12 6.53 1.09E+06 1.02E+06 93.6 17.4 31.52753 1.276643 4.65 7.53 -
22.69 6.47 2.04E+06 1.92E+06 94.3 18.2 30.08437 1.054618 2.66 8.15 -
48.54 6.42 2.04E+06 1.90E+06 93.0 22.5 27.03153 0.943606 0.52 8.99 -
75.34 6.44 2.20E+06 1.75E+06 79.4 22.5 - - - - -
95.12 6.52 2.11E+06 9.80E+05 46.4 20.7 24.81128 0.477353 0.6 9.17 -
117.46 6.60 2.29E+06 4.10E+05 17.9 18.8 24.58925 0 0.57 9.38 2.13
145.47 6.52 2.53E+06 1.90E+05 7.5 16.2 21.64742 1.443162 0.71 9.95 3.26
165.11 6.47 3.77E+06 4.60E+05 12.2 12.4 21.48091 1.52087 0.79 10.2 3.36
Feed 4.01 6.43 1.19E+06 1.06E+06 89.2 17.6 31.69405 1.087922 11.1 7.63 -
22.55 6.39 1.99E+06 1.85E+06 93.1 17.8 30.3619 0.821492 8.59 8.23 -
48.43 6.13 2.33E+06 2.12E+06 90.8 22.1 27.58659 0.788188 5.94 9.24 -
75.21 6.04 2.03E+06 1.32E+06 64.9 23.3 - - - - -
95.00 6.02 2.05E+06 1.15E+06 56.1 22.2 22.25799 0.377442 3.09 10.7 -
117.34 6.14 2.73E+06 3.80E+05 13.9 18.5 21.4254 0.643872 3 10.8 4.99
145.35 6.17 3.16E+06 3.00E+05 9.5 14.5 20.03774 0.854796 2.23 11.1 5.78
164.99 6.16 6.65E+06 1.53E+06 23.0 10.7 19.92673 0.932504 3.14 11.6 5.62
Process ID
Time Post 
Planting
in h
Biomass 
(1000 kHz)
in pF cm-1
Suspension 
Conductivity
in mS cm-1
Δε
in pF cm-1
fc
in kHz
alpha
in -
C(300kHz)
in pF
C(373kHz)
in pF
C(465kHz)
in pF
C(578kHz)
in pF
C(720kHz)
in pF
C(897kHz)
in pF
C(1117kHz)
in pF
C(1391kHz)
in pF
C(1732kHz)
in pF
C(2156kHz)
in pF
C(2684kHz)
in pF
C(3342kHz)
in pF
C(4161kHz)
in pF
C(5181kHz)
in pF
C(6451kHz)
in pF
C(8031kHz)
in pF
C(10000kHz)
in pF
Control 4.12 1.772037 15.3906231 6.91599 613 0.1 6.618226 5.581463 4.66713 3.782806 3.081171 2.426299 1.8574311 1.3789051 0.9847919 0.6892858 0.4732932 0.2895484 0.1469247 0.094945 -0.022048 -0.086472 -0.0928525
22.69 3.520216 15.3432503 14.6308 585 0.1 13.13961 11.23397 9.474277 7.829559 6.369656 5.052717 3.9275022 2.9870319 2.1929705 1.5756511 1.1776362 0.8144739 0.5455471 0.3693789 0.2290637 0.1335092 0.06996669
48.54 8.369818 15.2468033 47.0937 468 0.1 34.74996 29.72658 24.82864 20.27864 16.15495 12.55817 9.611393 7.2206907 5.3465462 3.8561835 2.8636558 2.0535946 1.4513317 1.0276656 0.7158355 0.4905789 0.32089767
75.34 9.605576 15.2318602 43.99 532 0.11 33.64694 29.32894 25.21212 20.99023 17.1005 13.65582 10.69285 8.1572828 6.1612539 4.4845371 3.4139037 2.481256 1.7880591 1.2813509 0.8961675 0.6105601 0.39529347
95.12 8.671052 15.2587042 33.058 619 0.1 26.99294 23.97098 20.92532 17.84129 14.81455 12.03302 9.5526619 7.3948669 5.6394968 4.1365895 3.2161226 2.3872724 1.7606514 1.2872435 0.9501884 0.6875886 0.48140889
117.46 4.642787 15.3392248 16.6109 642 0.12 14.33879 12.63733 11.01181 9.386242 7.864574 6.420316 5.1395712 4.0826769 3.1811836 2.3027129 1.9035246 1.4518582 1.0857714 0.8243457 0.5977089 0.4279186 0.29034355
145.47 1.55443 15.4455681 3.50682 1014 0.11 4.628018 3.995035 3.502506 3.058959 2.633806 2.241779 1.8916332 1.6158381 1.3418291 0.9709244 0.9631108 0.7803788 0.6319814 0.4976793 0.4160866 0.3391576 0.26114056
165.11 0.994966 15.4922056 2.05828 1138 0.1 3.207094 2.714792 2.326603 2.010926 1.71436 1.454457 1.2376629 1.0834 0.9082126 0.601979 0.6714909 0.536634 0.4333783 0.3388367 0.2789753 0.220995 0.15521973
Feed 4.01 0.823237 15.4185591 3.27979 646 0.1 2.060111 1.938161 1.749458 1.672286 1.278595 1.171813 0.8385067 0.6300283 0.4582248 0.3109188 0.218081 0.1514564 0.0521164 0.0505116 0.0269404 0.0052156 -0.0029247
22.55 2.153198 15.3785391 9.53545 564 0.09 7.661045 6.693769 5.702089 4.692727 3.841083 3.052455 2.3560515 1.7721763 1.2958384 0.8550239 0.6030426 0.4117906 0.2656438 0.1656144 0.0993774 0.0577872 0.05167937
48.43 6.455876 15.3095207 41.3147 439 0.09 29.87471 25.33142 20.85945 16.78102 13.2068 10.16756 7.6845012 5.7372232 4.2026281 2.9672279 2.1695633 1.567426 1.117018 0.7877698 0.58375 0.4206245 0.32427764
75.21 8.506663 15.2577858 47.2624 461 0.11 32.38194 28.20683 23.84612 19.66783 15.83775 12.50804 9.7180367 7.4398599 5.6119099 4.0267444 3.0463443 2.2554195 1.6474712 1.1939297 0.869417 0.6225355 0.46899962
95.00 9.543404 15.2166681 40.1308 577 0.1 30.83285 27.56336 23.94574 20.3618 16.76596 13.55187 10.676249 8.267273 6.2253094 4.5915389 3.5294318 2.6719401 2.012152 1.4928575 1.139622 0.8695662 0.66611266
117.34 1.999394 15.3496342 5.78911 769 0.11 5.261179 4.942243 4.419866 3.876546 3.357001 2.877297 2.4349818 2.0647516 1.6845837 1.2482677 1.1475291 0.9662521 0.812916 0.667553 0.5711286 0.4771025 0.40966392
145.35 -0.27777 15.4431286 1E-08 500 0.1 -0.61087 -0.46169 -0.42877 -0.37647 -0.25173 -0.14917 -0.025417 0.0840559 0.1374669 0.0248504 0.2093968 0.2536871 0.2596424 0.2492704 0.2580044 0.2400136 0.23058367
164.99 -0.83453 15.5050545 1E-08 500 0.1 -1.85425 -1.60221 -1.50087 -1.36425 -1.1645 -0.92244 -0.692281 -0.471188 -0.306989 -0.377954 -0.114439 -0.015149 0.0396934 0.0736544 0.1029656 0.1165752 0.14023018
